BindingDB Reactant_set_id	Ligand SMILES	Ligand InChI	Ligand InChI Key	BindingDB MonomerID	BindingDB Ligand Name	Target Name	Target Source Organism According to Curator or DataSource	Ki (nM)	IC50 (nM)	Kd (nM)	EC50 (nM)	kon (M-1-s-1)	koff (s-1)	pH	Temp (C)	Curation/DataSource	Article DOI	BindingDB Entry DOI	PMID	PubChem AID	Patent Number	Authors	Date of publication	Date in BindingDB	Institution	Link to Ligand in BindingDB	Link to Target in BindingDB	Link to Ligand-Target Pair in BindingDB	Ligand HET ID in PDB	PDB ID(s) for Ligand-Target Complex	PubChem CID	PubChem SID	ChEBI ID of Ligand	ChEMBL ID of Ligand	DrugBank ID of Ligand	IUPHAR_GRAC ID of Ligand	KEGG ID of Ligand	ZINC ID of Ligand	Number of Protein Chains in Target (>1 implies a multichain complex)	BindingDB Target Chain Sequence 1	PDB ID(s) of Target Chain 1	UniProt (SwissProt) Recommended Name of Target Chain 1	UniProt (SwissProt) Entry Name of Target Chain 1	UniProt (SwissProt) Primary ID of Target Chain 1	UniProt (SwissProt) Secondary ID(s) of Target Chain 1	UniProt (SwissProt) Alternative ID(s) of Target Chain 1	UniProt (TrEMBL) Submitted Name of Target Chain 1	UniProt (TrEMBL) Entry Name of Target Chain 1	UniProt (TrEMBL) Primary ID of Target Chain 1	UniProt (TrEMBL) Secondary ID(s) of Target Chain 1	UniProt (TrEMBL) Alternative ID(s) of Target Chain 1	BindingDB Target Chain Sequence 2	PDB ID(s) of Target Chain 2	UniProt (SwissProt) Recommended Name of Target Chain 2	UniProt (SwissProt) Entry Name of Target Chain 2	UniProt (SwissProt) Primary ID of Target Chain 2	UniProt (SwissProt) Secondary ID(s) of Target Chain 2	UniProt (SwissProt) Alternative ID(s) of Target Chain 2	UniProt (TrEMBL) Submitted Name of Target Chain 2	UniProt (TrEMBL) Entry Name of Target Chain 2	UniProt (TrEMBL) Primary ID of Target Chain 2	UniProt (TrEMBL) Secondary ID(s) of Target Chain 2	UniProt (TrEMBL) Alternative ID(s) of Target Chain 2	BindingDB Target Chain Sequence 3	PDB ID(s) of Target Chain 3	UniProt (SwissProt) Recommended Name of Target Chain 3	UniProt (SwissProt) Entry Name of Target Chain 3	UniProt (SwissProt) Primary ID of Target Chain 3	UniProt (SwissProt) Secondary ID(s) of Target Chain 3	UniProt (SwissProt) Alternative ID(s) of Target Chain 3	UniProt (TrEMBL) Submitted Name of Target Chain 3	UniProt (TrEMBL) Entry Name of Target Chain 3	UniProt (TrEMBL) Primary ID of Target Chain 3	UniProt (TrEMBL) Secondary ID(s) of Target Chain 3	UniProt (TrEMBL) Alternative ID(s) of Target Chain 3	BindingDB Target Chain Sequence 4	PDB ID(s) of Target Chain 4	UniProt (SwissProt) Recommended Name of Target Chain 4	UniProt (SwissProt) Entry Name of Target Chain 4	UniProt (SwissProt) Primary ID of Target Chain 4	UniProt (SwissProt) Secondary ID(s) of Target Chain 4	UniProt (SwissProt) Alternative ID(s) of Target Chain 4	UniProt (TrEMBL) Submitted Name of Target Chain 4	UniProt (TrEMBL) Entry Name of Target Chain 4	UniProt (TrEMBL) Primary ID of Target Chain 4	UniProt (TrEMBL) Secondary ID(s) of Target Chain 4	UniProt (TrEMBL) Alternative ID(s) of Target Chain 4	BindingDB Target Chain Sequence 5	PDB ID(s) of Target Chain 5	UniProt (SwissProt) Recommended Name of Target Chain 5	UniProt (SwissProt) Entry Name of Target Chain 5	UniProt (SwissProt) Primary ID of Target Chain 5	UniProt (SwissProt) Secondary ID(s) of Target Chain 5	UniProt (SwissProt) Alternative ID(s) of Target Chain 5	UniProt (TrEMBL) Submitted Name of Target Chain 5	UniProt (TrEMBL) Entry Name of Target Chain 5	UniProt (TrEMBL) Primary ID of Target Chain 5	UniProt (TrEMBL) Secondary ID(s) of Target Chain 5	UniProt (TrEMBL) Alternative ID(s) of Target Chain 5	BindingDB Target Chain Sequence 6	PDB ID(s) of Target Chain 6	UniProt (SwissProt) Recommended Name of Target Chain 6	UniProt (SwissProt) Entry Name of Target Chain 6	UniProt (SwissProt) Primary ID of Target Chain 6	UniProt (SwissProt) Secondary ID(s) of Target Chain 6	UniProt (SwissProt) Alternative ID(s) of Target Chain 6	UniProt (TrEMBL) Submitted Name of Target Chain 6	UniProt (TrEMBL) Entry Name of Target Chain 6	UniProt (TrEMBL) Primary ID of Target Chain 6	UniProt (TrEMBL) Secondary ID(s) of Target Chain 6	UniProt (TrEMBL) Alternative ID(s) of Target Chain 6	BindingDB Target Chain Sequence 7	PDB ID(s) of Target Chain 7	UniProt (SwissProt) Recommended Name of Target Chain 7	UniProt (SwissProt) Entry Name of Target Chain 7	UniProt (SwissProt) Primary ID of Target Chain 7	UniProt (SwissProt) Secondary ID(s) of Target Chain 7	UniProt (SwissProt) Alternative ID(s) of Target Chain 7	UniProt (TrEMBL) Submitted Name of Target Chain 7	UniProt (TrEMBL) Entry Name of Target Chain 7	UniProt (TrEMBL) Primary ID of Target Chain 7	UniProt (TrEMBL) Secondary ID(s) of Target Chain 7	UniProt (TrEMBL) Alternative ID(s) of Target Chain 7	BindingDB Target Chain Sequence 8	PDB ID(s) of Target Chain 8	UniProt (SwissProt) Recommended Name of Target Chain 8	UniProt (SwissProt) Entry Name of Target Chain 8	UniProt (SwissProt) Primary ID of Target Chain 8	UniProt (SwissProt) Secondary ID(s) of Target Chain 8	UniProt (SwissProt) Alternative ID(s) of Target Chain 8	UniProt (TrEMBL) Submitted Name of Target Chain 8	UniProt (TrEMBL) Entry Name of Target Chain 8	UniProt (TrEMBL) Primary ID of Target Chain 8	UniProt (TrEMBL) Secondary ID(s) of Target Chain 8	UniProt (TrEMBL) Alternative ID(s) of Target Chain 8	BindingDB Target Chain Sequence 9	PDB ID(s) of Target Chain 9	UniProt (SwissProt) Recommended Name of Target Chain 9	UniProt (SwissProt) Entry Name of Target Chain 9	UniProt (SwissProt) Primary ID of Target Chain 9	UniProt (SwissProt) Secondary ID(s) of Target Chain 9	UniProt (SwissProt) Alternative ID(s) of Target Chain 9	UniProt (TrEMBL) Submitted Name of Target Chain 9	UniProt (TrEMBL) Entry Name of Target Chain 9	UniProt (TrEMBL) Primary ID of Target Chain 9	UniProt (TrEMBL) Secondary ID(s) of Target Chain 9	UniProt (TrEMBL) Alternative ID(s) of Target Chain 9	BindingDB Target Chain Sequence 10	PDB ID(s) of Target Chain 10	UniProt (SwissProt) Recommended Name of Target Chain 10	UniProt (SwissProt) Entry Name of Target Chain 10	UniProt (SwissProt) Primary ID of Target Chain 10	UniProt (SwissProt) Secondary ID(s) of Target Chain 10	UniProt (SwissProt) Alternative ID(s) of Target Chain 10	UniProt (TrEMBL) Submitted Name of Target Chain 10	UniProt (TrEMBL) Entry Name of Target Chain 10	UniProt (TrEMBL) Primary ID of Target Chain 10	UniProt (TrEMBL) Secondary ID(s) of Target Chain 10	UniProt (TrEMBL) Alternative ID(s) of Target Chain 10	BindingDB Target Chain Sequence 11	PDB ID(s) of Target Chain 11	UniProt (SwissProt) Recommended Name of Target Chain 11	UniProt (SwissProt) Entry Name of Target Chain 11	UniProt (SwissProt) Primary ID of Target Chain 11	UniProt (SwissProt) Secondary ID(s) of Target Chain 11	UniProt (SwissProt) Alternative ID(s) of Target Chain 11	UniProt (TrEMBL) Submitted Name of Target Chain 11	UniProt (TrEMBL) Entry Name of Target Chain 11	UniProt (TrEMBL) Primary ID of Target Chain 11	UniProt (TrEMBL) Secondary ID(s) of Target Chain 11	UniProt (TrEMBL) Alternative ID(s) of Target Chain 11	BindingDB Target Chain Sequence 12	PDB ID(s) of Target Chain 12	UniProt (SwissProt) Recommended Name of Target Chain 12	UniProt (SwissProt) Entry Name of Target Chain 12	UniProt (SwissProt) Primary ID of Target Chain 12	UniProt (SwissProt) Secondary ID(s) of Target Chain 12	UniProt (SwissProt) Alternative ID(s) of Target Chain 12	UniProt (TrEMBL) Submitted Name of Target Chain 12	UniProt (TrEMBL) Entry Name of Target Chain 12	UniProt (TrEMBL) Primary ID of Target Chain 12	UniProt (TrEMBL) Secondary ID(s) of Target Chain 12	UniProt (TrEMBL) Alternative ID(s) of Target Chain 12	BindingDB Target Chain Sequence 13	PDB ID(s) of Target Chain 13	UniProt (SwissProt) Recommended Name of Target Chain 13	UniProt (SwissProt) Entry Name of Target Chain 13	UniProt (SwissProt) Primary ID of Target Chain 13	UniProt (SwissProt) Secondary ID(s) of Target Chain 13	UniProt (SwissProt) Alternative ID(s) of Target Chain 13	UniProt (TrEMBL) Submitted Name of Target Chain 13	UniProt (TrEMBL) Entry Name of Target Chain 13	UniProt (TrEMBL) Primary ID of Target Chain 13	UniProt (TrEMBL) Secondary ID(s) of Target Chain 13	UniProt (TrEMBL) Alternative ID(s) of Target Chain 13	BindingDB Target Chain Sequence 14	PDB ID(s) of Target Chain 14	UniProt (SwissProt) Recommended Name of Target Chain 14	UniProt (SwissProt) Entry Name of Target Chain 14	UniProt (SwissProt) Primary ID of Target Chain 14	UniProt (SwissProt) Secondary ID(s) of Target Chain 14	UniProt (SwissProt) Alternative ID(s) of Target Chain 14	UniProt (TrEMBL) Submitted Name of Target Chain 14	UniProt (TrEMBL) Entry Name of Target Chain 14	UniProt (TrEMBL) Primary ID of Target Chain 14	UniProt (TrEMBL) Secondary ID(s) of Target Chain 14	UniProt (TrEMBL) Alternative ID(s) of Target Chain 14	BindingDB Target Chain Sequence 15	PDB ID(s) of Target Chain 15	UniProt (SwissProt) Recommended Name of Target Chain 15	UniProt (SwissProt) Entry Name of Target Chain 15	UniProt (SwissProt) Primary ID of Target Chain 15	UniProt (SwissProt) Secondary ID(s) of Target Chain 15	UniProt (SwissProt) Alternative ID(s) of Target Chain 15	UniProt (TrEMBL) Submitted Name of Target Chain 15	UniProt (TrEMBL) Entry Name of Target Chain 15	UniProt (TrEMBL) Primary ID of Target Chain 15	UniProt (TrEMBL) Secondary ID(s) of Target Chain 15	UniProt (TrEMBL) Alternative ID(s) of Target Chain 15	BindingDB Target Chain Sequence 16	PDB ID(s) of Target Chain 16	UniProt (SwissProt) Recommended Name of Target Chain 16	UniProt (SwissProt) Entry Name of Target Chain 16	UniProt (SwissProt) Primary ID of Target Chain 16	UniProt (SwissProt) Secondary ID(s) of Target Chain 16	UniProt (SwissProt) Alternative ID(s) of Target Chain 16	UniProt (TrEMBL) Submitted Name of Target Chain 16	UniProt (TrEMBL) Entry Name of Target Chain 16	UniProt (TrEMBL) Primary ID of Target Chain 16	UniProt (TrEMBL) Secondary ID(s) of Target Chain 16	UniProt (TrEMBL) Alternative ID(s) of Target Chain 16	BindingDB Target Chain Sequence 17	PDB ID(s) of Target Chain 17	UniProt (SwissProt) Recommended Name of Target Chain 17	UniProt (SwissProt) Entry Name of Target Chain 17	UniProt (SwissProt) Primary ID of Target Chain 17	UniProt (SwissProt) Secondary ID(s) of Target Chain 17	UniProt (SwissProt) Alternative ID(s) of Target Chain 17	UniProt (TrEMBL) Submitted Name of Target Chain 17	UniProt (TrEMBL) Entry Name of Target Chain 17	UniProt (TrEMBL) Primary ID of Target Chain 17	UniProt (TrEMBL) Secondary ID(s) of Target Chain 17	UniProt (TrEMBL) Alternative ID(s) of Target Chain 17	BindingDB Target Chain Sequence 18	PDB ID(s) of Target Chain 18	UniProt (SwissProt) Recommended Name of Target Chain 18	UniProt (SwissProt) Entry Name of Target Chain 18	UniProt (SwissProt) Primary ID of Target Chain 18	UniProt (SwissProt) Secondary ID(s) of Target Chain 18	UniProt (SwissProt) Alternative ID(s) of Target Chain 18	UniProt (TrEMBL) Submitted Name of Target Chain 18	UniProt (TrEMBL) Entry Name of Target Chain 18	UniProt (TrEMBL) Primary ID of Target Chain 18	UniProt (TrEMBL) Secondary ID(s) of Target Chain 18	UniProt (TrEMBL) Alternative ID(s) of Target Chain 18	BindingDB Target Chain Sequence 19	PDB ID(s) of Target Chain 19	UniProt (SwissProt) Recommended Name of Target Chain 19	UniProt (SwissProt) Entry Name of Target Chain 19	UniProt (SwissProt) Primary ID of Target Chain 19	UniProt (SwissProt) Secondary ID(s) of Target Chain 19	UniProt (SwissProt) Alternative ID(s) of Target Chain 19	UniProt (TrEMBL) Submitted Name of Target Chain 19	UniProt (TrEMBL) Entry Name of Target Chain 19	UniProt (TrEMBL) Primary ID of Target Chain 19	UniProt (TrEMBL) Secondary ID(s) of Target Chain 19	UniProt (TrEMBL) Alternative ID(s) of Target Chain 19	BindingDB Target Chain Sequence 20	PDB ID(s) of Target Chain 20	UniProt (SwissProt) Recommended Name of Target Chain 20	UniProt (SwissProt) Entry Name of Target Chain 20	UniProt (SwissProt) Primary ID of Target Chain 20	UniProt (SwissProt) Secondary ID(s) of Target Chain 20	UniProt (SwissProt) Alternative ID(s) of Target Chain 20	UniProt (TrEMBL) Submitted Name of Target Chain 20	UniProt (TrEMBL) Entry Name of Target Chain 20	UniProt (TrEMBL) Primary ID of Target Chain 20	UniProt (TrEMBL) Secondary ID(s) of Target Chain 20	UniProt (TrEMBL) Alternative ID(s) of Target Chain 20	BindingDB Target Chain Sequence 21	PDB ID(s) of Target Chain 21	UniProt (SwissProt) Recommended Name of Target Chain 21	UniProt (SwissProt) Entry Name of Target Chain 21	UniProt (SwissProt) Primary ID of Target Chain 21	UniProt (SwissProt) Secondary ID(s) of Target Chain 21	UniProt (SwissProt) Alternative ID(s) of Target Chain 21	UniProt (TrEMBL) Submitted Name of Target Chain 21	UniProt (TrEMBL) Entry Name of Target Chain 21	UniProt (TrEMBL) Primary ID of Target Chain 21	UniProt (TrEMBL) Secondary ID(s) of Target Chain 21	UniProt (TrEMBL) Alternative ID(s) of Target Chain 21	BindingDB Target Chain Sequence 22	PDB ID(s) of Target Chain 22	UniProt (SwissProt) Recommended Name of Target Chain 22	UniProt (SwissProt) Entry Name of Target Chain 22	UniProt (SwissProt) Primary ID of Target Chain 22	UniProt (SwissProt) Secondary ID(s) of Target Chain 22	UniProt (SwissProt) Alternative ID(s) of Target Chain 22	UniProt (TrEMBL) Submitted Name of Target Chain 22	UniProt (TrEMBL) Entry Name of Target Chain 22	UniProt (TrEMBL) Primary ID of Target Chain 22	UniProt (TrEMBL) Secondary ID(s) of Target Chain 22	UniProt (TrEMBL) Alternative ID(s) of Target Chain 22	BindingDB Target Chain Sequence 23	PDB ID(s) of Target Chain 23	UniProt (SwissProt) Recommended Name of Target Chain 23	UniProt (SwissProt) Entry Name of Target Chain 23	UniProt (SwissProt) Primary ID of Target Chain 23	UniProt (SwissProt) Secondary ID(s) of Target Chain 23	UniProt (SwissProt) Alternative ID(s) of Target Chain 23	UniProt (TrEMBL) Submitted Name of Target Chain 23	UniProt (TrEMBL) Entry Name of Target Chain 23	UniProt (TrEMBL) Primary ID of Target Chain 23	UniProt (TrEMBL) Secondary ID(s) of Target Chain 23	UniProt (TrEMBL) Alternative ID(s) of Target Chain 23	BindingDB Target Chain Sequence 24	PDB ID(s) of Target Chain 24	UniProt (SwissProt) Recommended Name of Target Chain 24	UniProt (SwissProt) Entry Name of Target Chain 24	UniProt (SwissProt) Primary ID of Target Chain 24	UniProt (SwissProt) Secondary ID(s) of Target Chain 24	UniProt (SwissProt) Alternative ID(s) of Target Chain 24	UniProt (TrEMBL) Submitted Name of Target Chain 24	UniProt (TrEMBL) Entry Name of Target Chain 24	UniProt (TrEMBL) Primary ID of Target Chain 24	UniProt (TrEMBL) Secondary ID(s) of Target Chain 24	UniProt (TrEMBL) Alternative ID(s) of Target Chain 24	BindingDB Target Chain Sequence 25	PDB ID(s) of Target Chain 25	UniProt (SwissProt) Recommended Name of Target Chain 25	UniProt (SwissProt) Entry Name of Target Chain 25	UniProt (SwissProt) Primary ID of Target Chain 25	UniProt (SwissProt) Secondary ID(s) of Target Chain 25	UniProt (SwissProt) Alternative ID(s) of Target Chain 25	UniProt (TrEMBL) Submitted Name of Target Chain 25	UniProt (TrEMBL) Entry Name of Target Chain 25	UniProt (TrEMBL) Primary ID of Target Chain 25	UniProt (TrEMBL) Secondary ID(s) of Target Chain 25	UniProt (TrEMBL) Alternative ID(s) of Target Chain 25	BindingDB Target Chain Sequence 26	PDB ID(s) of Target Chain 26	UniProt (SwissProt) Recommended Name of Target Chain 26	UniProt (SwissProt) Entry Name of Target Chain 26	UniProt (SwissProt) Primary ID of Target Chain 26	UniProt (SwissProt) Secondary ID(s) of Target Chain 26	UniProt (SwissProt) Alternative ID(s) of Target Chain 26	UniProt (TrEMBL) Submitted Name of Target Chain 26	UniProt (TrEMBL) Entry Name of Target Chain 26	UniProt (TrEMBL) Primary ID of Target Chain 26	UniProt (TrEMBL) Secondary ID(s) of Target Chain 26	UniProt (TrEMBL) Alternative ID(s) of Target Chain 26	BindingDB Target Chain Sequence 27	PDB ID(s) of Target Chain 27	UniProt (SwissProt) Recommended Name of Target Chain 27	UniProt (SwissProt) Entry Name of Target Chain 27	UniProt (SwissProt) Primary ID of Target Chain 27	UniProt (SwissProt) Secondary ID(s) of Target Chain 27	UniProt (SwissProt) Alternative ID(s) of Target Chain 27	UniProt (TrEMBL) Submitted Name of Target Chain 27	UniProt (TrEMBL) Entry Name of Target Chain 27	UniProt (TrEMBL) Primary ID of Target Chain 27	UniProt (TrEMBL) Secondary ID(s) of Target Chain 27	UniProt (TrEMBL) Alternative ID(s) of Target Chain 27	BindingDB Target Chain Sequence 28	PDB ID(s) of Target Chain 28	UniProt (SwissProt) Recommended Name of Target Chain 28	UniProt (SwissProt) Entry Name of Target Chain 28	UniProt (SwissProt) Primary ID of Target Chain 28	UniProt (SwissProt) Secondary ID(s) of Target Chain 28	UniProt (SwissProt) Alternative ID(s) of Target Chain 28	UniProt (TrEMBL) Submitted Name of Target Chain 28	UniProt (TrEMBL) Entry Name of Target Chain 28	UniProt (TrEMBL) Primary ID of Target Chain 28	UniProt (TrEMBL) Secondary ID(s) of Target Chain 28	UniProt (TrEMBL) Alternative ID(s) of Target Chain 28	BindingDB Target Chain Sequence 29	PDB ID(s) of Target Chain 29	UniProt (SwissProt) Recommended Name of Target Chain 29	UniProt (SwissProt) Entry Name of Target Chain 29	UniProt (SwissProt) Primary ID of Target Chain 29	UniProt (SwissProt) Secondary ID(s) of Target Chain 29	UniProt (SwissProt) Alternative ID(s) of Target Chain 29	UniProt (TrEMBL) Submitted Name of Target Chain 29	UniProt (TrEMBL) Entry Name of Target Chain 29	UniProt (TrEMBL) Primary ID of Target Chain 29	UniProt (TrEMBL) Secondary ID(s) of Target Chain 29	UniProt (TrEMBL) Alternative ID(s) of Target Chain 29	BindingDB Target Chain Sequence 30	PDB ID(s) of Target Chain 30	UniProt (SwissProt) Recommended Name of Target Chain 30	UniProt (SwissProt) Entry Name of Target Chain 30	UniProt (SwissProt) Primary ID of Target Chain 30	UniProt (SwissProt) Secondary ID(s) of Target Chain 30	UniProt (SwissProt) Alternative ID(s) of Target Chain 30	UniProt (TrEMBL) Submitted Name of Target Chain 30	UniProt (TrEMBL) Entry Name of Target Chain 30	UniProt (TrEMBL) Primary ID of Target Chain 30	UniProt (TrEMBL) Secondary ID(s) of Target Chain 30	UniProt (TrEMBL) Alternative ID(s) of Target Chain 30	BindingDB Target Chain Sequence 31	PDB ID(s) of Target Chain 31	UniProt (SwissProt) Recommended Name of Target Chain 31	UniProt (SwissProt) Entry Name of Target Chain 31	UniProt (SwissProt) Primary ID of Target Chain 31	UniProt (SwissProt) Secondary ID(s) of Target Chain 31	UniProt (SwissProt) Alternative ID(s) of Target Chain 31	UniProt (TrEMBL) Submitted Name of Target Chain 31	UniProt (TrEMBL) Entry Name of Target Chain 31	UniProt (TrEMBL) Primary ID of Target Chain 31	UniProt (TrEMBL) Secondary ID(s) of Target Chain 31	UniProt (TrEMBL) Alternative ID(s) of Target Chain 31	BindingDB Target Chain Sequence 32	PDB ID(s) of Target Chain 32	UniProt (SwissProt) Recommended Name of Target Chain 32	UniProt (SwissProt) Entry Name of Target Chain 32	UniProt (SwissProt) Primary ID of Target Chain 32	UniProt (SwissProt) Secondary ID(s) of Target Chain 32	UniProt (SwissProt) Alternative ID(s) of Target Chain 32	UniProt (TrEMBL) Submitted Name of Target Chain 32	UniProt (TrEMBL) Entry Name of Target Chain 32	UniProt (TrEMBL) Primary ID of Target Chain 32	UniProt (TrEMBL) Secondary ID(s) of Target Chain 32	UniProt (TrEMBL) Alternative ID(s) of Target Chain 32	BindingDB Target Chain Sequence 33	PDB ID(s) of Target Chain 33	UniProt (SwissProt) Recommended Name of Target Chain 33	UniProt (SwissProt) Entry Name of Target Chain 33	UniProt (SwissProt) Primary ID of Target Chain 33	UniProt (SwissProt) Secondary ID(s) of Target Chain 33	UniProt (SwissProt) Alternative ID(s) of Target Chain 33	UniProt (TrEMBL) Submitted Name of Target Chain 33	UniProt (TrEMBL) Entry Name of Target Chain 33	UniProt (TrEMBL) Primary ID of Target Chain 33	UniProt (TrEMBL) Secondary ID(s) of Target Chain 33	UniProt (TrEMBL) Alternative ID(s) of Target Chain 33	BindingDB Target Chain Sequence 34	PDB ID(s) of Target Chain 34	UniProt (SwissProt) Recommended Name of Target Chain 34	UniProt (SwissProt) Entry Name of Target Chain 34	UniProt (SwissProt) Primary ID of Target Chain 34	UniProt (SwissProt) Secondary ID(s) of Target Chain 34	UniProt (SwissProt) Alternative ID(s) of Target Chain 34	UniProt (TrEMBL) Submitted Name of Target Chain 34	UniProt (TrEMBL) Entry Name of Target Chain 34	UniProt (TrEMBL) Primary ID of Target Chain 34	UniProt (TrEMBL) Secondary ID(s) of Target Chain 34	UniProt (TrEMBL) Alternative ID(s) of Target Chain 34	BindingDB Target Chain Sequence 35	PDB ID(s) of Target Chain 35	UniProt (SwissProt) Recommended Name of Target Chain 35	UniProt (SwissProt) Entry Name of Target Chain 35	UniProt (SwissProt) Primary ID of Target Chain 35	UniProt (SwissProt) Secondary ID(s) of Target Chain 35	UniProt (SwissProt) Alternative ID(s) of Target Chain 35	UniProt (TrEMBL) Submitted Name of Target Chain 35	UniProt (TrEMBL) Entry Name of Target Chain 35	UniProt (TrEMBL) Primary ID of Target Chain 35	UniProt (TrEMBL) Secondary ID(s) of Target Chain 35	UniProt (TrEMBL) Alternative ID(s) of Target Chain 35	BindingDB Target Chain Sequence 36	PDB ID(s) of Target Chain 36	UniProt (SwissProt) Recommended Name of Target Chain 36	UniProt (SwissProt) Entry Name of Target Chain 36	UniProt (SwissProt) Primary ID of Target Chain 36	UniProt (SwissProt) Secondary ID(s) of Target Chain 36	UniProt (SwissProt) Alternative ID(s) of Target Chain 36	UniProt (TrEMBL) Submitted Name of Target Chain 36	UniProt (TrEMBL) Entry Name of Target Chain 36	UniProt (TrEMBL) Primary ID of Target Chain 36	UniProt (TrEMBL) Secondary ID(s) of Target Chain 36	UniProt (TrEMBL) Alternative ID(s) of Target Chain 36	BindingDB Target Chain Sequence 37	PDB ID(s) of Target Chain 37	UniProt (SwissProt) Recommended Name of Target Chain 37	UniProt (SwissProt) Entry Name of Target Chain 37	UniProt (SwissProt) Primary ID of Target Chain 37	UniProt (SwissProt) Secondary ID(s) of Target Chain 37	UniProt (SwissProt) Alternative ID(s) of Target Chain 37	UniProt (TrEMBL) Submitted Name of Target Chain 37	UniProt (TrEMBL) Entry Name of Target Chain 37	UniProt (TrEMBL) Primary ID of Target Chain 37	UniProt (TrEMBL) Secondary ID(s) of Target Chain 37	UniProt (TrEMBL) Alternative ID(s) of Target Chain 37	BindingDB Target Chain Sequence 38	PDB ID(s) of Target Chain 38	UniProt (SwissProt) Recommended Name of Target Chain 38	UniProt (SwissProt) Entry Name of Target Chain 38	UniProt (SwissProt) Primary ID of Target Chain 38	UniProt (SwissProt) Secondary ID(s) of Target Chain 38	UniProt (SwissProt) Alternative ID(s) of Target Chain 38	UniProt (TrEMBL) Submitted Name of Target Chain 38	UniProt (TrEMBL) Entry Name of Target Chain 38	UniProt (TrEMBL) Primary ID of Target Chain 38	UniProt (TrEMBL) Secondary ID(s) of Target Chain 38	UniProt (TrEMBL) Alternative ID(s) of Target Chain 38	BindingDB Target Chain Sequence 39	PDB ID(s) of Target Chain 39	UniProt (SwissProt) Recommended Name of Target Chain 39	UniProt (SwissProt) Entry Name of Target Chain 39	UniProt (SwissProt) Primary ID of Target Chain 39	UniProt (SwissProt) Secondary ID(s) of Target Chain 39	UniProt (SwissProt) Alternative ID(s) of Target Chain 39	UniProt (TrEMBL) Submitted Name of Target Chain 39	UniProt (TrEMBL) Entry Name of Target Chain 39	UniProt (TrEMBL) Primary ID of Target Chain 39	UniProt (TrEMBL) Secondary ID(s) of Target Chain 39	UniProt (TrEMBL) Alternative ID(s) of Target Chain 39	BindingDB Target Chain Sequence 40	PDB ID(s) of Target Chain 40	UniProt (SwissProt) Recommended Name of Target Chain 40	UniProt (SwissProt) Entry Name of Target Chain 40	UniProt (SwissProt) Primary ID of Target Chain 40	UniProt (SwissProt) Secondary ID(s) of Target Chain 40	UniProt (SwissProt) Alternative ID(s) of Target Chain 40	UniProt (TrEMBL) Submitted Name of Target Chain 40	UniProt (TrEMBL) Entry Name of Target Chain 40	UniProt (TrEMBL) Primary ID of Target Chain 40	UniProt (TrEMBL) Secondary ID(s) of Target Chain 40	UniProt (TrEMBL) Alternative ID(s) of Target Chain 40	BindingDB Target Chain Sequence 41	PDB ID(s) of Target Chain 41	UniProt (SwissProt) Recommended Name of Target Chain 41	UniProt (SwissProt) Entry Name of Target Chain 41	UniProt (SwissProt) Primary ID of Target Chain 41	UniProt (SwissProt) Secondary ID(s) of Target Chain 41	UniProt (SwissProt) Alternative ID(s) of Target Chain 41	UniProt (TrEMBL) Submitted Name of Target Chain 41	UniProt (TrEMBL) Entry Name of Target Chain 41	UniProt (TrEMBL) Primary ID of Target Chain 41	UniProt (TrEMBL) Secondary ID(s) of Target Chain 41	UniProt (TrEMBL) Alternative ID(s) of Target Chain 41	BindingDB Target Chain Sequence 42	PDB ID(s) of Target Chain 42	UniProt (SwissProt) Recommended Name of Target Chain 42	UniProt (SwissProt) Entry Name of Target Chain 42	UniProt (SwissProt) Primary ID of Target Chain 42	UniProt (SwissProt) Secondary ID(s) of Target Chain 42	UniProt (SwissProt) Alternative ID(s) of Target Chain 42	UniProt (TrEMBL) Submitted Name of Target Chain 42	UniProt (TrEMBL) Entry Name of Target Chain 42	UniProt (TrEMBL) Primary ID of Target Chain 42	UniProt (TrEMBL) Secondary ID(s) of Target Chain 42	UniProt (TrEMBL) Alternative ID(s) of Target Chain 42	BindingDB Target Chain Sequence 43	PDB ID(s) of Target Chain 43	UniProt (SwissProt) Recommended Name of Target Chain 43	UniProt (SwissProt) Entry Name of Target Chain 43	UniProt (SwissProt) Primary ID of Target Chain 43	UniProt (SwissProt) Secondary ID(s) of Target Chain 43	UniProt (SwissProt) Alternative ID(s) of Target Chain 43	UniProt (TrEMBL) Submitted Name of Target Chain 43	UniProt (TrEMBL) Entry Name of Target Chain 43	UniProt (TrEMBL) Primary ID of Target Chain 43	UniProt (TrEMBL) Secondary ID(s) of Target Chain 43	UniProt (TrEMBL) Alternative ID(s) of Target Chain 43	BindingDB Target Chain Sequence 44	PDB ID(s) of Target Chain 44	UniProt (SwissProt) Recommended Name of Target Chain 44	UniProt (SwissProt) Entry Name of Target Chain 44	UniProt (SwissProt) Primary ID of Target Chain 44	UniProt (SwissProt) Secondary ID(s) of Target Chain 44	UniProt (SwissProt) Alternative ID(s) of Target Chain 44	UniProt (TrEMBL) Submitted Name of Target Chain 44	UniProt (TrEMBL) Entry Name of Target Chain 44	UniProt (TrEMBL) Primary ID of Target Chain 44	UniProt (TrEMBL) Secondary ID(s) of Target Chain 44	UniProt (TrEMBL) Alternative ID(s) of Target Chain 44	BindingDB Target Chain Sequence 45	PDB ID(s) of Target Chain 45	UniProt (SwissProt) Recommended Name of Target Chain 45	UniProt (SwissProt) Entry Name of Target Chain 45	UniProt (SwissProt) Primary ID of Target Chain 45	UniProt (SwissProt) Secondary ID(s) of Target Chain 45	UniProt (SwissProt) Alternative ID(s) of Target Chain 45	UniProt (TrEMBL) Submitted Name of Target Chain 45	UniProt (TrEMBL) Entry Name of Target Chain 45	UniProt (TrEMBL) Primary ID of Target Chain 45	UniProt (TrEMBL) Secondary ID(s) of Target Chain 45	UniProt (TrEMBL) Alternative ID(s) of Target Chain 45	BindingDB Target Chain Sequence 46	PDB ID(s) of Target Chain 46	UniProt (SwissProt) Recommended Name of Target Chain 46	UniProt (SwissProt) Entry Name of Target Chain 46	UniProt (SwissProt) Primary ID of Target Chain 46	UniProt (SwissProt) Secondary ID(s) of Target Chain 46	UniProt (SwissProt) Alternative ID(s) of Target Chain 46	UniProt (TrEMBL) Submitted Name of Target Chain 46	UniProt (TrEMBL) Entry Name of Target Chain 46	UniProt (TrEMBL) Primary ID of Target Chain 46	UniProt (TrEMBL) Secondary ID(s) of Target Chain 46	UniProt (TrEMBL) Alternative ID(s) of Target Chain 46	BindingDB Target Chain Sequence 47	PDB ID(s) of Target Chain 47	UniProt (SwissProt) Recommended Name of Target Chain 47	UniProt (SwissProt) Entry Name of Target Chain 47	UniProt (SwissProt) Primary ID of Target Chain 47	UniProt (SwissProt) Secondary ID(s) of Target Chain 47	UniProt (SwissProt) Alternative ID(s) of Target Chain 47	UniProt (TrEMBL) Submitted Name of Target Chain 47	UniProt (TrEMBL) Entry Name of Target Chain 47	UniProt (TrEMBL) Primary ID of Target Chain 47	UniProt (TrEMBL) Secondary ID(s) of Target Chain 47	UniProt (TrEMBL) Alternative ID(s) of Target Chain 47	BindingDB Target Chain Sequence 48	PDB ID(s) of Target Chain 48	UniProt (SwissProt) Recommended Name of Target Chain 48	UniProt (SwissProt) Entry Name of Target Chain 48	UniProt (SwissProt) Primary ID of Target Chain 48	UniProt (SwissProt) Secondary ID(s) of Target Chain 48	UniProt (SwissProt) Alternative ID(s) of Target Chain 48	UniProt (TrEMBL) Submitted Name of Target Chain 48	UniProt (TrEMBL) Entry Name of Target Chain 48	UniProt (TrEMBL) Primary ID of Target Chain 48	UniProt (TrEMBL) Secondary ID(s) of Target Chain 48	UniProt (TrEMBL) Alternative ID(s) of Target Chain 48	BindingDB Target Chain Sequence 49	PDB ID(s) of Target Chain 49	UniProt (SwissProt) Recommended Name of Target Chain 49	UniProt (SwissProt) Entry Name of Target Chain 49	UniProt (SwissProt) Primary ID of Target Chain 49	UniProt (SwissProt) Secondary ID(s) of Target Chain 49	UniProt (SwissProt) Alternative ID(s) of Target Chain 49	UniProt (TrEMBL) Submitted Name of Target Chain 49	UniProt (TrEMBL) Entry Name of Target Chain 49	UniProt (TrEMBL) Primary ID of Target Chain 49	UniProt (TrEMBL) Secondary ID(s) of Target Chain 49	UniProt (TrEMBL) Alternative ID(s) of Target Chain 49	BindingDB Target Chain Sequence 50	PDB ID(s) of Target Chain 50	UniProt (SwissProt) Recommended Name of Target Chain 50	UniProt (SwissProt) Entry Name of Target Chain 50	UniProt (SwissProt) Primary ID of Target Chain 50	UniProt (SwissProt) Secondary ID(s) of Target Chain 50	UniProt (SwissProt) Alternative ID(s) of Target Chain 50	UniProt (TrEMBL) Submitted Name of Target Chain 50	UniProt (TrEMBL) Entry Name of Target Chain 50	UniProt (TrEMBL) Primary ID of Target Chain 50	UniProt (TrEMBL) Secondary ID(s) of Target Chain 50	UniProt (TrEMBL) Alternative ID(s) of Target Chain 50
1320775	Cc1c(O)c(ncc1-c1cccc(F)c1)C(=O)NCC(O)=O	InChI=1S/C15H13FN2O4/c1-8-11(9-3-2-4-10(16)5-9)6-17-13(14(8)21)15(22)18-7-12(19)20/h2-6,21H,7H2,1H3,(H,18,22)(H,19,20)	QPACVKJGLSGMIM-UHFFFAOYSA-N	618967	US20230295110, Compound 1	Egl nine homolog 1	Homo sapiens		<100							US Patent		10.7270/Q22V2M76		aid1919747	US20230295110	BLAISDELL, TP; ALLU, SR; FLEMING, PE	9/21/2023	10/30/2023	Akebia Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=618967	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5440&target=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=618967&enzyme=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search			162731764	485226282							1	MANDSGGPGGPSPSERDRQYCELCGKMENLLRCSRCRSSFYCCKEHQRQDWKKHKLVCQGSEGALGHGVGPHQHSGPAPPAAVPPPRAGAREPRKAAARRDNASGDAAKGKVKAKPPADPAAAASPCRAAAGGQGSAVAAEAEPGKEEPPARSSLFQEKANLYPPSNTPGDALSPGGGLRPNGQTKPLPALKLALEYIVPCMNKHGICVVDDFLGKETGQQIGDEVRALHDTGKFTDGQLVSQKSDSSKDIRGDKITWIEGKEPGCETIGLLMSSMDDLIRHCNGKLGSYKINGRTKAMVACYPGNGTGYVRHVDNPNGDGRCVTCIYYLNKDWDAKVSGGILRIFPEGKAQFADIEPKFDRLLFFWSDRRNPHEVQPAYATRYAITVWYFDADERARAKVKYLTGEKGVRVELNKPSDSVGKDVF	6YW0,6YVZ,6YVX,6YVW,6YVT,5OX6,5OX5,5A3U,4BQY,4BQX,4BQW,2Y34,2Y33,8Y0V,7UJV,3HQU,2G1M,5LA9,5L9V,8Z33,8Z32,2HBU,2HBT,2G19,3OUJ,3OUH,5V18,8Q6E,8Q6D,8Q5S,7Q5X,7Q5V,6YW3,6YW2,6YW1,6ST3,6QGV,6ZBO,6ZBN,8J1K,8Z35,8Z31,6NMQ,3OUI	Egl nine homolog 1	EGLN1_HUMAN	Q9GZT9	Q8N3M8 Q9BZS8 Q9BZT0		hypoxia-inducible factor-proline dioxygenase	R4SCQ0_HUMAN	R4SCQ0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
1320776	Cc1c(O)c(ncc1-c1cccc(F)c1)C(=O)NCC(O)=O	InChI=1S/C15H13FN2O4/c1-8-11(9-3-2-4-10(16)5-9)6-17-13(14(8)21)15(22)18-7-12(19)20/h2-6,21H,7H2,1H3,(H,18,22)(H,19,20)	QPACVKJGLSGMIM-UHFFFAOYSA-N	618967	US20230295110, Compound 1	Prolyl hydroxylase EGLN2	Homo sapiens		<100							US Patent		10.7270/Q22V2M76		aid1919747	US20230295110	BLAISDELL, TP; ALLU, SR; FLEMING, PE	9/21/2023	10/30/2023	Akebia Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=618967	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=618967&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search			162731764	485226282							1	MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT		Prolyl hydroxylase EGLN2	EGLN2_HUMAN	Q96KS0	A8K5S0 Q8WWY4 Q9BV14																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1320777	COc1cccc(c1)-c1cnc(C(=O)NCC(O)=O)c(O)c1C	InChI=1S/C16H16N2O5/c1-9-12(10-4-3-5-11(6-10)23-2)7-17-14(15(9)21)16(22)18-8-13(19)20/h3-7,21H,8H2,1-2H3,(H,18,22)(H,19,20)	WQNFTSRKCWNADH-UHFFFAOYSA-N	618968	US20230295110, Compound 2.	Egl nine homolog 1	Homo sapiens		<100							US Patent		10.7270/Q22V2M76		aid1919747	US20230295110	BLAISDELL, TP; ALLU, SR; FLEMING, PE	9/21/2023	10/30/2023	Akebia Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=618968	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5440&target=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=618968&enzyme=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search			162731776	485226283							1	MANDSGGPGGPSPSERDRQYCELCGKMENLLRCSRCRSSFYCCKEHQRQDWKKHKLVCQGSEGALGHGVGPHQHSGPAPPAAVPPPRAGAREPRKAAARRDNASGDAAKGKVKAKPPADPAAAASPCRAAAGGQGSAVAAEAEPGKEEPPARSSLFQEKANLYPPSNTPGDALSPGGGLRPNGQTKPLPALKLALEYIVPCMNKHGICVVDDFLGKETGQQIGDEVRALHDTGKFTDGQLVSQKSDSSKDIRGDKITWIEGKEPGCETIGLLMSSMDDLIRHCNGKLGSYKINGRTKAMVACYPGNGTGYVRHVDNPNGDGRCVTCIYYLNKDWDAKVSGGILRIFPEGKAQFADIEPKFDRLLFFWSDRRNPHEVQPAYATRYAITVWYFDADERARAKVKYLTGEKGVRVELNKPSDSVGKDVF	6YW0,6YVZ,6YVX,6YVW,6YVT,5OX6,5OX5,5A3U,4BQY,4BQX,4BQW,2Y34,2Y33,8Y0V,7UJV,3HQU,2G1M,5LA9,5L9V,8Z33,8Z32,2HBU,2HBT,2G19,3OUJ,3OUH,5V18,8Q6E,8Q6D,8Q5S,7Q5X,7Q5V,6YW3,6YW2,6YW1,6ST3,6QGV,6ZBO,6ZBN,8J1K,8Z35,8Z31,6NMQ,3OUI	Egl nine homolog 1	EGLN1_HUMAN	Q9GZT9	Q8N3M8 Q9BZS8 Q9BZT0		hypoxia-inducible factor-proline dioxygenase	R4SCQ0_HUMAN	R4SCQ0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
1320778	COc1cccc(c1)-c1cnc(C(=O)NCC(O)=O)c(O)c1C	InChI=1S/C16H16N2O5/c1-9-12(10-4-3-5-11(6-10)23-2)7-17-14(15(9)21)16(22)18-8-13(19)20/h3-7,21H,8H2,1-2H3,(H,18,22)(H,19,20)	WQNFTSRKCWNADH-UHFFFAOYSA-N	618968	US20230295110, Compound 2.	Prolyl hydroxylase EGLN2	Homo sapiens		<100							US Patent		10.7270/Q22V2M76		aid1919747	US20230295110	BLAISDELL, TP; ALLU, SR; FLEMING, PE	9/21/2023	10/30/2023	Akebia Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=618968	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=618968&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search			162731776	485226283							1	MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT		Prolyl hydroxylase EGLN2	EGLN2_HUMAN	Q96KS0	A8K5S0 Q8WWY4 Q9BV14																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1320779	COc1cccc(c1)-c1cnc(C(=O)NCC(O)=O)c(O)c1C	InChI=1S/C16H16N2O5/c1-9-12(10-4-3-5-11(6-10)23-2)7-17-14(15(9)21)16(22)18-8-13(19)20/h3-7,21H,8H2,1-2H3,(H,18,22)(H,19,20)	WQNFTSRKCWNADH-UHFFFAOYSA-N	618968	US20230295110, Compound 2.	Prolyl hydroxylase EGLN3	Homo sapiens		<100							US Patent		10.7270/Q22V2M76		aid1919747	US20230295110	BLAISDELL, TP; ALLU, SR; FLEMING, PE	9/21/2023	10/30/2023	Akebia Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=618968	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5442&target=Prolyl+hydroxylase+EGLN3&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=618968&enzyme=Prolyl+hydroxylase+EGLN3&column=ki&startPg=0&Increment=50&submit=Search			162731776	485226283							1	MPLGHIMRLDLEKIALEYIVPCLHEVGFCYLDNFLGEVVGDCVLERVKQLHCTGALRDGQLAGPRAGVSKRHLRGDQITWIGGNEEGCEAISFLLSLIDRLVLYCGSRLGKYYVKERSKAMVACYPGNGTGYVRHVDNPNGDGRCITCIYYLNKNWDAKLHGGILRIFPEGKSFIADVEPIFDRLLFFWSDRRNPHEVQPSYATRYAMTVWYFDAEERAEAKKKFRNLTRKTESALTED		Prolyl hydroxylase EGLN3	EGLN3_HUMAN	Q9H6Z9	Q2TA79 Q3B8N4 Q6P1R2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1320780	Cc1c(O)c(ncc1-c1ccc2cnccc2c1)C(=O)NCC(O)=O	InChI=1S/C18H15N3O4/c1-10-14(12-2-3-13-7-19-5-4-11(13)6-12)8-20-16(17(10)24)18(25)21-9-15(22)23/h2-8,24H,9H2,1H3,(H,21,25)(H,22,23)	PAQLCJHHCRSSJY-UHFFFAOYSA-N	618969	US20230295110, Compound 3.	Egl nine homolog 1	Homo sapiens		<100							US Patent		10.7270/Q22V2M76		aid1919747	US20230295110	BLAISDELL, TP; ALLU, SR; FLEMING, PE	9/21/2023	10/30/2023	Akebia Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=618969	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5440&target=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=618969&enzyme=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search			162731509	485226284							1	MANDSGGPGGPSPSERDRQYCELCGKMENLLRCSRCRSSFYCCKEHQRQDWKKHKLVCQGSEGALGHGVGPHQHSGPAPPAAVPPPRAGAREPRKAAARRDNASGDAAKGKVKAKPPADPAAAASPCRAAAGGQGSAVAAEAEPGKEEPPARSSLFQEKANLYPPSNTPGDALSPGGGLRPNGQTKPLPALKLALEYIVPCMNKHGICVVDDFLGKETGQQIGDEVRALHDTGKFTDGQLVSQKSDSSKDIRGDKITWIEGKEPGCETIGLLMSSMDDLIRHCNGKLGSYKINGRTKAMVACYPGNGTGYVRHVDNPNGDGRCVTCIYYLNKDWDAKVSGGILRIFPEGKAQFADIEPKFDRLLFFWSDRRNPHEVQPAYATRYAITVWYFDADERARAKVKYLTGEKGVRVELNKPSDSVGKDVF	6YW0,6YVZ,6YVX,6YVW,6YVT,5OX6,5OX5,5A3U,4BQY,4BQX,4BQW,2Y34,2Y33,8Y0V,7UJV,3HQU,2G1M,5LA9,5L9V,8Z33,8Z32,2HBU,2HBT,2G19,3OUJ,3OUH,5V18,8Q6E,8Q6D,8Q5S,7Q5X,7Q5V,6YW3,6YW2,6YW1,6ST3,6QGV,6ZBO,6ZBN,8J1K,8Z35,8Z31,6NMQ,3OUI	Egl nine homolog 1	EGLN1_HUMAN	Q9GZT9	Q8N3M8 Q9BZS8 Q9BZT0		hypoxia-inducible factor-proline dioxygenase	R4SCQ0_HUMAN	R4SCQ0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
1320781	Cc1c(O)c(ncc1-c1ccc2cnccc2c1)C(=O)NCC(O)=O	InChI=1S/C18H15N3O4/c1-10-14(12-2-3-13-7-19-5-4-11(13)6-12)8-20-16(17(10)24)18(25)21-9-15(22)23/h2-8,24H,9H2,1H3,(H,21,25)(H,22,23)	PAQLCJHHCRSSJY-UHFFFAOYSA-N	618969	US20230295110, Compound 3.	Prolyl hydroxylase EGLN2	Homo sapiens		<100							US Patent		10.7270/Q22V2M76		aid1919747	US20230295110	BLAISDELL, TP; ALLU, SR; FLEMING, PE	9/21/2023	10/30/2023	Akebia Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=618969	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=618969&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search			162731509	485226284							1	MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT		Prolyl hydroxylase EGLN2	EGLN2_HUMAN	Q96KS0	A8K5S0 Q8WWY4 Q9BV14																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1320782	Cc1c(O)c(ncc1-c1ccc2cnccc2c1)C(=O)NCC(O)=O	InChI=1S/C18H15N3O4/c1-10-14(12-2-3-13-7-19-5-4-11(13)6-12)8-20-16(17(10)24)18(25)21-9-15(22)23/h2-8,24H,9H2,1H3,(H,21,25)(H,22,23)	PAQLCJHHCRSSJY-UHFFFAOYSA-N	618969	US20230295110, Compound 3.	Prolyl hydroxylase EGLN3	Homo sapiens		<100							US Patent		10.7270/Q22V2M76		aid1919747	US20230295110	BLAISDELL, TP; ALLU, SR; FLEMING, PE	9/21/2023	10/30/2023	Akebia Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=618969	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5442&target=Prolyl+hydroxylase+EGLN3&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=618969&enzyme=Prolyl+hydroxylase+EGLN3&column=ki&startPg=0&Increment=50&submit=Search			162731509	485226284							1	MPLGHIMRLDLEKIALEYIVPCLHEVGFCYLDNFLGEVVGDCVLERVKQLHCTGALRDGQLAGPRAGVSKRHLRGDQITWIGGNEEGCEAISFLLSLIDRLVLYCGSRLGKYYVKERSKAMVACYPGNGTGYVRHVDNPNGDGRCITCIYYLNKNWDAKLHGGILRIFPEGKSFIADVEPIFDRLLFFWSDRRNPHEVQPSYATRYAMTVWYFDAEERAEAKKKFRNLTRKTESALTED		Prolyl hydroxylase EGLN3	EGLN3_HUMAN	Q9H6Z9	Q2TA79 Q3B8N4 Q6P1R2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1320783	Cc1c(O)c(ncc1-c1cnn(c1)-c1ccccc1)C(=O)NCC(O)=O	InChI=1S/C18H16N4O4/c1-11-14(8-19-16(17(11)25)18(26)20-9-15(23)24)12-7-21-22(10-12)13-5-3-2-4-6-13/h2-8,10,25H,9H2,1H3,(H,20,26)(H,23,24)	ADZOKWWFAGEXFM-UHFFFAOYSA-N	618970	US20230295110, Compound 4.	Egl nine homolog 1	Homo sapiens		<100							US Patent		10.7270/Q22V2M76		aid1919747	US20230295110	BLAISDELL, TP; ALLU, SR; FLEMING, PE	9/21/2023	10/30/2023	Akebia Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=618970	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5440&target=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=618970&enzyme=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search			162731530	485226285							1	MANDSGGPGGPSPSERDRQYCELCGKMENLLRCSRCRSSFYCCKEHQRQDWKKHKLVCQGSEGALGHGVGPHQHSGPAPPAAVPPPRAGAREPRKAAARRDNASGDAAKGKVKAKPPADPAAAASPCRAAAGGQGSAVAAEAEPGKEEPPARSSLFQEKANLYPPSNTPGDALSPGGGLRPNGQTKPLPALKLALEYIVPCMNKHGICVVDDFLGKETGQQIGDEVRALHDTGKFTDGQLVSQKSDSSKDIRGDKITWIEGKEPGCETIGLLMSSMDDLIRHCNGKLGSYKINGRTKAMVACYPGNGTGYVRHVDNPNGDGRCVTCIYYLNKDWDAKVSGGILRIFPEGKAQFADIEPKFDRLLFFWSDRRNPHEVQPAYATRYAITVWYFDADERARAKVKYLTGEKGVRVELNKPSDSVGKDVF	6YW0,6YVZ,6YVX,6YVW,6YVT,5OX6,5OX5,5A3U,4BQY,4BQX,4BQW,2Y34,2Y33,8Y0V,7UJV,3HQU,2G1M,5LA9,5L9V,8Z33,8Z32,2HBU,2HBT,2G19,3OUJ,3OUH,5V18,8Q6E,8Q6D,8Q5S,7Q5X,7Q5V,6YW3,6YW2,6YW1,6ST3,6QGV,6ZBO,6ZBN,8J1K,8Z35,8Z31,6NMQ,3OUI	Egl nine homolog 1	EGLN1_HUMAN	Q9GZT9	Q8N3M8 Q9BZS8 Q9BZT0		hypoxia-inducible factor-proline dioxygenase	R4SCQ0_HUMAN	R4SCQ0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
1320784	Cc1c(O)c(ncc1-c1cnn(c1)-c1ccccc1)C(=O)NCC(O)=O	InChI=1S/C18H16N4O4/c1-11-14(8-19-16(17(11)25)18(26)20-9-15(23)24)12-7-21-22(10-12)13-5-3-2-4-6-13/h2-8,10,25H,9H2,1H3,(H,20,26)(H,23,24)	ADZOKWWFAGEXFM-UHFFFAOYSA-N	618970	US20230295110, Compound 4.	Prolyl hydroxylase EGLN2	Homo sapiens		<100							US Patent		10.7270/Q22V2M76		aid1919747	US20230295110	BLAISDELL, TP; ALLU, SR; FLEMING, PE	9/21/2023	10/30/2023	Akebia Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=618970	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=618970&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search			162731530	485226285							1	MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT		Prolyl hydroxylase EGLN2	EGLN2_HUMAN	Q96KS0	A8K5S0 Q8WWY4 Q9BV14																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1320785	Cc1ccc2cc(ccc2n1)-c1cnc(C(=O)NCC(O)=O)c(O)c1C	InChI=1S/C19H17N3O4/c1-10-3-4-13-7-12(5-6-15(13)22-10)14-8-20-17(18(25)11(14)2)19(26)21-9-16(23)24/h3-8,25H,9H2,1-2H3,(H,21,26)(H,23,24)	DUJVQVABBCSDNL-UHFFFAOYSA-N	618971	US20230295110, Compound 5.	Egl nine homolog 1	Homo sapiens		<100							US Patent		10.7270/Q22V2M76		aid1919747	US20230295110	BLAISDELL, TP; ALLU, SR; FLEMING, PE	9/21/2023	10/30/2023	Akebia Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=618971	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5440&target=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=618971&enzyme=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search			162731561	485226286							1	MANDSGGPGGPSPSERDRQYCELCGKMENLLRCSRCRSSFYCCKEHQRQDWKKHKLVCQGSEGALGHGVGPHQHSGPAPPAAVPPPRAGAREPRKAAARRDNASGDAAKGKVKAKPPADPAAAASPCRAAAGGQGSAVAAEAEPGKEEPPARSSLFQEKANLYPPSNTPGDALSPGGGLRPNGQTKPLPALKLALEYIVPCMNKHGICVVDDFLGKETGQQIGDEVRALHDTGKFTDGQLVSQKSDSSKDIRGDKITWIEGKEPGCETIGLLMSSMDDLIRHCNGKLGSYKINGRTKAMVACYPGNGTGYVRHVDNPNGDGRCVTCIYYLNKDWDAKVSGGILRIFPEGKAQFADIEPKFDRLLFFWSDRRNPHEVQPAYATRYAITVWYFDADERARAKVKYLTGEKGVRVELNKPSDSVGKDVF	6YW0,6YVZ,6YVX,6YVW,6YVT,5OX6,5OX5,5A3U,4BQY,4BQX,4BQW,2Y34,2Y33,8Y0V,7UJV,3HQU,2G1M,5LA9,5L9V,8Z33,8Z32,2HBU,2HBT,2G19,3OUJ,3OUH,5V18,8Q6E,8Q6D,8Q5S,7Q5X,7Q5V,6YW3,6YW2,6YW1,6ST3,6QGV,6ZBO,6ZBN,8J1K,8Z35,8Z31,6NMQ,3OUI	Egl nine homolog 1	EGLN1_HUMAN	Q9GZT9	Q8N3M8 Q9BZS8 Q9BZT0		hypoxia-inducible factor-proline dioxygenase	R4SCQ0_HUMAN	R4SCQ0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
1320786	Cc1ccc2cc(ccc2n1)-c1cnc(C(=O)NCC(O)=O)c(O)c1C	InChI=1S/C19H17N3O4/c1-10-3-4-13-7-12(5-6-15(13)22-10)14-8-20-17(18(25)11(14)2)19(26)21-9-16(23)24/h3-8,25H,9H2,1-2H3,(H,21,26)(H,23,24)	DUJVQVABBCSDNL-UHFFFAOYSA-N	618971	US20230295110, Compound 5.	Prolyl hydroxylase EGLN2	Homo sapiens		<100							US Patent		10.7270/Q22V2M76		aid1919747	US20230295110	BLAISDELL, TP; ALLU, SR; FLEMING, PE	9/21/2023	10/30/2023	Akebia Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=618971	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=618971&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search			162731561	485226286							1	MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT		Prolyl hydroxylase EGLN2	EGLN2_HUMAN	Q96KS0	A8K5S0 Q8WWY4 Q9BV14																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1320787	Cc1ccc2cc(ccc2n1)-c1cnc(C(=O)NCC(O)=O)c(O)c1C	InChI=1S/C19H17N3O4/c1-10-3-4-13-7-12(5-6-15(13)22-10)14-8-20-17(18(25)11(14)2)19(26)21-9-16(23)24/h3-8,25H,9H2,1-2H3,(H,21,26)(H,23,24)	DUJVQVABBCSDNL-UHFFFAOYSA-N	618971	US20230295110, Compound 5.	Prolyl hydroxylase EGLN3	Homo sapiens		<100							US Patent		10.7270/Q22V2M76		aid1919747	US20230295110	BLAISDELL, TP; ALLU, SR; FLEMING, PE	9/21/2023	10/30/2023	Akebia Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=618971	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5442&target=Prolyl+hydroxylase+EGLN3&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=618971&enzyme=Prolyl+hydroxylase+EGLN3&column=ki&startPg=0&Increment=50&submit=Search			162731561	485226286							1	MPLGHIMRLDLEKIALEYIVPCLHEVGFCYLDNFLGEVVGDCVLERVKQLHCTGALRDGQLAGPRAGVSKRHLRGDQITWIGGNEEGCEAISFLLSLIDRLVLYCGSRLGKYYVKERSKAMVACYPGNGTGYVRHVDNPNGDGRCITCIYYLNKNWDAKLHGGILRIFPEGKSFIADVEPIFDRLLFFWSDRRNPHEVQPSYATRYAMTVWYFDAEERAEAKKKFRNLTRKTESALTED		Prolyl hydroxylase EGLN3	EGLN3_HUMAN	Q9H6Z9	Q2TA79 Q3B8N4 Q6P1R2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1320788	Cc1c(O)c(ncc1-c1cnn(c1)C1CCN(CC1)C(=O)OC(C)(C)C)C(=O)NCC(O)=O	InChI=1S/C22H29N5O6/c1-13-16(10-23-18(19(13)30)20(31)24-11-17(28)29)14-9-25-27(12-14)15-5-7-26(8-6-15)21(32)33-22(2,3)4/h9-10,12,15,30H,5-8,11H2,1-4H3,(H,24,31)(H,28,29)	HXNZJRFVQLJEBY-UHFFFAOYSA-N	618972	US20230295110, Compound 6	Egl nine homolog 1	Homo sapiens		<100							US Patent		10.7270/Q22V2M76		aid1919747	US20230295110	BLAISDELL, TP; ALLU, SR; FLEMING, PE	9/21/2023	10/30/2023	Akebia Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=618972	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5440&target=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=618972&enzyme=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search			162731618	485226287							1	MANDSGGPGGPSPSERDRQYCELCGKMENLLRCSRCRSSFYCCKEHQRQDWKKHKLVCQGSEGALGHGVGPHQHSGPAPPAAVPPPRAGAREPRKAAARRDNASGDAAKGKVKAKPPADPAAAASPCRAAAGGQGSAVAAEAEPGKEEPPARSSLFQEKANLYPPSNTPGDALSPGGGLRPNGQTKPLPALKLALEYIVPCMNKHGICVVDDFLGKETGQQIGDEVRALHDTGKFTDGQLVSQKSDSSKDIRGDKITWIEGKEPGCETIGLLMSSMDDLIRHCNGKLGSYKINGRTKAMVACYPGNGTGYVRHVDNPNGDGRCVTCIYYLNKDWDAKVSGGILRIFPEGKAQFADIEPKFDRLLFFWSDRRNPHEVQPAYATRYAITVWYFDADERARAKVKYLTGEKGVRVELNKPSDSVGKDVF	6YW0,6YVZ,6YVX,6YVW,6YVT,5OX6,5OX5,5A3U,4BQY,4BQX,4BQW,2Y34,2Y33,8Y0V,7UJV,3HQU,2G1M,5LA9,5L9V,8Z33,8Z32,2HBU,2HBT,2G19,3OUJ,3OUH,5V18,8Q6E,8Q6D,8Q5S,7Q5X,7Q5V,6YW3,6YW2,6YW1,6ST3,6QGV,6ZBO,6ZBN,8J1K,8Z35,8Z31,6NMQ,3OUI	Egl nine homolog 1	EGLN1_HUMAN	Q9GZT9	Q8N3M8 Q9BZS8 Q9BZT0		hypoxia-inducible factor-proline dioxygenase	R4SCQ0_HUMAN	R4SCQ0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
1320789	Cc1c(O)c(ncc1-c1cnn(c1)C1CCN(CC1)C(=O)OC(C)(C)C)C(=O)NCC(O)=O	InChI=1S/C22H29N5O6/c1-13-16(10-23-18(19(13)30)20(31)24-11-17(28)29)14-9-25-27(12-14)15-5-7-26(8-6-15)21(32)33-22(2,3)4/h9-10,12,15,30H,5-8,11H2,1-4H3,(H,24,31)(H,28,29)	HXNZJRFVQLJEBY-UHFFFAOYSA-N	618972	US20230295110, Compound 6	Prolyl hydroxylase EGLN2	Homo sapiens		<100							US Patent		10.7270/Q22V2M76		aid1919747	US20230295110	BLAISDELL, TP; ALLU, SR; FLEMING, PE	9/21/2023	10/30/2023	Akebia Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=618972	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=618972&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search			162731618	485226287							1	MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT		Prolyl hydroxylase EGLN2	EGLN2_HUMAN	Q96KS0	A8K5S0 Q8WWY4 Q9BV14																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1320790	Cc1c(O)c(ncc1-c1cnc(s1)-c1ccccc1)C(=O)NCC(O)=O	InChI=1S/C18H15N3O4S/c1-10-12(7-19-15(16(10)24)17(25)20-9-14(22)23)13-8-21-18(26-13)11-5-3-2-4-6-11/h2-8,24H,9H2,1H3,(H,20,25)(H,22,23)	BHIRGYDDAGFULU-UHFFFAOYSA-N	618973	US20230295110, Compound 7.	Egl nine homolog 1	Homo sapiens		<100							US Patent		10.7270/Q22V2M76		aid1919747	US20230295110	BLAISDELL, TP; ALLU, SR; FLEMING, PE	9/21/2023	10/30/2023	Akebia Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=618973	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5440&target=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=618973&enzyme=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search			162731674	485226288							1	MANDSGGPGGPSPSERDRQYCELCGKMENLLRCSRCRSSFYCCKEHQRQDWKKHKLVCQGSEGALGHGVGPHQHSGPAPPAAVPPPRAGAREPRKAAARRDNASGDAAKGKVKAKPPADPAAAASPCRAAAGGQGSAVAAEAEPGKEEPPARSSLFQEKANLYPPSNTPGDALSPGGGLRPNGQTKPLPALKLALEYIVPCMNKHGICVVDDFLGKETGQQIGDEVRALHDTGKFTDGQLVSQKSDSSKDIRGDKITWIEGKEPGCETIGLLMSSMDDLIRHCNGKLGSYKINGRTKAMVACYPGNGTGYVRHVDNPNGDGRCVTCIYYLNKDWDAKVSGGILRIFPEGKAQFADIEPKFDRLLFFWSDRRNPHEVQPAYATRYAITVWYFDADERARAKVKYLTGEKGVRVELNKPSDSVGKDVF	6YW0,6YVZ,6YVX,6YVW,6YVT,5OX6,5OX5,5A3U,4BQY,4BQX,4BQW,2Y34,2Y33,8Y0V,7UJV,3HQU,2G1M,5LA9,5L9V,8Z33,8Z32,2HBU,2HBT,2G19,3OUJ,3OUH,5V18,8Q6E,8Q6D,8Q5S,7Q5X,7Q5V,6YW3,6YW2,6YW1,6ST3,6QGV,6ZBO,6ZBN,8J1K,8Z35,8Z31,6NMQ,3OUI	Egl nine homolog 1	EGLN1_HUMAN	Q9GZT9	Q8N3M8 Q9BZS8 Q9BZT0		hypoxia-inducible factor-proline dioxygenase	R4SCQ0_HUMAN	R4SCQ0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
1320791	Cc1c(O)c(ncc1-c1cnc(s1)-c1ccccc1)C(=O)NCC(O)=O	InChI=1S/C18H15N3O4S/c1-10-12(7-19-15(16(10)24)17(25)20-9-14(22)23)13-8-21-18(26-13)11-5-3-2-4-6-11/h2-8,24H,9H2,1H3,(H,20,25)(H,22,23)	BHIRGYDDAGFULU-UHFFFAOYSA-N	618973	US20230295110, Compound 7.	Prolyl hydroxylase EGLN2	Homo sapiens		<100							US Patent		10.7270/Q22V2M76		aid1919747	US20230295110	BLAISDELL, TP; ALLU, SR; FLEMING, PE	9/21/2023	10/30/2023	Akebia Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=618973	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=618973&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search			162731674	485226288							1	MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT		Prolyl hydroxylase EGLN2	EGLN2_HUMAN	Q96KS0	A8K5S0 Q8WWY4 Q9BV14																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1320792	Cc1c(O)c(ncc1-c1cnc(s1)-c1ccccc1)C(=O)NCC(O)=O	InChI=1S/C18H15N3O4S/c1-10-12(7-19-15(16(10)24)17(25)20-9-14(22)23)13-8-21-18(26-13)11-5-3-2-4-6-11/h2-8,24H,9H2,1H3,(H,20,25)(H,22,23)	BHIRGYDDAGFULU-UHFFFAOYSA-N	618973	US20230295110, Compound 7.	Prolyl hydroxylase EGLN3	Homo sapiens		<100							US Patent		10.7270/Q22V2M76		aid1919747	US20230295110	BLAISDELL, TP; ALLU, SR; FLEMING, PE	9/21/2023	10/30/2023	Akebia Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=618973	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5442&target=Prolyl+hydroxylase+EGLN3&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=618973&enzyme=Prolyl+hydroxylase+EGLN3&column=ki&startPg=0&Increment=50&submit=Search			162731674	485226288							1	MPLGHIMRLDLEKIALEYIVPCLHEVGFCYLDNFLGEVVGDCVLERVKQLHCTGALRDGQLAGPRAGVSKRHLRGDQITWIGGNEEGCEAISFLLSLIDRLVLYCGSRLGKYYVKERSKAMVACYPGNGTGYVRHVDNPNGDGRCITCIYYLNKNWDAKLHGGILRIFPEGKSFIADVEPIFDRLLFFWSDRRNPHEVQPSYATRYAMTVWYFDAEERAEAKKKFRNLTRKTESALTED		Prolyl hydroxylase EGLN3	EGLN3_HUMAN	Q9H6Z9	Q2TA79 Q3B8N4 Q6P1R2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1320793	Cc1c(O)c(ncc1-c1cccc(Oc2ccccc2)c1)C(=O)NCC(O)=O	InChI=1S/C21H18N2O5/c1-13-17(11-22-19(20(13)26)21(27)23-12-18(24)25)14-6-5-9-16(10-14)28-15-7-3-2-4-8-15/h2-11,26H,12H2,1H3,(H,23,27)(H,24,25)	XCNIQMSDAMAHGL-UHFFFAOYSA-N	618974	US20230295110, Compound 8.	Egl nine homolog 1	Homo sapiens		<100							US Patent		10.7270/Q22V2M76		aid1919747	US20230295110	BLAISDELL, TP; ALLU, SR; FLEMING, PE	9/21/2023	10/30/2023	Akebia Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=618974	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5440&target=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=618974&enzyme=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search			162731608	485226289							1	MANDSGGPGGPSPSERDRQYCELCGKMENLLRCSRCRSSFYCCKEHQRQDWKKHKLVCQGSEGALGHGVGPHQHSGPAPPAAVPPPRAGAREPRKAAARRDNASGDAAKGKVKAKPPADPAAAASPCRAAAGGQGSAVAAEAEPGKEEPPARSSLFQEKANLYPPSNTPGDALSPGGGLRPNGQTKPLPALKLALEYIVPCMNKHGICVVDDFLGKETGQQIGDEVRALHDTGKFTDGQLVSQKSDSSKDIRGDKITWIEGKEPGCETIGLLMSSMDDLIRHCNGKLGSYKINGRTKAMVACYPGNGTGYVRHVDNPNGDGRCVTCIYYLNKDWDAKVSGGILRIFPEGKAQFADIEPKFDRLLFFWSDRRNPHEVQPAYATRYAITVWYFDADERARAKVKYLTGEKGVRVELNKPSDSVGKDVF	6YW0,6YVZ,6YVX,6YVW,6YVT,5OX6,5OX5,5A3U,4BQY,4BQX,4BQW,2Y34,2Y33,8Y0V,7UJV,3HQU,2G1M,5LA9,5L9V,8Z33,8Z32,2HBU,2HBT,2G19,3OUJ,3OUH,5V18,8Q6E,8Q6D,8Q5S,7Q5X,7Q5V,6YW3,6YW2,6YW1,6ST3,6QGV,6ZBO,6ZBN,8J1K,8Z35,8Z31,6NMQ,3OUI	Egl nine homolog 1	EGLN1_HUMAN	Q9GZT9	Q8N3M8 Q9BZS8 Q9BZT0		hypoxia-inducible factor-proline dioxygenase	R4SCQ0_HUMAN	R4SCQ0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
1320794	Cc1c(O)c(ncc1-c1cccc(Oc2ccccc2)c1)C(=O)NCC(O)=O	InChI=1S/C21H18N2O5/c1-13-17(11-22-19(20(13)26)21(27)23-12-18(24)25)14-6-5-9-16(10-14)28-15-7-3-2-4-8-15/h2-11,26H,12H2,1H3,(H,23,27)(H,24,25)	XCNIQMSDAMAHGL-UHFFFAOYSA-N	618974	US20230295110, Compound 8.	Prolyl hydroxylase EGLN2	Homo sapiens		<100							US Patent		10.7270/Q22V2M76		aid1919747	US20230295110	BLAISDELL, TP; ALLU, SR; FLEMING, PE	9/21/2023	10/30/2023	Akebia Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=618974	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=618974&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search			162731608	485226289							1	MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT		Prolyl hydroxylase EGLN2	EGLN2_HUMAN	Q96KS0	A8K5S0 Q8WWY4 Q9BV14																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1320795	Cc1c(O)c(ncc1-c1ccc(nc1)C(F)(F)F)C(=O)NCC(O)=O	InChI=1S/C15H12F3N3O4/c1-7-9(8-2-3-10(19-4-8)15(16,17)18)5-20-12(13(7)24)14(25)21-6-11(22)23/h2-5,24H,6H2,1H3,(H,21,25)(H,22,23)	COQYEYFGBWPFGZ-UHFFFAOYSA-N	618975	US20230295110, Compound 9.	Egl nine homolog 1	Homo sapiens		<100							US Patent		10.7270/Q22V2M76		aid1919747	US20230295110	BLAISDELL, TP; ALLU, SR; FLEMING, PE	9/21/2023	10/30/2023	Akebia Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=618975	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5440&target=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=618975&enzyme=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search			162731525	485226290							1	MANDSGGPGGPSPSERDRQYCELCGKMENLLRCSRCRSSFYCCKEHQRQDWKKHKLVCQGSEGALGHGVGPHQHSGPAPPAAVPPPRAGAREPRKAAARRDNASGDAAKGKVKAKPPADPAAAASPCRAAAGGQGSAVAAEAEPGKEEPPARSSLFQEKANLYPPSNTPGDALSPGGGLRPNGQTKPLPALKLALEYIVPCMNKHGICVVDDFLGKETGQQIGDEVRALHDTGKFTDGQLVSQKSDSSKDIRGDKITWIEGKEPGCETIGLLMSSMDDLIRHCNGKLGSYKINGRTKAMVACYPGNGTGYVRHVDNPNGDGRCVTCIYYLNKDWDAKVSGGILRIFPEGKAQFADIEPKFDRLLFFWSDRRNPHEVQPAYATRYAITVWYFDADERARAKVKYLTGEKGVRVELNKPSDSVGKDVF	6YW0,6YVZ,6YVX,6YVW,6YVT,5OX6,5OX5,5A3U,4BQY,4BQX,4BQW,2Y34,2Y33,8Y0V,7UJV,3HQU,2G1M,5LA9,5L9V,8Z33,8Z32,2HBU,2HBT,2G19,3OUJ,3OUH,5V18,8Q6E,8Q6D,8Q5S,7Q5X,7Q5V,6YW3,6YW2,6YW1,6ST3,6QGV,6ZBO,6ZBN,8J1K,8Z35,8Z31,6NMQ,3OUI	Egl nine homolog 1	EGLN1_HUMAN	Q9GZT9	Q8N3M8 Q9BZS8 Q9BZT0		hypoxia-inducible factor-proline dioxygenase	R4SCQ0_HUMAN	R4SCQ0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
1320796	Cc1c(O)c(ncc1-c1ccc(nc1)C(F)(F)F)C(=O)NCC(O)=O	InChI=1S/C15H12F3N3O4/c1-7-9(8-2-3-10(19-4-8)15(16,17)18)5-20-12(13(7)24)14(25)21-6-11(22)23/h2-5,24H,6H2,1H3,(H,21,25)(H,22,23)	COQYEYFGBWPFGZ-UHFFFAOYSA-N	618975	US20230295110, Compound 9.	Prolyl hydroxylase EGLN2	Homo sapiens		<100							US Patent		10.7270/Q22V2M76		aid1919747	US20230295110	BLAISDELL, TP; ALLU, SR; FLEMING, PE	9/21/2023	10/30/2023	Akebia Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=618975	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=618975&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search			162731525	485226290							1	MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT		Prolyl hydroxylase EGLN2	EGLN2_HUMAN	Q96KS0	A8K5S0 Q8WWY4 Q9BV14																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1320797	Cc1c(O)c(ncc1-c1ccc(nc1)C(F)(F)F)C(=O)NCC(O)=O	InChI=1S/C15H12F3N3O4/c1-7-9(8-2-3-10(19-4-8)15(16,17)18)5-20-12(13(7)24)14(25)21-6-11(22)23/h2-5,24H,6H2,1H3,(H,21,25)(H,22,23)	COQYEYFGBWPFGZ-UHFFFAOYSA-N	618975	US20230295110, Compound 9.	Prolyl hydroxylase EGLN3	Homo sapiens		<100							US Patent		10.7270/Q22V2M76		aid1919747	US20230295110	BLAISDELL, TP; ALLU, SR; FLEMING, PE	9/21/2023	10/30/2023	Akebia Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=618975	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5442&target=Prolyl+hydroxylase+EGLN3&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=618975&enzyme=Prolyl+hydroxylase+EGLN3&column=ki&startPg=0&Increment=50&submit=Search			162731525	485226290							1	MPLGHIMRLDLEKIALEYIVPCLHEVGFCYLDNFLGEVVGDCVLERVKQLHCTGALRDGQLAGPRAGVSKRHLRGDQITWIGGNEEGCEAISFLLSLIDRLVLYCGSRLGKYYVKERSKAMVACYPGNGTGYVRHVDNPNGDGRCITCIYYLNKNWDAKLHGGILRIFPEGKSFIADVEPIFDRLLFFWSDRRNPHEVQPSYATRYAMTVWYFDAEERAEAKKKFRNLTRKTESALTED		Prolyl hydroxylase EGLN3	EGLN3_HUMAN	Q9H6Z9	Q2TA79 Q3B8N4 Q6P1R2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1320798	Cc1c(O)c(ncc1-c1cccnc1)C(=O)NCC(O)=O	InChI=1S/C14H13N3O4/c1-8-10(9-3-2-4-15-5-9)6-16-12(13(8)20)14(21)17-7-11(18)19/h2-6,20H,7H2,1H3,(H,17,21)(H,18,19)	HOHLJTZNHRBKPG-UHFFFAOYSA-N	618976	US20230295110, Compound 10.	Egl nine homolog 1	Homo sapiens		<100							US Patent		10.7270/Q22V2M76		aid1919747	US20230295110	BLAISDELL, TP; ALLU, SR; FLEMING, PE	9/21/2023	10/30/2023	Akebia Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=618976	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5440&target=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=618976&enzyme=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search			162731492	485226291							1	MANDSGGPGGPSPSERDRQYCELCGKMENLLRCSRCRSSFYCCKEHQRQDWKKHKLVCQGSEGALGHGVGPHQHSGPAPPAAVPPPRAGAREPRKAAARRDNASGDAAKGKVKAKPPADPAAAASPCRAAAGGQGSAVAAEAEPGKEEPPARSSLFQEKANLYPPSNTPGDALSPGGGLRPNGQTKPLPALKLALEYIVPCMNKHGICVVDDFLGKETGQQIGDEVRALHDTGKFTDGQLVSQKSDSSKDIRGDKITWIEGKEPGCETIGLLMSSMDDLIRHCNGKLGSYKINGRTKAMVACYPGNGTGYVRHVDNPNGDGRCVTCIYYLNKDWDAKVSGGILRIFPEGKAQFADIEPKFDRLLFFWSDRRNPHEVQPAYATRYAITVWYFDADERARAKVKYLTGEKGVRVELNKPSDSVGKDVF	6YW0,6YVZ,6YVX,6YVW,6YVT,5OX6,5OX5,5A3U,4BQY,4BQX,4BQW,2Y34,2Y33,8Y0V,7UJV,3HQU,2G1M,5LA9,5L9V,8Z33,8Z32,2HBU,2HBT,2G19,3OUJ,3OUH,5V18,8Q6E,8Q6D,8Q5S,7Q5X,7Q5V,6YW3,6YW2,6YW1,6ST3,6QGV,6ZBO,6ZBN,8J1K,8Z35,8Z31,6NMQ,3OUI	Egl nine homolog 1	EGLN1_HUMAN	Q9GZT9	Q8N3M8 Q9BZS8 Q9BZT0		hypoxia-inducible factor-proline dioxygenase	R4SCQ0_HUMAN	R4SCQ0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
1320799	Cc1c(O)c(ncc1-c1cccnc1)C(=O)NCC(O)=O	InChI=1S/C14H13N3O4/c1-8-10(9-3-2-4-15-5-9)6-16-12(13(8)20)14(21)17-7-11(18)19/h2-6,20H,7H2,1H3,(H,17,21)(H,18,19)	HOHLJTZNHRBKPG-UHFFFAOYSA-N	618976	US20230295110, Compound 10.	Prolyl hydroxylase EGLN2	Homo sapiens		<100							US Patent		10.7270/Q22V2M76		aid1919747	US20230295110	BLAISDELL, TP; ALLU, SR; FLEMING, PE	9/21/2023	10/30/2023	Akebia Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=618976	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=618976&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search			162731492	485226291							1	MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT		Prolyl hydroxylase EGLN2	EGLN2_HUMAN	Q96KS0	A8K5S0 Q8WWY4 Q9BV14																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1320800	Cc1c(O)c(ncc1-c1cccnc1)C(=O)NCC(O)=O	InChI=1S/C14H13N3O4/c1-8-10(9-3-2-4-15-5-9)6-16-12(13(8)20)14(21)17-7-11(18)19/h2-6,20H,7H2,1H3,(H,17,21)(H,18,19)	HOHLJTZNHRBKPG-UHFFFAOYSA-N	618976	US20230295110, Compound 10.	Prolyl hydroxylase EGLN3	Homo sapiens		<100							US Patent		10.7270/Q22V2M76		aid1919747	US20230295110	BLAISDELL, TP; ALLU, SR; FLEMING, PE	9/21/2023	10/30/2023	Akebia Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=618976	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5442&target=Prolyl+hydroxylase+EGLN3&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=618976&enzyme=Prolyl+hydroxylase+EGLN3&column=ki&startPg=0&Increment=50&submit=Search			162731492	485226291							1	MPLGHIMRLDLEKIALEYIVPCLHEVGFCYLDNFLGEVVGDCVLERVKQLHCTGALRDGQLAGPRAGVSKRHLRGDQITWIGGNEEGCEAISFLLSLIDRLVLYCGSRLGKYYVKERSKAMVACYPGNGTGYVRHVDNPNGDGRCITCIYYLNKNWDAKLHGGILRIFPEGKSFIADVEPIFDRLLFFWSDRRNPHEVQPSYATRYAMTVWYFDAEERAEAKKKFRNLTRKTESALTED		Prolyl hydroxylase EGLN3	EGLN3_HUMAN	Q9H6Z9	Q2TA79 Q3B8N4 Q6P1R2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1320801	Cc1c(O)c(ncc1-c1ccncc1)C(=O)NCC(O)=O	InChI=1S/C14H13N3O4/c1-8-10(9-2-4-15-5-3-9)6-16-12(13(8)20)14(21)17-7-11(18)19/h2-6,20H,7H2,1H3,(H,17,21)(H,18,19)	RSAYDVDKMDAEAG-UHFFFAOYSA-N	618977	US20230295110, Compound 11.	Egl nine homolog 1	Homo sapiens		<100							US Patent		10.7270/Q22V2M76		aid1919747	US20230295110	BLAISDELL, TP; ALLU, SR; FLEMING, PE	9/21/2023	10/30/2023	Akebia Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=618977	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5440&target=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=618977&enzyme=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search			162731769	485226292							1	MANDSGGPGGPSPSERDRQYCELCGKMENLLRCSRCRSSFYCCKEHQRQDWKKHKLVCQGSEGALGHGVGPHQHSGPAPPAAVPPPRAGAREPRKAAARRDNASGDAAKGKVKAKPPADPAAAASPCRAAAGGQGSAVAAEAEPGKEEPPARSSLFQEKANLYPPSNTPGDALSPGGGLRPNGQTKPLPALKLALEYIVPCMNKHGICVVDDFLGKETGQQIGDEVRALHDTGKFTDGQLVSQKSDSSKDIRGDKITWIEGKEPGCETIGLLMSSMDDLIRHCNGKLGSYKINGRTKAMVACYPGNGTGYVRHVDNPNGDGRCVTCIYYLNKDWDAKVSGGILRIFPEGKAQFADIEPKFDRLLFFWSDRRNPHEVQPAYATRYAITVWYFDADERARAKVKYLTGEKGVRVELNKPSDSVGKDVF	6YW0,6YVZ,6YVX,6YVW,6YVT,5OX6,5OX5,5A3U,4BQY,4BQX,4BQW,2Y34,2Y33,8Y0V,7UJV,3HQU,2G1M,5LA9,5L9V,8Z33,8Z32,2HBU,2HBT,2G19,3OUJ,3OUH,5V18,8Q6E,8Q6D,8Q5S,7Q5X,7Q5V,6YW3,6YW2,6YW1,6ST3,6QGV,6ZBO,6ZBN,8J1K,8Z35,8Z31,6NMQ,3OUI	Egl nine homolog 1	EGLN1_HUMAN	Q9GZT9	Q8N3M8 Q9BZS8 Q9BZT0		hypoxia-inducible factor-proline dioxygenase	R4SCQ0_HUMAN	R4SCQ0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
1320802	Cc1c(O)c(ncc1-c1ccncc1)C(=O)NCC(O)=O	InChI=1S/C14H13N3O4/c1-8-10(9-2-4-15-5-3-9)6-16-12(13(8)20)14(21)17-7-11(18)19/h2-6,20H,7H2,1H3,(H,17,21)(H,18,19)	RSAYDVDKMDAEAG-UHFFFAOYSA-N	618977	US20230295110, Compound 11.	Prolyl hydroxylase EGLN2	Homo sapiens		<100							US Patent		10.7270/Q22V2M76		aid1919747	US20230295110	BLAISDELL, TP; ALLU, SR; FLEMING, PE	9/21/2023	10/30/2023	Akebia Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=618977	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=618977&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search			162731769	485226292							1	MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT		Prolyl hydroxylase EGLN2	EGLN2_HUMAN	Q96KS0	A8K5S0 Q8WWY4 Q9BV14																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1320803	Cc1c(O)c(ncc1-c1ccccn1)C(=O)NCC(O)=O	InChI=1S/C14H13N3O4/c1-8-9(10-4-2-3-5-15-10)6-16-12(13(8)20)14(21)17-7-11(18)19/h2-6,20H,7H2,1H3,(H,17,21)(H,18,19)	KSERPQZEEYPBAE-UHFFFAOYSA-N	618979	US20230295110, Compound 12.	Egl nine homolog 1	Homo sapiens		<100							US Patent		10.7270/Q22V2M76		aid1919747	US20230295110	BLAISDELL, TP; ALLU, SR; FLEMING, PE	9/21/2023	10/30/2023	Akebia Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=618979	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5440&target=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=618979&enzyme=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search			162731761	485226294							1	MANDSGGPGGPSPSERDRQYCELCGKMENLLRCSRCRSSFYCCKEHQRQDWKKHKLVCQGSEGALGHGVGPHQHSGPAPPAAVPPPRAGAREPRKAAARRDNASGDAAKGKVKAKPPADPAAAASPCRAAAGGQGSAVAAEAEPGKEEPPARSSLFQEKANLYPPSNTPGDALSPGGGLRPNGQTKPLPALKLALEYIVPCMNKHGICVVDDFLGKETGQQIGDEVRALHDTGKFTDGQLVSQKSDSSKDIRGDKITWIEGKEPGCETIGLLMSSMDDLIRHCNGKLGSYKINGRTKAMVACYPGNGTGYVRHVDNPNGDGRCVTCIYYLNKDWDAKVSGGILRIFPEGKAQFADIEPKFDRLLFFWSDRRNPHEVQPAYATRYAITVWYFDADERARAKVKYLTGEKGVRVELNKPSDSVGKDVF	6YW0,6YVZ,6YVX,6YVW,6YVT,5OX6,5OX5,5A3U,4BQY,4BQX,4BQW,2Y34,2Y33,8Y0V,7UJV,3HQU,2G1M,5LA9,5L9V,8Z33,8Z32,2HBU,2HBT,2G19,3OUJ,3OUH,5V18,8Q6E,8Q6D,8Q5S,7Q5X,7Q5V,6YW3,6YW2,6YW1,6ST3,6QGV,6ZBO,6ZBN,8J1K,8Z35,8Z31,6NMQ,3OUI	Egl nine homolog 1	EGLN1_HUMAN	Q9GZT9	Q8N3M8 Q9BZS8 Q9BZT0		hypoxia-inducible factor-proline dioxygenase	R4SCQ0_HUMAN	R4SCQ0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
1320804	Cc1c(O)c(ncc1-c1ccccn1)C(=O)NCC(O)=O	InChI=1S/C14H13N3O4/c1-8-9(10-4-2-3-5-15-10)6-16-12(13(8)20)14(21)17-7-11(18)19/h2-6,20H,7H2,1H3,(H,17,21)(H,18,19)	KSERPQZEEYPBAE-UHFFFAOYSA-N	618979	US20230295110, Compound 12.	Prolyl hydroxylase EGLN2	Homo sapiens		<100							US Patent		10.7270/Q22V2M76		aid1919747	US20230295110	BLAISDELL, TP; ALLU, SR; FLEMING, PE	9/21/2023	10/30/2023	Akebia Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=618979	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=618979&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search			162731761	485226294							1	MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT		Prolyl hydroxylase EGLN2	EGLN2_HUMAN	Q96KS0	A8K5S0 Q8WWY4 Q9BV14																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1320805	Cc1c(O)c(ncc1-c1cccc(Cl)c1)C(=O)NC(C)(C)C(O)=O	InChI=1S/C17H17ClN2O4/c1-9-12(10-5-4-6-11(18)7-10)8-19-13(14(9)21)15(22)20-17(2,3)16(23)24/h4-8,21H,1-3H3,(H,20,22)(H,23,24)	KKYDVQHAKKOKGV-UHFFFAOYSA-N	618980	US20230295110, Compound 13.	Egl nine homolog 1	Homo sapiens		 5500							US Patent		10.7270/Q22V2M76		aid1919747	US20230295110	BLAISDELL, TP; ALLU, SR; FLEMING, PE	9/21/2023	10/30/2023	Akebia Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=618980	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5440&target=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=618980&enzyme=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search			162731469	485226295							1	MANDSGGPGGPSPSERDRQYCELCGKMENLLRCSRCRSSFYCCKEHQRQDWKKHKLVCQGSEGALGHGVGPHQHSGPAPPAAVPPPRAGAREPRKAAARRDNASGDAAKGKVKAKPPADPAAAASPCRAAAGGQGSAVAAEAEPGKEEPPARSSLFQEKANLYPPSNTPGDALSPGGGLRPNGQTKPLPALKLALEYIVPCMNKHGICVVDDFLGKETGQQIGDEVRALHDTGKFTDGQLVSQKSDSSKDIRGDKITWIEGKEPGCETIGLLMSSMDDLIRHCNGKLGSYKINGRTKAMVACYPGNGTGYVRHVDNPNGDGRCVTCIYYLNKDWDAKVSGGILRIFPEGKAQFADIEPKFDRLLFFWSDRRNPHEVQPAYATRYAITVWYFDADERARAKVKYLTGEKGVRVELNKPSDSVGKDVF	6YW0,6YVZ,6YVX,6YVW,6YVT,5OX6,5OX5,5A3U,4BQY,4BQX,4BQW,2Y34,2Y33,8Y0V,7UJV,3HQU,2G1M,5LA9,5L9V,8Z33,8Z32,2HBU,2HBT,2G19,3OUJ,3OUH,5V18,8Q6E,8Q6D,8Q5S,7Q5X,7Q5V,6YW3,6YW2,6YW1,6ST3,6QGV,6ZBO,6ZBN,8J1K,8Z35,8Z31,6NMQ,3OUI	Egl nine homolog 1	EGLN1_HUMAN	Q9GZT9	Q8N3M8 Q9BZS8 Q9BZT0		hypoxia-inducible factor-proline dioxygenase	R4SCQ0_HUMAN	R4SCQ0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
1320806	Cc1c(O)c(ncc1-c1cccc(Cl)c1)C(=O)NC(C)(C)C(O)=O	InChI=1S/C17H17ClN2O4/c1-9-12(10-5-4-6-11(18)7-10)8-19-13(14(9)21)15(22)20-17(2,3)16(23)24/h4-8,21H,1-3H3,(H,20,22)(H,23,24)	KKYDVQHAKKOKGV-UHFFFAOYSA-N	618980	US20230295110, Compound 13.	Prolyl hydroxylase EGLN2	Homo sapiens		 5500							US Patent		10.7270/Q22V2M76		aid1919747	US20230295110	BLAISDELL, TP; ALLU, SR; FLEMING, PE	9/21/2023	10/30/2023	Akebia Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=618980	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=618980&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search			162731469	485226295							1	MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT		Prolyl hydroxylase EGLN2	EGLN2_HUMAN	Q96KS0	A8K5S0 Q8WWY4 Q9BV14																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1320807	Cc1c(O)c(ncc1-c1cccc(Cl)c1)C(=O)NC1(CC1)C(O)=O	InChI=1S/C17H15ClN2O4/c1-9-12(10-3-2-4-11(18)7-10)8-19-13(14(9)21)15(22)20-17(5-6-17)16(23)24/h2-4,7-8,21H,5-6H2,1H3,(H,20,22)(H,23,24)	JFKARLNXRVYWNG-UHFFFAOYSA-N	618981	US20230295110, Compound 14.	Egl nine homolog 1	Homo sapiens		 5500							US Patent		10.7270/Q22V2M76		aid1919747	US20230295110	BLAISDELL, TP; ALLU, SR; FLEMING, PE	9/21/2023	10/30/2023	Akebia Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=618981	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5440&target=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=618981&enzyme=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search			162731569	485226296							1	MANDSGGPGGPSPSERDRQYCELCGKMENLLRCSRCRSSFYCCKEHQRQDWKKHKLVCQGSEGALGHGVGPHQHSGPAPPAAVPPPRAGAREPRKAAARRDNASGDAAKGKVKAKPPADPAAAASPCRAAAGGQGSAVAAEAEPGKEEPPARSSLFQEKANLYPPSNTPGDALSPGGGLRPNGQTKPLPALKLALEYIVPCMNKHGICVVDDFLGKETGQQIGDEVRALHDTGKFTDGQLVSQKSDSSKDIRGDKITWIEGKEPGCETIGLLMSSMDDLIRHCNGKLGSYKINGRTKAMVACYPGNGTGYVRHVDNPNGDGRCVTCIYYLNKDWDAKVSGGILRIFPEGKAQFADIEPKFDRLLFFWSDRRNPHEVQPAYATRYAITVWYFDADERARAKVKYLTGEKGVRVELNKPSDSVGKDVF	6YW0,6YVZ,6YVX,6YVW,6YVT,5OX6,5OX5,5A3U,4BQY,4BQX,4BQW,2Y34,2Y33,8Y0V,7UJV,3HQU,2G1M,5LA9,5L9V,8Z33,8Z32,2HBU,2HBT,2G19,3OUJ,3OUH,5V18,8Q6E,8Q6D,8Q5S,7Q5X,7Q5V,6YW3,6YW2,6YW1,6ST3,6QGV,6ZBO,6ZBN,8J1K,8Z35,8Z31,6NMQ,3OUI	Egl nine homolog 1	EGLN1_HUMAN	Q9GZT9	Q8N3M8 Q9BZS8 Q9BZT0		hypoxia-inducible factor-proline dioxygenase	R4SCQ0_HUMAN	R4SCQ0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
1320808	Cc1c(O)c(ncc1-c1cccc(Cl)c1)C(=O)NC1(CC1)C(O)=O	InChI=1S/C17H15ClN2O4/c1-9-12(10-3-2-4-11(18)7-10)8-19-13(14(9)21)15(22)20-17(5-6-17)16(23)24/h2-4,7-8,21H,5-6H2,1H3,(H,20,22)(H,23,24)	JFKARLNXRVYWNG-UHFFFAOYSA-N	618981	US20230295110, Compound 14.	Prolyl hydroxylase EGLN2	Homo sapiens		 5500							US Patent		10.7270/Q22V2M76		aid1919747	US20230295110	BLAISDELL, TP; ALLU, SR; FLEMING, PE	9/21/2023	10/30/2023	Akebia Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=618981	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=618981&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search			162731569	485226296							1	MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT		Prolyl hydroxylase EGLN2	EGLN2_HUMAN	Q96KS0	A8K5S0 Q8WWY4 Q9BV14																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1320809	Cc1c(O)c(ncc1-c1cccc(Cl)c1)C(=O)NC1(CCC1)C(O)=O	InChI=1S/C18H17ClN2O4/c1-10-13(11-4-2-5-12(19)8-11)9-20-14(15(10)22)16(23)21-18(17(24)25)6-3-7-18/h2,4-5,8-9,22H,3,6-7H2,1H3,(H,21,23)(H,24,25)	XDKNDMJZMQNVIC-UHFFFAOYSA-N	618983	US20230295110, Compound 15.	Egl nine homolog 1	Homo sapiens		 5500							US Patent		10.7270/Q22V2M76		aid1919747	US20230295110	BLAISDELL, TP; ALLU, SR; FLEMING, PE	9/21/2023	10/30/2023	Akebia Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=618983	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5440&target=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=618983&enzyme=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search			162731573	485226298							1	MANDSGGPGGPSPSERDRQYCELCGKMENLLRCSRCRSSFYCCKEHQRQDWKKHKLVCQGSEGALGHGVGPHQHSGPAPPAAVPPPRAGAREPRKAAARRDNASGDAAKGKVKAKPPADPAAAASPCRAAAGGQGSAVAAEAEPGKEEPPARSSLFQEKANLYPPSNTPGDALSPGGGLRPNGQTKPLPALKLALEYIVPCMNKHGICVVDDFLGKETGQQIGDEVRALHDTGKFTDGQLVSQKSDSSKDIRGDKITWIEGKEPGCETIGLLMSSMDDLIRHCNGKLGSYKINGRTKAMVACYPGNGTGYVRHVDNPNGDGRCVTCIYYLNKDWDAKVSGGILRIFPEGKAQFADIEPKFDRLLFFWSDRRNPHEVQPAYATRYAITVWYFDADERARAKVKYLTGEKGVRVELNKPSDSVGKDVF	6YW0,6YVZ,6YVX,6YVW,6YVT,5OX6,5OX5,5A3U,4BQY,4BQX,4BQW,2Y34,2Y33,8Y0V,7UJV,3HQU,2G1M,5LA9,5L9V,8Z33,8Z32,2HBU,2HBT,2G19,3OUJ,3OUH,5V18,8Q6E,8Q6D,8Q5S,7Q5X,7Q5V,6YW3,6YW2,6YW1,6ST3,6QGV,6ZBO,6ZBN,8J1K,8Z35,8Z31,6NMQ,3OUI	Egl nine homolog 1	EGLN1_HUMAN	Q9GZT9	Q8N3M8 Q9BZS8 Q9BZT0		hypoxia-inducible factor-proline dioxygenase	R4SCQ0_HUMAN	R4SCQ0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
1320810	Cc1c(O)c(ncc1-c1cccc(Cl)c1)C(=O)NC1(CCC1)C(O)=O	InChI=1S/C18H17ClN2O4/c1-10-13(11-4-2-5-12(19)8-11)9-20-14(15(10)22)16(23)21-18(17(24)25)6-3-7-18/h2,4-5,8-9,22H,3,6-7H2,1H3,(H,21,23)(H,24,25)	XDKNDMJZMQNVIC-UHFFFAOYSA-N	618983	US20230295110, Compound 15.	Prolyl hydroxylase EGLN2	Homo sapiens		 5500							US Patent		10.7270/Q22V2M76		aid1919747	US20230295110	BLAISDELL, TP; ALLU, SR; FLEMING, PE	9/21/2023	10/30/2023	Akebia Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=618983	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=618983&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search			162731573	485226298							1	MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT		Prolyl hydroxylase EGLN2	EGLN2_HUMAN	Q96KS0	A8K5S0 Q8WWY4 Q9BV14																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1320811	Cc1c(O)c(ncc1-c1cccc(Cl)c1)C(=O)NC1(COC1)C(O)=O	InChI=1S/C17H15ClN2O5/c1-9-12(10-3-2-4-11(18)5-10)6-19-13(14(9)21)15(22)20-17(16(23)24)7-25-8-17/h2-6,21H,7-8H2,1H3,(H,20,22)(H,23,24)	YVODCGVXOKWYEV-UHFFFAOYSA-N	618984	US20230295110, Compound 16.	Egl nine homolog 1	Homo sapiens		 5500							US Patent		10.7270/Q22V2M76		aid1919747	US20230295110	BLAISDELL, TP; ALLU, SR; FLEMING, PE	9/21/2023	10/30/2023	Akebia Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=618984	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5440&target=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=618984&enzyme=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search			162731516	485226299							1	MANDSGGPGGPSPSERDRQYCELCGKMENLLRCSRCRSSFYCCKEHQRQDWKKHKLVCQGSEGALGHGVGPHQHSGPAPPAAVPPPRAGAREPRKAAARRDNASGDAAKGKVKAKPPADPAAAASPCRAAAGGQGSAVAAEAEPGKEEPPARSSLFQEKANLYPPSNTPGDALSPGGGLRPNGQTKPLPALKLALEYIVPCMNKHGICVVDDFLGKETGQQIGDEVRALHDTGKFTDGQLVSQKSDSSKDIRGDKITWIEGKEPGCETIGLLMSSMDDLIRHCNGKLGSYKINGRTKAMVACYPGNGTGYVRHVDNPNGDGRCVTCIYYLNKDWDAKVSGGILRIFPEGKAQFADIEPKFDRLLFFWSDRRNPHEVQPAYATRYAITVWYFDADERARAKVKYLTGEKGVRVELNKPSDSVGKDVF	6YW0,6YVZ,6YVX,6YVW,6YVT,5OX6,5OX5,5A3U,4BQY,4BQX,4BQW,2Y34,2Y33,8Y0V,7UJV,3HQU,2G1M,5LA9,5L9V,8Z33,8Z32,2HBU,2HBT,2G19,3OUJ,3OUH,5V18,8Q6E,8Q6D,8Q5S,7Q5X,7Q5V,6YW3,6YW2,6YW1,6ST3,6QGV,6ZBO,6ZBN,8J1K,8Z35,8Z31,6NMQ,3OUI	Egl nine homolog 1	EGLN1_HUMAN	Q9GZT9	Q8N3M8 Q9BZS8 Q9BZT0		hypoxia-inducible factor-proline dioxygenase	R4SCQ0_HUMAN	R4SCQ0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
1320812	Cc1c(O)c(ncc1-c1cccc(Cl)c1)C(=O)NC1(COC1)C(O)=O	InChI=1S/C17H15ClN2O5/c1-9-12(10-3-2-4-11(18)5-10)6-19-13(14(9)21)15(22)20-17(16(23)24)7-25-8-17/h2-6,21H,7-8H2,1H3,(H,20,22)(H,23,24)	YVODCGVXOKWYEV-UHFFFAOYSA-N	618984	US20230295110, Compound 16.	Prolyl hydroxylase EGLN2	Homo sapiens		 5500							US Patent		10.7270/Q22V2M76		aid1919747	US20230295110	BLAISDELL, TP; ALLU, SR; FLEMING, PE	9/21/2023	10/30/2023	Akebia Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=618984	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=618984&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search			162731516	485226299							1	MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT		Prolyl hydroxylase EGLN2	EGLN2_HUMAN	Q96KS0	A8K5S0 Q8WWY4 Q9BV14																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1320813	CC1CCc2cc(ccc2N1)-c1cnc(C(=O)NCC(O)=O)c(O)c1C	InChI=1S/C19H21N3O4/c1-10-3-4-13-7-12(5-6-15(13)22-10)14-8-20-17(18(25)11(14)2)19(26)21-9-16(23)24/h5-8,10,22,25H,3-4,9H2,1-2H3,(H,21,26)(H,23,24)	UAHUCKIDGWEFHA-UHFFFAOYSA-N	618985	US20230295110, Compound 17.	Egl nine homolog 1	Homo sapiens		<100							US Patent		10.7270/Q22V2M76		aid1919747	US20230295110	BLAISDELL, TP; ALLU, SR; FLEMING, PE	9/21/2023	10/30/2023	Akebia Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=618985	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5440&target=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=618985&enzyme=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search			162731499	485226300							1	MANDSGGPGGPSPSERDRQYCELCGKMENLLRCSRCRSSFYCCKEHQRQDWKKHKLVCQGSEGALGHGVGPHQHSGPAPPAAVPPPRAGAREPRKAAARRDNASGDAAKGKVKAKPPADPAAAASPCRAAAGGQGSAVAAEAEPGKEEPPARSSLFQEKANLYPPSNTPGDALSPGGGLRPNGQTKPLPALKLALEYIVPCMNKHGICVVDDFLGKETGQQIGDEVRALHDTGKFTDGQLVSQKSDSSKDIRGDKITWIEGKEPGCETIGLLMSSMDDLIRHCNGKLGSYKINGRTKAMVACYPGNGTGYVRHVDNPNGDGRCVTCIYYLNKDWDAKVSGGILRIFPEGKAQFADIEPKFDRLLFFWSDRRNPHEVQPAYATRYAITVWYFDADERARAKVKYLTGEKGVRVELNKPSDSVGKDVF	6YW0,6YVZ,6YVX,6YVW,6YVT,5OX6,5OX5,5A3U,4BQY,4BQX,4BQW,2Y34,2Y33,8Y0V,7UJV,3HQU,2G1M,5LA9,5L9V,8Z33,8Z32,2HBU,2HBT,2G19,3OUJ,3OUH,5V18,8Q6E,8Q6D,8Q5S,7Q5X,7Q5V,6YW3,6YW2,6YW1,6ST3,6QGV,6ZBO,6ZBN,8J1K,8Z35,8Z31,6NMQ,3OUI	Egl nine homolog 1	EGLN1_HUMAN	Q9GZT9	Q8N3M8 Q9BZS8 Q9BZT0		hypoxia-inducible factor-proline dioxygenase	R4SCQ0_HUMAN	R4SCQ0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
1320814	CC1CCc2cc(ccc2N1)-c1cnc(C(=O)NCC(O)=O)c(O)c1C	InChI=1S/C19H21N3O4/c1-10-3-4-13-7-12(5-6-15(13)22-10)14-8-20-17(18(25)11(14)2)19(26)21-9-16(23)24/h5-8,10,22,25H,3-4,9H2,1-2H3,(H,21,26)(H,23,24)	UAHUCKIDGWEFHA-UHFFFAOYSA-N	618985	US20230295110, Compound 17.	Prolyl hydroxylase EGLN2	Homo sapiens		<100							US Patent		10.7270/Q22V2M76		aid1919747	US20230295110	BLAISDELL, TP; ALLU, SR; FLEMING, PE	9/21/2023	10/30/2023	Akebia Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=618985	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=618985&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search			162731499	485226300							1	MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT		Prolyl hydroxylase EGLN2	EGLN2_HUMAN	Q96KS0	A8K5S0 Q8WWY4 Q9BV14																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1320815	Cc1c(O)c(ncc1-c1cnn(c1)-c1ccccn1)C(=O)NCC(O)=O	InChI=1S/C17H15N5O4/c1-10-12(7-19-15(16(10)25)17(26)20-8-14(23)24)11-6-21-22(9-11)13-4-2-3-5-18-13/h2-7,9,25H,8H2,1H3,(H,20,26)(H,23,24)	VIIRJLYIJFEJJB-UHFFFAOYSA-N	618986	US20230295110, Compound 18.	Egl nine homolog 1	Homo sapiens		<100							US Patent		10.7270/Q22V2M76		aid1919747	US20230295110	BLAISDELL, TP; ALLU, SR; FLEMING, PE	9/21/2023	10/30/2023	Akebia Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=618986	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5440&target=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=618986&enzyme=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search			162731758	485226301							1	MANDSGGPGGPSPSERDRQYCELCGKMENLLRCSRCRSSFYCCKEHQRQDWKKHKLVCQGSEGALGHGVGPHQHSGPAPPAAVPPPRAGAREPRKAAARRDNASGDAAKGKVKAKPPADPAAAASPCRAAAGGQGSAVAAEAEPGKEEPPARSSLFQEKANLYPPSNTPGDALSPGGGLRPNGQTKPLPALKLALEYIVPCMNKHGICVVDDFLGKETGQQIGDEVRALHDTGKFTDGQLVSQKSDSSKDIRGDKITWIEGKEPGCETIGLLMSSMDDLIRHCNGKLGSYKINGRTKAMVACYPGNGTGYVRHVDNPNGDGRCVTCIYYLNKDWDAKVSGGILRIFPEGKAQFADIEPKFDRLLFFWSDRRNPHEVQPAYATRYAITVWYFDADERARAKVKYLTGEKGVRVELNKPSDSVGKDVF	6YW0,6YVZ,6YVX,6YVW,6YVT,5OX6,5OX5,5A3U,4BQY,4BQX,4BQW,2Y34,2Y33,8Y0V,7UJV,3HQU,2G1M,5LA9,5L9V,8Z33,8Z32,2HBU,2HBT,2G19,3OUJ,3OUH,5V18,8Q6E,8Q6D,8Q5S,7Q5X,7Q5V,6YW3,6YW2,6YW1,6ST3,6QGV,6ZBO,6ZBN,8J1K,8Z35,8Z31,6NMQ,3OUI	Egl nine homolog 1	EGLN1_HUMAN	Q9GZT9	Q8N3M8 Q9BZS8 Q9BZT0		hypoxia-inducible factor-proline dioxygenase	R4SCQ0_HUMAN	R4SCQ0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
1320816	Cc1c(O)c(ncc1-c1cnn(c1)-c1ccccn1)C(=O)NCC(O)=O	InChI=1S/C17H15N5O4/c1-10-12(7-19-15(16(10)25)17(26)20-8-14(23)24)11-6-21-22(9-11)13-4-2-3-5-18-13/h2-7,9,25H,8H2,1H3,(H,20,26)(H,23,24)	VIIRJLYIJFEJJB-UHFFFAOYSA-N	618986	US20230295110, Compound 18.	Prolyl hydroxylase EGLN2	Homo sapiens		<100							US Patent		10.7270/Q22V2M76		aid1919747	US20230295110	BLAISDELL, TP; ALLU, SR; FLEMING, PE	9/21/2023	10/30/2023	Akebia Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=618986	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=618986&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search			162731758	485226301							1	MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT		Prolyl hydroxylase EGLN2	EGLN2_HUMAN	Q96KS0	A8K5S0 Q8WWY4 Q9BV14																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1320817	Cc1c(O)c(ncc1-c1cnn(c1)-c1ccccn1)C(=O)NCC(O)=O	InChI=1S/C17H15N5O4/c1-10-12(7-19-15(16(10)25)17(26)20-8-14(23)24)11-6-21-22(9-11)13-4-2-3-5-18-13/h2-7,9,25H,8H2,1H3,(H,20,26)(H,23,24)	VIIRJLYIJFEJJB-UHFFFAOYSA-N	618986	US20230295110, Compound 18.	Prolyl hydroxylase EGLN3	Homo sapiens		<100							US Patent		10.7270/Q22V2M76		aid1919747	US20230295110	BLAISDELL, TP; ALLU, SR; FLEMING, PE	9/21/2023	10/30/2023	Akebia Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=618986	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5442&target=Prolyl+hydroxylase+EGLN3&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=618986&enzyme=Prolyl+hydroxylase+EGLN3&column=ki&startPg=0&Increment=50&submit=Search			162731758	485226301							1	MPLGHIMRLDLEKIALEYIVPCLHEVGFCYLDNFLGEVVGDCVLERVKQLHCTGALRDGQLAGPRAGVSKRHLRGDQITWIGGNEEGCEAISFLLSLIDRLVLYCGSRLGKYYVKERSKAMVACYPGNGTGYVRHVDNPNGDGRCITCIYYLNKNWDAKLHGGILRIFPEGKSFIADVEPIFDRLLFFWSDRRNPHEVQPSYATRYAMTVWYFDAEERAEAKKKFRNLTRKTESALTED		Prolyl hydroxylase EGLN3	EGLN3_HUMAN	Q9H6Z9	Q2TA79 Q3B8N4 Q6P1R2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1320818	Cc1c(O)c(ncc1-c1cnn(c1)-c1ccc(F)cc1)C(=O)NCC(O)=O	InChI=1S/C18H15FN4O4/c1-10-14(7-20-16(17(10)26)18(27)21-8-15(24)25)11-6-22-23(9-11)13-4-2-12(19)3-5-13/h2-7,9,26H,8H2,1H3,(H,21,27)(H,24,25)	MJMQFHYWFYSYBC-UHFFFAOYSA-N	618987	US20230295110, Compound 19.	Egl nine homolog 1	Homo sapiens		<100							US Patent		10.7270/Q22V2M76		aid1919747	US20230295110	BLAISDELL, TP; ALLU, SR; FLEMING, PE	9/21/2023	10/30/2023	Akebia Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=618987	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5440&target=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=618987&enzyme=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search			162731464	485226302							1	MANDSGGPGGPSPSERDRQYCELCGKMENLLRCSRCRSSFYCCKEHQRQDWKKHKLVCQGSEGALGHGVGPHQHSGPAPPAAVPPPRAGAREPRKAAARRDNASGDAAKGKVKAKPPADPAAAASPCRAAAGGQGSAVAAEAEPGKEEPPARSSLFQEKANLYPPSNTPGDALSPGGGLRPNGQTKPLPALKLALEYIVPCMNKHGICVVDDFLGKETGQQIGDEVRALHDTGKFTDGQLVSQKSDSSKDIRGDKITWIEGKEPGCETIGLLMSSMDDLIRHCNGKLGSYKINGRTKAMVACYPGNGTGYVRHVDNPNGDGRCVTCIYYLNKDWDAKVSGGILRIFPEGKAQFADIEPKFDRLLFFWSDRRNPHEVQPAYATRYAITVWYFDADERARAKVKYLTGEKGVRVELNKPSDSVGKDVF	6YW0,6YVZ,6YVX,6YVW,6YVT,5OX6,5OX5,5A3U,4BQY,4BQX,4BQW,2Y34,2Y33,8Y0V,7UJV,3HQU,2G1M,5LA9,5L9V,8Z33,8Z32,2HBU,2HBT,2G19,3OUJ,3OUH,5V18,8Q6E,8Q6D,8Q5S,7Q5X,7Q5V,6YW3,6YW2,6YW1,6ST3,6QGV,6ZBO,6ZBN,8J1K,8Z35,8Z31,6NMQ,3OUI	Egl nine homolog 1	EGLN1_HUMAN	Q9GZT9	Q8N3M8 Q9BZS8 Q9BZT0		hypoxia-inducible factor-proline dioxygenase	R4SCQ0_HUMAN	R4SCQ0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
1320819	Cc1c(O)c(ncc1-c1cnn(c1)-c1ccc(F)cc1)C(=O)NCC(O)=O	InChI=1S/C18H15FN4O4/c1-10-14(7-20-16(17(10)26)18(27)21-8-15(24)25)11-6-22-23(9-11)13-4-2-12(19)3-5-13/h2-7,9,26H,8H2,1H3,(H,21,27)(H,24,25)	MJMQFHYWFYSYBC-UHFFFAOYSA-N	618987	US20230295110, Compound 19.	Prolyl hydroxylase EGLN2	Homo sapiens		<100							US Patent		10.7270/Q22V2M76		aid1919747	US20230295110	BLAISDELL, TP; ALLU, SR; FLEMING, PE	9/21/2023	10/30/2023	Akebia Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=618987	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=618987&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search			162731464	485226302							1	MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT		Prolyl hydroxylase EGLN2	EGLN2_HUMAN	Q96KS0	A8K5S0 Q8WWY4 Q9BV14																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1320820	Cc1c(O)c(ncc1-c1cnn(c1)-c1ccc(F)cc1)C(=O)NCC(O)=O	InChI=1S/C18H15FN4O4/c1-10-14(7-20-16(17(10)26)18(27)21-8-15(24)25)11-6-22-23(9-11)13-4-2-12(19)3-5-13/h2-7,9,26H,8H2,1H3,(H,21,27)(H,24,25)	MJMQFHYWFYSYBC-UHFFFAOYSA-N	618987	US20230295110, Compound 19.	Prolyl hydroxylase EGLN3	Homo sapiens		<100							US Patent		10.7270/Q22V2M76		aid1919747	US20230295110	BLAISDELL, TP; ALLU, SR; FLEMING, PE	9/21/2023	10/30/2023	Akebia Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=618987	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5442&target=Prolyl+hydroxylase+EGLN3&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=618987&enzyme=Prolyl+hydroxylase+EGLN3&column=ki&startPg=0&Increment=50&submit=Search			162731464	485226302							1	MPLGHIMRLDLEKIALEYIVPCLHEVGFCYLDNFLGEVVGDCVLERVKQLHCTGALRDGQLAGPRAGVSKRHLRGDQITWIGGNEEGCEAISFLLSLIDRLVLYCGSRLGKYYVKERSKAMVACYPGNGTGYVRHVDNPNGDGRCITCIYYLNKNWDAKLHGGILRIFPEGKSFIADVEPIFDRLLFFWSDRRNPHEVQPSYATRYAMTVWYFDAEERAEAKKKFRNLTRKTESALTED		Prolyl hydroxylase EGLN3	EGLN3_HUMAN	Q9H6Z9	Q2TA79 Q3B8N4 Q6P1R2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1320821	CC(C)n1cc(cn1)-c1cnc(C(=O)NCC(O)=O)c(O)c1C	InChI=1S/C15H18N4O4/c1-8(2)19-7-10(4-18-19)11-5-16-13(14(22)9(11)3)15(23)17-6-12(20)21/h4-5,7-8,22H,6H2,1-3H3,(H,17,23)(H,20,21)	OYKCHPWOEMJKKX-UHFFFAOYSA-N	618988	US20230295110, Compound 20.	Egl nine homolog 1	Homo sapiens		<100							US Patent		10.7270/Q22V2M76		aid1919747	US20230295110	BLAISDELL, TP; ALLU, SR; FLEMING, PE	9/21/2023	10/30/2023	Akebia Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=618988	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5440&target=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=618988&enzyme=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search			162731697	485226303							1	MANDSGGPGGPSPSERDRQYCELCGKMENLLRCSRCRSSFYCCKEHQRQDWKKHKLVCQGSEGALGHGVGPHQHSGPAPPAAVPPPRAGAREPRKAAARRDNASGDAAKGKVKAKPPADPAAAASPCRAAAGGQGSAVAAEAEPGKEEPPARSSLFQEKANLYPPSNTPGDALSPGGGLRPNGQTKPLPALKLALEYIVPCMNKHGICVVDDFLGKETGQQIGDEVRALHDTGKFTDGQLVSQKSDSSKDIRGDKITWIEGKEPGCETIGLLMSSMDDLIRHCNGKLGSYKINGRTKAMVACYPGNGTGYVRHVDNPNGDGRCVTCIYYLNKDWDAKVSGGILRIFPEGKAQFADIEPKFDRLLFFWSDRRNPHEVQPAYATRYAITVWYFDADERARAKVKYLTGEKGVRVELNKPSDSVGKDVF	6YW0,6YVZ,6YVX,6YVW,6YVT,5OX6,5OX5,5A3U,4BQY,4BQX,4BQW,2Y34,2Y33,8Y0V,7UJV,3HQU,2G1M,5LA9,5L9V,8Z33,8Z32,2HBU,2HBT,2G19,3OUJ,3OUH,5V18,8Q6E,8Q6D,8Q5S,7Q5X,7Q5V,6YW3,6YW2,6YW1,6ST3,6QGV,6ZBO,6ZBN,8J1K,8Z35,8Z31,6NMQ,3OUI	Egl nine homolog 1	EGLN1_HUMAN	Q9GZT9	Q8N3M8 Q9BZS8 Q9BZT0		hypoxia-inducible factor-proline dioxygenase	R4SCQ0_HUMAN	R4SCQ0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
1320822	CC(C)n1cc(cn1)-c1cnc(C(=O)NCC(O)=O)c(O)c1C	InChI=1S/C15H18N4O4/c1-8(2)19-7-10(4-18-19)11-5-16-13(14(22)9(11)3)15(23)17-6-12(20)21/h4-5,7-8,22H,6H2,1-3H3,(H,17,23)(H,20,21)	OYKCHPWOEMJKKX-UHFFFAOYSA-N	618988	US20230295110, Compound 20.	Prolyl hydroxylase EGLN2	Homo sapiens		<100							US Patent		10.7270/Q22V2M76		aid1919747	US20230295110	BLAISDELL, TP; ALLU, SR; FLEMING, PE	9/21/2023	10/30/2023	Akebia Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=618988	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=618988&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search			162731697	485226303							1	MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT		Prolyl hydroxylase EGLN2	EGLN2_HUMAN	Q96KS0	A8K5S0 Q8WWY4 Q9BV14																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1320823	CC(C)n1cc(cn1)-c1cnc(C(=O)NCC(O)=O)c(O)c1C	InChI=1S/C15H18N4O4/c1-8(2)19-7-10(4-18-19)11-5-16-13(14(22)9(11)3)15(23)17-6-12(20)21/h4-5,7-8,22H,6H2,1-3H3,(H,17,23)(H,20,21)	OYKCHPWOEMJKKX-UHFFFAOYSA-N	618988	US20230295110, Compound 20.	Prolyl hydroxylase EGLN3	Homo sapiens		<100							US Patent		10.7270/Q22V2M76		aid1919747	US20230295110	BLAISDELL, TP; ALLU, SR; FLEMING, PE	9/21/2023	10/30/2023	Akebia Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=618988	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5442&target=Prolyl+hydroxylase+EGLN3&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=618988&enzyme=Prolyl+hydroxylase+EGLN3&column=ki&startPg=0&Increment=50&submit=Search			162731697	485226303							1	MPLGHIMRLDLEKIALEYIVPCLHEVGFCYLDNFLGEVVGDCVLERVKQLHCTGALRDGQLAGPRAGVSKRHLRGDQITWIGGNEEGCEAISFLLSLIDRLVLYCGSRLGKYYVKERSKAMVACYPGNGTGYVRHVDNPNGDGRCITCIYYLNKNWDAKLHGGILRIFPEGKSFIADVEPIFDRLLFFWSDRRNPHEVQPSYATRYAMTVWYFDAEERAEAKKKFRNLTRKTESALTED		Prolyl hydroxylase EGLN3	EGLN3_HUMAN	Q9H6Z9	Q2TA79 Q3B8N4 Q6P1R2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1320824	Cc1c(O)c(ncc1-c1cnn(c1)C1CCOCC1)C(=O)NCC(O)=O	InChI=1S/C17H20N4O5/c1-10-13(7-18-15(16(10)24)17(25)19-8-14(22)23)11-6-20-21(9-11)12-2-4-26-5-3-12/h6-7,9,12,24H,2-5,8H2,1H3,(H,19,25)(H,22,23)	ARDDNRTYYJFYGF-UHFFFAOYSA-N	618989	US20230295110, Compound 21.	Egl nine homolog 1	Homo sapiens		<100							US Patent		10.7270/Q22V2M76		aid1919747	US20230295110	BLAISDELL, TP; ALLU, SR; FLEMING, PE	9/21/2023	10/30/2023	Akebia Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=618989	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5440&target=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=618989&enzyme=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search			162731692	485226304							1	MANDSGGPGGPSPSERDRQYCELCGKMENLLRCSRCRSSFYCCKEHQRQDWKKHKLVCQGSEGALGHGVGPHQHSGPAPPAAVPPPRAGAREPRKAAARRDNASGDAAKGKVKAKPPADPAAAASPCRAAAGGQGSAVAAEAEPGKEEPPARSSLFQEKANLYPPSNTPGDALSPGGGLRPNGQTKPLPALKLALEYIVPCMNKHGICVVDDFLGKETGQQIGDEVRALHDTGKFTDGQLVSQKSDSSKDIRGDKITWIEGKEPGCETIGLLMSSMDDLIRHCNGKLGSYKINGRTKAMVACYPGNGTGYVRHVDNPNGDGRCVTCIYYLNKDWDAKVSGGILRIFPEGKAQFADIEPKFDRLLFFWSDRRNPHEVQPAYATRYAITVWYFDADERARAKVKYLTGEKGVRVELNKPSDSVGKDVF	6YW0,6YVZ,6YVX,6YVW,6YVT,5OX6,5OX5,5A3U,4BQY,4BQX,4BQW,2Y34,2Y33,8Y0V,7UJV,3HQU,2G1M,5LA9,5L9V,8Z33,8Z32,2HBU,2HBT,2G19,3OUJ,3OUH,5V18,8Q6E,8Q6D,8Q5S,7Q5X,7Q5V,6YW3,6YW2,6YW1,6ST3,6QGV,6ZBO,6ZBN,8J1K,8Z35,8Z31,6NMQ,3OUI	Egl nine homolog 1	EGLN1_HUMAN	Q9GZT9	Q8N3M8 Q9BZS8 Q9BZT0		hypoxia-inducible factor-proline dioxygenase	R4SCQ0_HUMAN	R4SCQ0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
1320825	Cc1c(O)c(ncc1-c1cnn(c1)C1CCOCC1)C(=O)NCC(O)=O	InChI=1S/C17H20N4O5/c1-10-13(7-18-15(16(10)24)17(25)19-8-14(22)23)11-6-20-21(9-11)12-2-4-26-5-3-12/h6-7,9,12,24H,2-5,8H2,1H3,(H,19,25)(H,22,23)	ARDDNRTYYJFYGF-UHFFFAOYSA-N	618989	US20230295110, Compound 21.	Prolyl hydroxylase EGLN2	Homo sapiens		<100							US Patent		10.7270/Q22V2M76		aid1919747	US20230295110	BLAISDELL, TP; ALLU, SR; FLEMING, PE	9/21/2023	10/30/2023	Akebia Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=618989	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=618989&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search			162731692	485226304							1	MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT		Prolyl hydroxylase EGLN2	EGLN2_HUMAN	Q96KS0	A8K5S0 Q8WWY4 Q9BV14																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1320826	Cc1c(O)c(ncc1-c1cnn(c1)C1CCOCC1)C(=O)NCC(O)=O	InChI=1S/C17H20N4O5/c1-10-13(7-18-15(16(10)24)17(25)19-8-14(22)23)11-6-20-21(9-11)12-2-4-26-5-3-12/h6-7,9,12,24H,2-5,8H2,1H3,(H,19,25)(H,22,23)	ARDDNRTYYJFYGF-UHFFFAOYSA-N	618989	US20230295110, Compound 21.	Prolyl hydroxylase EGLN3	Homo sapiens		<100							US Patent		10.7270/Q22V2M76		aid1919747	US20230295110	BLAISDELL, TP; ALLU, SR; FLEMING, PE	9/21/2023	10/30/2023	Akebia Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=618989	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5442&target=Prolyl+hydroxylase+EGLN3&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=618989&enzyme=Prolyl+hydroxylase+EGLN3&column=ki&startPg=0&Increment=50&submit=Search			162731692	485226304							1	MPLGHIMRLDLEKIALEYIVPCLHEVGFCYLDNFLGEVVGDCVLERVKQLHCTGALRDGQLAGPRAGVSKRHLRGDQITWIGGNEEGCEAISFLLSLIDRLVLYCGSRLGKYYVKERSKAMVACYPGNGTGYVRHVDNPNGDGRCITCIYYLNKNWDAKLHGGILRIFPEGKSFIADVEPIFDRLLFFWSDRRNPHEVQPSYATRYAMTVWYFDAEERAEAKKKFRNLTRKTESALTED		Prolyl hydroxylase EGLN3	EGLN3_HUMAN	Q9H6Z9	Q2TA79 Q3B8N4 Q6P1R2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1320827	CC(C)Cn1cc(cn1)-c1cnc(C(=O)NCC(O)=O)c(O)c1C	InChI=1S/C16H20N4O4/c1-9(2)7-20-8-11(4-19-20)12-5-17-14(15(23)10(12)3)16(24)18-6-13(21)22/h4-5,8-9,23H,6-7H2,1-3H3,(H,18,24)(H,21,22)	LYNZXAKHMBDTGR-UHFFFAOYSA-N	618990	US20230295110, Compound 22.	Egl nine homolog 1	Homo sapiens		<100							US Patent		10.7270/Q22V2M76		aid1919747	US20230295110	BLAISDELL, TP; ALLU, SR; FLEMING, PE	9/21/2023	10/30/2023	Akebia Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=618990	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5440&target=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=618990&enzyme=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search			162731559	485226305							1	MANDSGGPGGPSPSERDRQYCELCGKMENLLRCSRCRSSFYCCKEHQRQDWKKHKLVCQGSEGALGHGVGPHQHSGPAPPAAVPPPRAGAREPRKAAARRDNASGDAAKGKVKAKPPADPAAAASPCRAAAGGQGSAVAAEAEPGKEEPPARSSLFQEKANLYPPSNTPGDALSPGGGLRPNGQTKPLPALKLALEYIVPCMNKHGICVVDDFLGKETGQQIGDEVRALHDTGKFTDGQLVSQKSDSSKDIRGDKITWIEGKEPGCETIGLLMSSMDDLIRHCNGKLGSYKINGRTKAMVACYPGNGTGYVRHVDNPNGDGRCVTCIYYLNKDWDAKVSGGILRIFPEGKAQFADIEPKFDRLLFFWSDRRNPHEVQPAYATRYAITVWYFDADERARAKVKYLTGEKGVRVELNKPSDSVGKDVF	6YW0,6YVZ,6YVX,6YVW,6YVT,5OX6,5OX5,5A3U,4BQY,4BQX,4BQW,2Y34,2Y33,8Y0V,7UJV,3HQU,2G1M,5LA9,5L9V,8Z33,8Z32,2HBU,2HBT,2G19,3OUJ,3OUH,5V18,8Q6E,8Q6D,8Q5S,7Q5X,7Q5V,6YW3,6YW2,6YW1,6ST3,6QGV,6ZBO,6ZBN,8J1K,8Z35,8Z31,6NMQ,3OUI	Egl nine homolog 1	EGLN1_HUMAN	Q9GZT9	Q8N3M8 Q9BZS8 Q9BZT0		hypoxia-inducible factor-proline dioxygenase	R4SCQ0_HUMAN	R4SCQ0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
1320828	CC(C)Cn1cc(cn1)-c1cnc(C(=O)NCC(O)=O)c(O)c1C	InChI=1S/C16H20N4O4/c1-9(2)7-20-8-11(4-19-20)12-5-17-14(15(23)10(12)3)16(24)18-6-13(21)22/h4-5,8-9,23H,6-7H2,1-3H3,(H,18,24)(H,21,22)	LYNZXAKHMBDTGR-UHFFFAOYSA-N	618990	US20230295110, Compound 22.	Prolyl hydroxylase EGLN2	Homo sapiens		<100							US Patent		10.7270/Q22V2M76		aid1919747	US20230295110	BLAISDELL, TP; ALLU, SR; FLEMING, PE	9/21/2023	10/30/2023	Akebia Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=618990	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=618990&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search			162731559	485226305							1	MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT		Prolyl hydroxylase EGLN2	EGLN2_HUMAN	Q96KS0	A8K5S0 Q8WWY4 Q9BV14																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1320829	CC(C)Cn1cc(cn1)-c1cnc(C(=O)NCC(O)=O)c(O)c1C	InChI=1S/C16H20N4O4/c1-9(2)7-20-8-11(4-19-20)12-5-17-14(15(23)10(12)3)16(24)18-6-13(21)22/h4-5,8-9,23H,6-7H2,1-3H3,(H,18,24)(H,21,22)	LYNZXAKHMBDTGR-UHFFFAOYSA-N	618990	US20230295110, Compound 22.	Prolyl hydroxylase EGLN3	Homo sapiens		<100							US Patent		10.7270/Q22V2M76		aid1919747	US20230295110	BLAISDELL, TP; ALLU, SR; FLEMING, PE	9/21/2023	10/30/2023	Akebia Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=618990	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5442&target=Prolyl+hydroxylase+EGLN3&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=618990&enzyme=Prolyl+hydroxylase+EGLN3&column=ki&startPg=0&Increment=50&submit=Search			162731559	485226305							1	MPLGHIMRLDLEKIALEYIVPCLHEVGFCYLDNFLGEVVGDCVLERVKQLHCTGALRDGQLAGPRAGVSKRHLRGDQITWIGGNEEGCEAISFLLSLIDRLVLYCGSRLGKYYVKERSKAMVACYPGNGTGYVRHVDNPNGDGRCITCIYYLNKNWDAKLHGGILRIFPEGKSFIADVEPIFDRLLFFWSDRRNPHEVQPSYATRYAMTVWYFDAEERAEAKKKFRNLTRKTESALTED		Prolyl hydroxylase EGLN3	EGLN3_HUMAN	Q9H6Z9	Q2TA79 Q3B8N4 Q6P1R2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1320830	Cc1cc(CCOCc2ccccc2)c(O)c(n1)C(=O)NCC(O)=O	InChI=1S/C18H20N2O5/c1-12-9-14(7-8-25-11-13-5-3-2-4-6-13)17(23)16(20-12)18(24)19-10-15(21)22/h2-6,9,23H,7-8,10-11H2,1H3,(H,19,24)(H,21,22)	MIHYPJYUTPLPEK-UHFFFAOYSA-N	618991	US20230295110, Compound 23.	Egl nine homolog 1	Homo sapiens		 550							US Patent		10.7270/Q22V2M76		aid1919747	US20230295110	BLAISDELL, TP; ALLU, SR; FLEMING, PE	9/21/2023	10/30/2023	Akebia Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=618991	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5440&target=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=618991&enzyme=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search			162731587	485226306							1	MANDSGGPGGPSPSERDRQYCELCGKMENLLRCSRCRSSFYCCKEHQRQDWKKHKLVCQGSEGALGHGVGPHQHSGPAPPAAVPPPRAGAREPRKAAARRDNASGDAAKGKVKAKPPADPAAAASPCRAAAGGQGSAVAAEAEPGKEEPPARSSLFQEKANLYPPSNTPGDALSPGGGLRPNGQTKPLPALKLALEYIVPCMNKHGICVVDDFLGKETGQQIGDEVRALHDTGKFTDGQLVSQKSDSSKDIRGDKITWIEGKEPGCETIGLLMSSMDDLIRHCNGKLGSYKINGRTKAMVACYPGNGTGYVRHVDNPNGDGRCVTCIYYLNKDWDAKVSGGILRIFPEGKAQFADIEPKFDRLLFFWSDRRNPHEVQPAYATRYAITVWYFDADERARAKVKYLTGEKGVRVELNKPSDSVGKDVF	6YW0,6YVZ,6YVX,6YVW,6YVT,5OX6,5OX5,5A3U,4BQY,4BQX,4BQW,2Y34,2Y33,8Y0V,7UJV,3HQU,2G1M,5LA9,5L9V,8Z33,8Z32,2HBU,2HBT,2G19,3OUJ,3OUH,5V18,8Q6E,8Q6D,8Q5S,7Q5X,7Q5V,6YW3,6YW2,6YW1,6ST3,6QGV,6ZBO,6ZBN,8J1K,8Z35,8Z31,6NMQ,3OUI	Egl nine homolog 1	EGLN1_HUMAN	Q9GZT9	Q8N3M8 Q9BZS8 Q9BZT0		hypoxia-inducible factor-proline dioxygenase	R4SCQ0_HUMAN	R4SCQ0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
1320831	Cc1cc(CCOCc2ccccc2)c(O)c(n1)C(=O)NCC(O)=O	InChI=1S/C18H20N2O5/c1-12-9-14(7-8-25-11-13-5-3-2-4-6-13)17(23)16(20-12)18(24)19-10-15(21)22/h2-6,9,23H,7-8,10-11H2,1H3,(H,19,24)(H,21,22)	MIHYPJYUTPLPEK-UHFFFAOYSA-N	618991	US20230295110, Compound 23.	Prolyl hydroxylase EGLN2	Homo sapiens		 550							US Patent		10.7270/Q22V2M76		aid1919747	US20230295110	BLAISDELL, TP; ALLU, SR; FLEMING, PE	9/21/2023	10/30/2023	Akebia Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=618991	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=618991&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search			162731587	485226306							1	MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT		Prolyl hydroxylase EGLN2	EGLN2_HUMAN	Q96KS0	A8K5S0 Q8WWY4 Q9BV14																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1320832	Cc1cc(Cc2ccc(F)cc2)c(O)c(n1)C(=O)NCC(O)=O	InChI=1S/C16H15FN2O4/c1-9-6-11(7-10-2-4-12(17)5-3-10)15(22)14(19-9)16(23)18-8-13(20)21/h2-6,22H,7-8H2,1H3,(H,18,23)(H,20,21)	CSYUTQRJJAMPMQ-UHFFFAOYSA-N	618992	US20230295110, Compound 24.	Egl nine homolog 1	Homo sapiens		 550							US Patent		10.7270/Q22V2M76		aid1919747	US20230295110	BLAISDELL, TP; ALLU, SR; FLEMING, PE	9/21/2023	10/30/2023	Akebia Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=618992	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5440&target=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=618992&enzyme=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search			162731662	485226307							1	MANDSGGPGGPSPSERDRQYCELCGKMENLLRCSRCRSSFYCCKEHQRQDWKKHKLVCQGSEGALGHGVGPHQHSGPAPPAAVPPPRAGAREPRKAAARRDNASGDAAKGKVKAKPPADPAAAASPCRAAAGGQGSAVAAEAEPGKEEPPARSSLFQEKANLYPPSNTPGDALSPGGGLRPNGQTKPLPALKLALEYIVPCMNKHGICVVDDFLGKETGQQIGDEVRALHDTGKFTDGQLVSQKSDSSKDIRGDKITWIEGKEPGCETIGLLMSSMDDLIRHCNGKLGSYKINGRTKAMVACYPGNGTGYVRHVDNPNGDGRCVTCIYYLNKDWDAKVSGGILRIFPEGKAQFADIEPKFDRLLFFWSDRRNPHEVQPAYATRYAITVWYFDADERARAKVKYLTGEKGVRVELNKPSDSVGKDVF	6YW0,6YVZ,6YVX,6YVW,6YVT,5OX6,5OX5,5A3U,4BQY,4BQX,4BQW,2Y34,2Y33,8Y0V,7UJV,3HQU,2G1M,5LA9,5L9V,8Z33,8Z32,2HBU,2HBT,2G19,3OUJ,3OUH,5V18,8Q6E,8Q6D,8Q5S,7Q5X,7Q5V,6YW3,6YW2,6YW1,6ST3,6QGV,6ZBO,6ZBN,8J1K,8Z35,8Z31,6NMQ,3OUI	Egl nine homolog 1	EGLN1_HUMAN	Q9GZT9	Q8N3M8 Q9BZS8 Q9BZT0		hypoxia-inducible factor-proline dioxygenase	R4SCQ0_HUMAN	R4SCQ0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
1320833	Cc1cc(Cc2ccc(F)cc2)c(O)c(n1)C(=O)NCC(O)=O	InChI=1S/C16H15FN2O4/c1-9-6-11(7-10-2-4-12(17)5-3-10)15(22)14(19-9)16(23)18-8-13(20)21/h2-6,22H,7-8H2,1H3,(H,18,23)(H,20,21)	CSYUTQRJJAMPMQ-UHFFFAOYSA-N	618992	US20230295110, Compound 24.	Prolyl hydroxylase EGLN2	Homo sapiens		 550							US Patent		10.7270/Q22V2M76		aid1919747	US20230295110	BLAISDELL, TP; ALLU, SR; FLEMING, PE	9/21/2023	10/30/2023	Akebia Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=618992	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=618992&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search			162731662	485226307							1	MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT		Prolyl hydroxylase EGLN2	EGLN2_HUMAN	Q96KS0	A8K5S0 Q8WWY4 Q9BV14																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1320834	Cc1nc(C(=O)NCC(O)=O)c(O)c(C)c1-c1cnn(c1)-c1ccccc1	InChI=1S/C19H18N4O4/c1-11-16(13-8-21-23(10-13)14-6-4-3-5-7-14)12(2)22-17(18(11)26)19(27)20-9-15(24)25/h3-8,10,26H,9H2,1-2H3,(H,20,27)(H,24,25)	LDWXYKXXQPAXLK-UHFFFAOYSA-N	618993	US20230295110, Compound 25.	Egl nine homolog 1	Homo sapiens		<100							US Patent		10.7270/Q22V2M76		aid1919747	US20230295110	BLAISDELL, TP; ALLU, SR; FLEMING, PE	9/21/2023	10/30/2023	Akebia Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=618993	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5440&target=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=618993&enzyme=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search			162731636	485226308							1	MANDSGGPGGPSPSERDRQYCELCGKMENLLRCSRCRSSFYCCKEHQRQDWKKHKLVCQGSEGALGHGVGPHQHSGPAPPAAVPPPRAGAREPRKAAARRDNASGDAAKGKVKAKPPADPAAAASPCRAAAGGQGSAVAAEAEPGKEEPPARSSLFQEKANLYPPSNTPGDALSPGGGLRPNGQTKPLPALKLALEYIVPCMNKHGICVVDDFLGKETGQQIGDEVRALHDTGKFTDGQLVSQKSDSSKDIRGDKITWIEGKEPGCETIGLLMSSMDDLIRHCNGKLGSYKINGRTKAMVACYPGNGTGYVRHVDNPNGDGRCVTCIYYLNKDWDAKVSGGILRIFPEGKAQFADIEPKFDRLLFFWSDRRNPHEVQPAYATRYAITVWYFDADERARAKVKYLTGEKGVRVELNKPSDSVGKDVF	6YW0,6YVZ,6YVX,6YVW,6YVT,5OX6,5OX5,5A3U,4BQY,4BQX,4BQW,2Y34,2Y33,8Y0V,7UJV,3HQU,2G1M,5LA9,5L9V,8Z33,8Z32,2HBU,2HBT,2G19,3OUJ,3OUH,5V18,8Q6E,8Q6D,8Q5S,7Q5X,7Q5V,6YW3,6YW2,6YW1,6ST3,6QGV,6ZBO,6ZBN,8J1K,8Z35,8Z31,6NMQ,3OUI	Egl nine homolog 1	EGLN1_HUMAN	Q9GZT9	Q8N3M8 Q9BZS8 Q9BZT0		hypoxia-inducible factor-proline dioxygenase	R4SCQ0_HUMAN	R4SCQ0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
1320835	Cc1nc(C(=O)NCC(O)=O)c(O)c(C)c1-c1cnn(c1)-c1ccccc1	InChI=1S/C19H18N4O4/c1-11-16(13-8-21-23(10-13)14-6-4-3-5-7-14)12(2)22-17(18(11)26)19(27)20-9-15(24)25/h3-8,10,26H,9H2,1-2H3,(H,20,27)(H,24,25)	LDWXYKXXQPAXLK-UHFFFAOYSA-N	618993	US20230295110, Compound 25.	Prolyl hydroxylase EGLN2	Homo sapiens		<100							US Patent		10.7270/Q22V2M76		aid1919747	US20230295110	BLAISDELL, TP; ALLU, SR; FLEMING, PE	9/21/2023	10/30/2023	Akebia Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=618993	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=618993&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search			162731636	485226308							1	MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT		Prolyl hydroxylase EGLN2	EGLN2_HUMAN	Q96KS0	A8K5S0 Q8WWY4 Q9BV14																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1320836	Cc1nc(C(=O)NCC(O)=O)c(O)c(C)c1-c1cnn(c1)-c1ccccc1	InChI=1S/C19H18N4O4/c1-11-16(13-8-21-23(10-13)14-6-4-3-5-7-14)12(2)22-17(18(11)26)19(27)20-9-15(24)25/h3-8,10,26H,9H2,1-2H3,(H,20,27)(H,24,25)	LDWXYKXXQPAXLK-UHFFFAOYSA-N	618993	US20230295110, Compound 25.	Prolyl hydroxylase EGLN3	Homo sapiens		<100							US Patent		10.7270/Q22V2M76		aid1919747	US20230295110	BLAISDELL, TP; ALLU, SR; FLEMING, PE	9/21/2023	10/30/2023	Akebia Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=618993	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5442&target=Prolyl+hydroxylase+EGLN3&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=618993&enzyme=Prolyl+hydroxylase+EGLN3&column=ki&startPg=0&Increment=50&submit=Search			162731636	485226308							1	MPLGHIMRLDLEKIALEYIVPCLHEVGFCYLDNFLGEVVGDCVLERVKQLHCTGALRDGQLAGPRAGVSKRHLRGDQITWIGGNEEGCEAISFLLSLIDRLVLYCGSRLGKYYVKERSKAMVACYPGNGTGYVRHVDNPNGDGRCITCIYYLNKNWDAKLHGGILRIFPEGKSFIADVEPIFDRLLFFWSDRRNPHEVQPSYATRYAMTVWYFDAEERAEAKKKFRNLTRKTESALTED		Prolyl hydroxylase EGLN3	EGLN3_HUMAN	Q9H6Z9	Q2TA79 Q3B8N4 Q6P1R2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1320837	Cc1c(O)c(ncc1-c1cnc(o1)-c1ccccc1)C(=O)NCC(O)=O	InChI=1S/C18H15N3O5/c1-10-12(7-19-15(16(10)24)17(25)20-9-14(22)23)13-8-21-18(26-13)11-5-3-2-4-6-11/h2-8,24H,9H2,1H3,(H,20,25)(H,22,23)	BSQNTRWBUKBXIZ-UHFFFAOYSA-N	618994	US20230295110, Compound 26.	Egl nine homolog 1	Homo sapiens		<100							US Patent		10.7270/Q22V2M76		aid1919747	US20230295110	BLAISDELL, TP; ALLU, SR; FLEMING, PE	9/21/2023	10/30/2023	Akebia Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=618994	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5440&target=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=618994&enzyme=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search			162731763	485226309							1	MANDSGGPGGPSPSERDRQYCELCGKMENLLRCSRCRSSFYCCKEHQRQDWKKHKLVCQGSEGALGHGVGPHQHSGPAPPAAVPPPRAGAREPRKAAARRDNASGDAAKGKVKAKPPADPAAAASPCRAAAGGQGSAVAAEAEPGKEEPPARSSLFQEKANLYPPSNTPGDALSPGGGLRPNGQTKPLPALKLALEYIVPCMNKHGICVVDDFLGKETGQQIGDEVRALHDTGKFTDGQLVSQKSDSSKDIRGDKITWIEGKEPGCETIGLLMSSMDDLIRHCNGKLGSYKINGRTKAMVACYPGNGTGYVRHVDNPNGDGRCVTCIYYLNKDWDAKVSGGILRIFPEGKAQFADIEPKFDRLLFFWSDRRNPHEVQPAYATRYAITVWYFDADERARAKVKYLTGEKGVRVELNKPSDSVGKDVF	6YW0,6YVZ,6YVX,6YVW,6YVT,5OX6,5OX5,5A3U,4BQY,4BQX,4BQW,2Y34,2Y33,8Y0V,7UJV,3HQU,2G1M,5LA9,5L9V,8Z33,8Z32,2HBU,2HBT,2G19,3OUJ,3OUH,5V18,8Q6E,8Q6D,8Q5S,7Q5X,7Q5V,6YW3,6YW2,6YW1,6ST3,6QGV,6ZBO,6ZBN,8J1K,8Z35,8Z31,6NMQ,3OUI	Egl nine homolog 1	EGLN1_HUMAN	Q9GZT9	Q8N3M8 Q9BZS8 Q9BZT0		hypoxia-inducible factor-proline dioxygenase	R4SCQ0_HUMAN	R4SCQ0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
1320838	Cc1c(O)c(ncc1-c1cnc(o1)-c1ccccc1)C(=O)NCC(O)=O	InChI=1S/C18H15N3O5/c1-10-12(7-19-15(16(10)24)17(25)20-9-14(22)23)13-8-21-18(26-13)11-5-3-2-4-6-11/h2-8,24H,9H2,1H3,(H,20,25)(H,22,23)	BSQNTRWBUKBXIZ-UHFFFAOYSA-N	618994	US20230295110, Compound 26.	Prolyl hydroxylase EGLN2	Homo sapiens		<100							US Patent		10.7270/Q22V2M76		aid1919747	US20230295110	BLAISDELL, TP; ALLU, SR; FLEMING, PE	9/21/2023	10/30/2023	Akebia Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=618994	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=618994&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search			162731763	485226309							1	MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT		Prolyl hydroxylase EGLN2	EGLN2_HUMAN	Q96KS0	A8K5S0 Q8WWY4 Q9BV14																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1320839	Cc1c(O)c(ncc1-c1cnc(o1)-c1ccccc1)C(=O)NCC(O)=O	InChI=1S/C18H15N3O5/c1-10-12(7-19-15(16(10)24)17(25)20-9-14(22)23)13-8-21-18(26-13)11-5-3-2-4-6-11/h2-8,24H,9H2,1H3,(H,20,25)(H,22,23)	BSQNTRWBUKBXIZ-UHFFFAOYSA-N	618994	US20230295110, Compound 26.	Prolyl hydroxylase EGLN3	Homo sapiens		<100							US Patent		10.7270/Q22V2M76		aid1919747	US20230295110	BLAISDELL, TP; ALLU, SR; FLEMING, PE	9/21/2023	10/30/2023	Akebia Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=618994	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5442&target=Prolyl+hydroxylase+EGLN3&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=618994&enzyme=Prolyl+hydroxylase+EGLN3&column=ki&startPg=0&Increment=50&submit=Search			162731763	485226309							1	MPLGHIMRLDLEKIALEYIVPCLHEVGFCYLDNFLGEVVGDCVLERVKQLHCTGALRDGQLAGPRAGVSKRHLRGDQITWIGGNEEGCEAISFLLSLIDRLVLYCGSRLGKYYVKERSKAMVACYPGNGTGYVRHVDNPNGDGRCITCIYYLNKNWDAKLHGGILRIFPEGKSFIADVEPIFDRLLFFWSDRRNPHEVQPSYATRYAMTVWYFDAEERAEAKKKFRNLTRKTESALTED		Prolyl hydroxylase EGLN3	EGLN3_HUMAN	Q9H6Z9	Q2TA79 Q3B8N4 Q6P1R2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1320840	Cc1ccc(cn1)-c1cnc(C(=O)NCC(O)=O)c(O)c1C	InChI=1S/C15H15N3O4/c1-8-3-4-10(5-16-8)11-6-17-13(14(21)9(11)2)15(22)18-7-12(19)20/h3-6,21H,7H2,1-2H3,(H,18,22)(H,19,20)	UGNZZIHWAWUTIH-UHFFFAOYSA-N	618995	US20230295110, Compound 27.	Egl nine homolog 1	Homo sapiens		<100							US Patent		10.7270/Q22V2M76		aid1919747	US20230295110	BLAISDELL, TP; ALLU, SR; FLEMING, PE	9/21/2023	10/30/2023	Akebia Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=618995	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5440&target=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=618995&enzyme=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search			162731594	485226310							1	MANDSGGPGGPSPSERDRQYCELCGKMENLLRCSRCRSSFYCCKEHQRQDWKKHKLVCQGSEGALGHGVGPHQHSGPAPPAAVPPPRAGAREPRKAAARRDNASGDAAKGKVKAKPPADPAAAASPCRAAAGGQGSAVAAEAEPGKEEPPARSSLFQEKANLYPPSNTPGDALSPGGGLRPNGQTKPLPALKLALEYIVPCMNKHGICVVDDFLGKETGQQIGDEVRALHDTGKFTDGQLVSQKSDSSKDIRGDKITWIEGKEPGCETIGLLMSSMDDLIRHCNGKLGSYKINGRTKAMVACYPGNGTGYVRHVDNPNGDGRCVTCIYYLNKDWDAKVSGGILRIFPEGKAQFADIEPKFDRLLFFWSDRRNPHEVQPAYATRYAITVWYFDADERARAKVKYLTGEKGVRVELNKPSDSVGKDVF	6YW0,6YVZ,6YVX,6YVW,6YVT,5OX6,5OX5,5A3U,4BQY,4BQX,4BQW,2Y34,2Y33,8Y0V,7UJV,3HQU,2G1M,5LA9,5L9V,8Z33,8Z32,2HBU,2HBT,2G19,3OUJ,3OUH,5V18,8Q6E,8Q6D,8Q5S,7Q5X,7Q5V,6YW3,6YW2,6YW1,6ST3,6QGV,6ZBO,6ZBN,8J1K,8Z35,8Z31,6NMQ,3OUI	Egl nine homolog 1	EGLN1_HUMAN	Q9GZT9	Q8N3M8 Q9BZS8 Q9BZT0		hypoxia-inducible factor-proline dioxygenase	R4SCQ0_HUMAN	R4SCQ0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
1320841	Cc1ccc(cn1)-c1cnc(C(=O)NCC(O)=O)c(O)c1C	InChI=1S/C15H15N3O4/c1-8-3-4-10(5-16-8)11-6-17-13(14(21)9(11)2)15(22)18-7-12(19)20/h3-6,21H,7H2,1-2H3,(H,18,22)(H,19,20)	UGNZZIHWAWUTIH-UHFFFAOYSA-N	618995	US20230295110, Compound 27.	Prolyl hydroxylase EGLN2	Homo sapiens		<100							US Patent		10.7270/Q22V2M76		aid1919747	US20230295110	BLAISDELL, TP; ALLU, SR; FLEMING, PE	9/21/2023	10/30/2023	Akebia Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=618995	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=618995&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search			162731594	485226310							1	MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT		Prolyl hydroxylase EGLN2	EGLN2_HUMAN	Q96KS0	A8K5S0 Q8WWY4 Q9BV14																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1320842	Cc1ccc(cn1)-c1cnc(C(=O)NCC(O)=O)c(O)c1C	InChI=1S/C15H15N3O4/c1-8-3-4-10(5-16-8)11-6-17-13(14(21)9(11)2)15(22)18-7-12(19)20/h3-6,21H,7H2,1-2H3,(H,18,22)(H,19,20)	UGNZZIHWAWUTIH-UHFFFAOYSA-N	618995	US20230295110, Compound 27.	Prolyl hydroxylase EGLN3	Homo sapiens		 550							US Patent		10.7270/Q22V2M76		aid1919747	US20230295110	BLAISDELL, TP; ALLU, SR; FLEMING, PE	9/21/2023	10/30/2023	Akebia Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=618995	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5442&target=Prolyl+hydroxylase+EGLN3&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=618995&enzyme=Prolyl+hydroxylase+EGLN3&column=ki&startPg=0&Increment=50&submit=Search			162731594	485226310							1	MPLGHIMRLDLEKIALEYIVPCLHEVGFCYLDNFLGEVVGDCVLERVKQLHCTGALRDGQLAGPRAGVSKRHLRGDQITWIGGNEEGCEAISFLLSLIDRLVLYCGSRLGKYYVKERSKAMVACYPGNGTGYVRHVDNPNGDGRCITCIYYLNKNWDAKLHGGILRIFPEGKSFIADVEPIFDRLLFFWSDRRNPHEVQPSYATRYAMTVWYFDAEERAEAKKKFRNLTRKTESALTED		Prolyl hydroxylase EGLN3	EGLN3_HUMAN	Q9H6Z9	Q2TA79 Q3B8N4 Q6P1R2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1320843	Cc1c(O)c(ncc1-c1cnc2ccccc2c1)C(=O)NCC(O)=O	InChI=1S/C18H15N3O4/c1-10-13(12-6-11-4-2-3-5-14(11)19-7-12)8-20-16(17(10)24)18(25)21-9-15(22)23/h2-8,24H,9H2,1H3,(H,21,25)(H,22,23)	IDZFZMOTUMCCLO-UHFFFAOYSA-N	618996	US20230295110, Compound 28.	Egl nine homolog 1	Homo sapiens		<100							US Patent		10.7270/Q22V2M76		aid1919747	US20230295110	BLAISDELL, TP; ALLU, SR; FLEMING, PE	9/21/2023	10/30/2023	Akebia Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=618996	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5440&target=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=618996&enzyme=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search			162731640	485226311							1	MANDSGGPGGPSPSERDRQYCELCGKMENLLRCSRCRSSFYCCKEHQRQDWKKHKLVCQGSEGALGHGVGPHQHSGPAPPAAVPPPRAGAREPRKAAARRDNASGDAAKGKVKAKPPADPAAAASPCRAAAGGQGSAVAAEAEPGKEEPPARSSLFQEKANLYPPSNTPGDALSPGGGLRPNGQTKPLPALKLALEYIVPCMNKHGICVVDDFLGKETGQQIGDEVRALHDTGKFTDGQLVSQKSDSSKDIRGDKITWIEGKEPGCETIGLLMSSMDDLIRHCNGKLGSYKINGRTKAMVACYPGNGTGYVRHVDNPNGDGRCVTCIYYLNKDWDAKVSGGILRIFPEGKAQFADIEPKFDRLLFFWSDRRNPHEVQPAYATRYAITVWYFDADERARAKVKYLTGEKGVRVELNKPSDSVGKDVF	6YW0,6YVZ,6YVX,6YVW,6YVT,5OX6,5OX5,5A3U,4BQY,4BQX,4BQW,2Y34,2Y33,8Y0V,7UJV,3HQU,2G1M,5LA9,5L9V,8Z33,8Z32,2HBU,2HBT,2G19,3OUJ,3OUH,5V18,8Q6E,8Q6D,8Q5S,7Q5X,7Q5V,6YW3,6YW2,6YW1,6ST3,6QGV,6ZBO,6ZBN,8J1K,8Z35,8Z31,6NMQ,3OUI	Egl nine homolog 1	EGLN1_HUMAN	Q9GZT9	Q8N3M8 Q9BZS8 Q9BZT0		hypoxia-inducible factor-proline dioxygenase	R4SCQ0_HUMAN	R4SCQ0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
1320844	Cc1c(O)c(ncc1-c1cnc2ccccc2c1)C(=O)NCC(O)=O	InChI=1S/C18H15N3O4/c1-10-13(12-6-11-4-2-3-5-14(11)19-7-12)8-20-16(17(10)24)18(25)21-9-15(22)23/h2-8,24H,9H2,1H3,(H,21,25)(H,22,23)	IDZFZMOTUMCCLO-UHFFFAOYSA-N	618996	US20230295110, Compound 28.	Prolyl hydroxylase EGLN2	Homo sapiens		<100							US Patent		10.7270/Q22V2M76		aid1919747	US20230295110	BLAISDELL, TP; ALLU, SR; FLEMING, PE	9/21/2023	10/30/2023	Akebia Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=618996	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=618996&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search			162731640	485226311							1	MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT		Prolyl hydroxylase EGLN2	EGLN2_HUMAN	Q96KS0	A8K5S0 Q8WWY4 Q9BV14																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1320845	Cc1c(O)c(ncc1-c1cnc2ccccc2c1)C(=O)NCC(O)=O	InChI=1S/C18H15N3O4/c1-10-13(12-6-11-4-2-3-5-14(11)19-7-12)8-20-16(17(10)24)18(25)21-9-15(22)23/h2-8,24H,9H2,1H3,(H,21,25)(H,22,23)	IDZFZMOTUMCCLO-UHFFFAOYSA-N	618996	US20230295110, Compound 28.	Prolyl hydroxylase EGLN3	Homo sapiens		<100							US Patent		10.7270/Q22V2M76		aid1919747	US20230295110	BLAISDELL, TP; ALLU, SR; FLEMING, PE	9/21/2023	10/30/2023	Akebia Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=618996	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5442&target=Prolyl+hydroxylase+EGLN3&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=618996&enzyme=Prolyl+hydroxylase+EGLN3&column=ki&startPg=0&Increment=50&submit=Search			162731640	485226311							1	MPLGHIMRLDLEKIALEYIVPCLHEVGFCYLDNFLGEVVGDCVLERVKQLHCTGALRDGQLAGPRAGVSKRHLRGDQITWIGGNEEGCEAISFLLSLIDRLVLYCGSRLGKYYVKERSKAMVACYPGNGTGYVRHVDNPNGDGRCITCIYYLNKNWDAKLHGGILRIFPEGKSFIADVEPIFDRLLFFWSDRRNPHEVQPSYATRYAMTVWYFDAEERAEAKKKFRNLTRKTESALTED		Prolyl hydroxylase EGLN3	EGLN3_HUMAN	Q9H6Z9	Q2TA79 Q3B8N4 Q6P1R2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1320846	Cc1ncccc1-c1cnc(C(=O)NCC(O)=O)c(O)c1C	InChI=1S/C15H15N3O4/c1-8-11(10-4-3-5-16-9(10)2)6-17-13(14(8)21)15(22)18-7-12(19)20/h3-6,21H,7H2,1-2H3,(H,18,22)(H,19,20)	RXOYHFQPJKSINW-UHFFFAOYSA-N	618997	US20230295110, Compound 29.	Egl nine homolog 1	Homo sapiens		 550							US Patent		10.7270/Q22V2M76		aid1919747	US20230295110	BLAISDELL, TP; ALLU, SR; FLEMING, PE	9/21/2023	10/30/2023	Akebia Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=618997	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5440&target=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=618997&enzyme=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search			162731609	485226312							1	MANDSGGPGGPSPSERDRQYCELCGKMENLLRCSRCRSSFYCCKEHQRQDWKKHKLVCQGSEGALGHGVGPHQHSGPAPPAAVPPPRAGAREPRKAAARRDNASGDAAKGKVKAKPPADPAAAASPCRAAAGGQGSAVAAEAEPGKEEPPARSSLFQEKANLYPPSNTPGDALSPGGGLRPNGQTKPLPALKLALEYIVPCMNKHGICVVDDFLGKETGQQIGDEVRALHDTGKFTDGQLVSQKSDSSKDIRGDKITWIEGKEPGCETIGLLMSSMDDLIRHCNGKLGSYKINGRTKAMVACYPGNGTGYVRHVDNPNGDGRCVTCIYYLNKDWDAKVSGGILRIFPEGKAQFADIEPKFDRLLFFWSDRRNPHEVQPAYATRYAITVWYFDADERARAKVKYLTGEKGVRVELNKPSDSVGKDVF	6YW0,6YVZ,6YVX,6YVW,6YVT,5OX6,5OX5,5A3U,4BQY,4BQX,4BQW,2Y34,2Y33,8Y0V,7UJV,3HQU,2G1M,5LA9,5L9V,8Z33,8Z32,2HBU,2HBT,2G19,3OUJ,3OUH,5V18,8Q6E,8Q6D,8Q5S,7Q5X,7Q5V,6YW3,6YW2,6YW1,6ST3,6QGV,6ZBO,6ZBN,8J1K,8Z35,8Z31,6NMQ,3OUI	Egl nine homolog 1	EGLN1_HUMAN	Q9GZT9	Q8N3M8 Q9BZS8 Q9BZT0		hypoxia-inducible factor-proline dioxygenase	R4SCQ0_HUMAN	R4SCQ0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
1320847	Cc1ncccc1-c1cnc(C(=O)NCC(O)=O)c(O)c1C	InChI=1S/C15H15N3O4/c1-8-11(10-4-3-5-16-9(10)2)6-17-13(14(8)21)15(22)18-7-12(19)20/h3-6,21H,7H2,1-2H3,(H,18,22)(H,19,20)	RXOYHFQPJKSINW-UHFFFAOYSA-N	618997	US20230295110, Compound 29.	Prolyl hydroxylase EGLN2	Homo sapiens		 550							US Patent		10.7270/Q22V2M76		aid1919747	US20230295110	BLAISDELL, TP; ALLU, SR; FLEMING, PE	9/21/2023	10/30/2023	Akebia Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=618997	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=618997&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search			162731609	485226312							1	MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT		Prolyl hydroxylase EGLN2	EGLN2_HUMAN	Q96KS0	A8K5S0 Q8WWY4 Q9BV14																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1320848	C[C@@H](NC(=O)c1ncc(-c2cnn(c2)-c2ccccc2)c(C)c1O)C(O)=O |r|	InChI=1S/C19H18N4O4/c1-11-15(13-8-21-23(10-13)14-6-4-3-5-7-14)9-20-16(17(11)24)18(25)22-12(2)19(26)27/h3-10,12,24H,1-2H3,(H,22,25)(H,26,27)	REMUREJFNJSHSC-UHFFFAOYSA-N	618998	US20230295110, Compound 48.::US20230295110, Compound 30.	Egl nine homolog 1	Homo sapiens		 5500							US Patent		10.7270/Q22V2M76		aid1919747	US20230295110	BLAISDELL, TP; ALLU, SR; FLEMING, PE	9/21/2023	10/30/2023	Akebia Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=618998	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5440&target=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=618998&enzyme=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search			162731615	485226313							1	MANDSGGPGGPSPSERDRQYCELCGKMENLLRCSRCRSSFYCCKEHQRQDWKKHKLVCQGSEGALGHGVGPHQHSGPAPPAAVPPPRAGAREPRKAAARRDNASGDAAKGKVKAKPPADPAAAASPCRAAAGGQGSAVAAEAEPGKEEPPARSSLFQEKANLYPPSNTPGDALSPGGGLRPNGQTKPLPALKLALEYIVPCMNKHGICVVDDFLGKETGQQIGDEVRALHDTGKFTDGQLVSQKSDSSKDIRGDKITWIEGKEPGCETIGLLMSSMDDLIRHCNGKLGSYKINGRTKAMVACYPGNGTGYVRHVDNPNGDGRCVTCIYYLNKDWDAKVSGGILRIFPEGKAQFADIEPKFDRLLFFWSDRRNPHEVQPAYATRYAITVWYFDADERARAKVKYLTGEKGVRVELNKPSDSVGKDVF	6YW0,6YVZ,6YVX,6YVW,6YVT,5OX6,5OX5,5A3U,4BQY,4BQX,4BQW,2Y34,2Y33,8Y0V,7UJV,3HQU,2G1M,5LA9,5L9V,8Z33,8Z32,2HBU,2HBT,2G19,3OUJ,3OUH,5V18,8Q6E,8Q6D,8Q5S,7Q5X,7Q5V,6YW3,6YW2,6YW1,6ST3,6QGV,6ZBO,6ZBN,8J1K,8Z35,8Z31,6NMQ,3OUI	Egl nine homolog 1	EGLN1_HUMAN	Q9GZT9	Q8N3M8 Q9BZS8 Q9BZT0		hypoxia-inducible factor-proline dioxygenase	R4SCQ0_HUMAN	R4SCQ0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
1320849	C[C@@H](NC(=O)c1ncc(-c2cnn(c2)-c2ccccc2)c(C)c1O)C(O)=O |r|	InChI=1S/C19H18N4O4/c1-11-15(13-8-21-23(10-13)14-6-4-3-5-7-14)9-20-16(17(11)24)18(25)22-12(2)19(26)27/h3-10,12,24H,1-2H3,(H,22,25)(H,26,27)	REMUREJFNJSHSC-UHFFFAOYSA-N	618998	US20230295110, Compound 48.::US20230295110, Compound 30.	Prolyl hydroxylase EGLN2	Homo sapiens		 5500							US Patent		10.7270/Q22V2M76		aid1919747	US20230295110	BLAISDELL, TP; ALLU, SR; FLEMING, PE	9/21/2023	10/30/2023	Akebia Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=618998	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=618998&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search			162731615	485226313							1	MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT		Prolyl hydroxylase EGLN2	EGLN2_HUMAN	Q96KS0	A8K5S0 Q8WWY4 Q9BV14																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1320850	C[C@H](NC(=O)c1ncc(-c2cnn(c2)-c2ccccc2)c(C)c1O)C(O)=O |r|	InChI=1S/C19H18N4O4/c1-11-15(13-8-21-23(10-13)14-6-4-3-5-7-14)9-20-16(17(11)24)18(25)22-12(2)19(26)27/h3-10,12,24H,1-2H3,(H,22,25)(H,26,27)	REMUREJFNJSHSC-UHFFFAOYSA-N	618999	US20230295110, Compound 47.::US20230295110, Compound 31.	Egl nine homolog 1	Homo sapiens		<100							US Patent		10.7270/Q22V2M76		aid1919747	US20230295110	BLAISDELL, TP; ALLU, SR; FLEMING, PE	9/21/2023	10/30/2023	Akebia Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=618999	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5440&target=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=618999&enzyme=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search			162731672	485226314							1	MANDSGGPGGPSPSERDRQYCELCGKMENLLRCSRCRSSFYCCKEHQRQDWKKHKLVCQGSEGALGHGVGPHQHSGPAPPAAVPPPRAGAREPRKAAARRDNASGDAAKGKVKAKPPADPAAAASPCRAAAGGQGSAVAAEAEPGKEEPPARSSLFQEKANLYPPSNTPGDALSPGGGLRPNGQTKPLPALKLALEYIVPCMNKHGICVVDDFLGKETGQQIGDEVRALHDTGKFTDGQLVSQKSDSSKDIRGDKITWIEGKEPGCETIGLLMSSMDDLIRHCNGKLGSYKINGRTKAMVACYPGNGTGYVRHVDNPNGDGRCVTCIYYLNKDWDAKVSGGILRIFPEGKAQFADIEPKFDRLLFFWSDRRNPHEVQPAYATRYAITVWYFDADERARAKVKYLTGEKGVRVELNKPSDSVGKDVF	6YW0,6YVZ,6YVX,6YVW,6YVT,5OX6,5OX5,5A3U,4BQY,4BQX,4BQW,2Y34,2Y33,8Y0V,7UJV,3HQU,2G1M,5LA9,5L9V,8Z33,8Z32,2HBU,2HBT,2G19,3OUJ,3OUH,5V18,8Q6E,8Q6D,8Q5S,7Q5X,7Q5V,6YW3,6YW2,6YW1,6ST3,6QGV,6ZBO,6ZBN,8J1K,8Z35,8Z31,6NMQ,3OUI	Egl nine homolog 1	EGLN1_HUMAN	Q9GZT9	Q8N3M8 Q9BZS8 Q9BZT0		hypoxia-inducible factor-proline dioxygenase	R4SCQ0_HUMAN	R4SCQ0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
1320851	C[C@H](NC(=O)c1ncc(-c2cnn(c2)-c2ccccc2)c(C)c1O)C(O)=O |r|	InChI=1S/C19H18N4O4/c1-11-15(13-8-21-23(10-13)14-6-4-3-5-7-14)9-20-16(17(11)24)18(25)22-12(2)19(26)27/h3-10,12,24H,1-2H3,(H,22,25)(H,26,27)	REMUREJFNJSHSC-UHFFFAOYSA-N	618999	US20230295110, Compound 47.::US20230295110, Compound 31.	Prolyl hydroxylase EGLN2	Homo sapiens		<100							US Patent		10.7270/Q22V2M76		aid1919747	US20230295110	BLAISDELL, TP; ALLU, SR; FLEMING, PE	9/21/2023	10/30/2023	Akebia Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=618999	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=618999&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search			162731672	485226314							1	MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT		Prolyl hydroxylase EGLN2	EGLN2_HUMAN	Q96KS0	A8K5S0 Q8WWY4 Q9BV14																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1320852	C[C@H](NC(=O)c1ncc(-c2cnn(c2)-c2ccccc2)c(C)c1O)C(O)=O |r|	InChI=1S/C19H18N4O4/c1-11-15(13-8-21-23(10-13)14-6-4-3-5-7-14)9-20-16(17(11)24)18(25)22-12(2)19(26)27/h3-10,12,24H,1-2H3,(H,22,25)(H,26,27)	REMUREJFNJSHSC-UHFFFAOYSA-N	618999	US20230295110, Compound 47.::US20230295110, Compound 31.	Prolyl hydroxylase EGLN3	Homo sapiens		<100							US Patent		10.7270/Q22V2M76		aid1919747	US20230295110	BLAISDELL, TP; ALLU, SR; FLEMING, PE	9/21/2023	10/30/2023	Akebia Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=618999	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5442&target=Prolyl+hydroxylase+EGLN3&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=618999&enzyme=Prolyl+hydroxylase+EGLN3&column=ki&startPg=0&Increment=50&submit=Search			162731672	485226314							1	MPLGHIMRLDLEKIALEYIVPCLHEVGFCYLDNFLGEVVGDCVLERVKQLHCTGALRDGQLAGPRAGVSKRHLRGDQITWIGGNEEGCEAISFLLSLIDRLVLYCGSRLGKYYVKERSKAMVACYPGNGTGYVRHVDNPNGDGRCITCIYYLNKNWDAKLHGGILRIFPEGKSFIADVEPIFDRLLFFWSDRRNPHEVQPSYATRYAMTVWYFDAEERAEAKKKFRNLTRKTESALTED		Prolyl hydroxylase EGLN3	EGLN3_HUMAN	Q9H6Z9	Q2TA79 Q3B8N4 Q6P1R2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1320853	Cc1c(O)c(ncc1-c1cccc(Cl)c1)C(=O)NCC(O)=O	InChI=1S/C15H13ClN2O4/c1-8-11(9-3-2-4-10(16)5-9)6-17-13(14(8)21)15(22)18-7-12(19)20/h2-6,21H,7H2,1H3,(H,18,22)(H,19,20)	IDZMQDVFOZTSQG-UHFFFAOYSA-N	619000	US20230295110, Compound 32.	Egl nine homolog 1	Homo sapiens		<100							US Patent		10.7270/Q22V2M76		aid1919747	US20230295110	BLAISDELL, TP; ALLU, SR; FLEMING, PE	9/21/2023	10/30/2023	Akebia Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=619000	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5440&target=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=619000&enzyme=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search			162731709	485226315							1	MANDSGGPGGPSPSERDRQYCELCGKMENLLRCSRCRSSFYCCKEHQRQDWKKHKLVCQGSEGALGHGVGPHQHSGPAPPAAVPPPRAGAREPRKAAARRDNASGDAAKGKVKAKPPADPAAAASPCRAAAGGQGSAVAAEAEPGKEEPPARSSLFQEKANLYPPSNTPGDALSPGGGLRPNGQTKPLPALKLALEYIVPCMNKHGICVVDDFLGKETGQQIGDEVRALHDTGKFTDGQLVSQKSDSSKDIRGDKITWIEGKEPGCETIGLLMSSMDDLIRHCNGKLGSYKINGRTKAMVACYPGNGTGYVRHVDNPNGDGRCVTCIYYLNKDWDAKVSGGILRIFPEGKAQFADIEPKFDRLLFFWSDRRNPHEVQPAYATRYAITVWYFDADERARAKVKYLTGEKGVRVELNKPSDSVGKDVF	6YW0,6YVZ,6YVX,6YVW,6YVT,5OX6,5OX5,5A3U,4BQY,4BQX,4BQW,2Y34,2Y33,8Y0V,7UJV,3HQU,2G1M,5LA9,5L9V,8Z33,8Z32,2HBU,2HBT,2G19,3OUJ,3OUH,5V18,8Q6E,8Q6D,8Q5S,7Q5X,7Q5V,6YW3,6YW2,6YW1,6ST3,6QGV,6ZBO,6ZBN,8J1K,8Z35,8Z31,6NMQ,3OUI	Egl nine homolog 1	EGLN1_HUMAN	Q9GZT9	Q8N3M8 Q9BZS8 Q9BZT0		hypoxia-inducible factor-proline dioxygenase	R4SCQ0_HUMAN	R4SCQ0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
1320854	Cc1c(O)c(ncc1-c1cccc(Cl)c1)C(=O)NCC(O)=O	InChI=1S/C15H13ClN2O4/c1-8-11(9-3-2-4-10(16)5-9)6-17-13(14(8)21)15(22)18-7-12(19)20/h2-6,21H,7H2,1H3,(H,18,22)(H,19,20)	IDZMQDVFOZTSQG-UHFFFAOYSA-N	619000	US20230295110, Compound 32.	Prolyl hydroxylase EGLN2	Homo sapiens		<100							US Patent		10.7270/Q22V2M76		aid1919747	US20230295110	BLAISDELL, TP; ALLU, SR; FLEMING, PE	9/21/2023	10/30/2023	Akebia Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=619000	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=619000&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search			162731709	485226315							1	MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT		Prolyl hydroxylase EGLN2	EGLN2_HUMAN	Q96KS0	A8K5S0 Q8WWY4 Q9BV14																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1320855	Cc1c(O)c(ncc1-c1cccc(Cl)c1)C(=O)NCC(O)=O	InChI=1S/C15H13ClN2O4/c1-8-11(9-3-2-4-10(16)5-9)6-17-13(14(8)21)15(22)18-7-12(19)20/h2-6,21H,7H2,1H3,(H,18,22)(H,19,20)	IDZMQDVFOZTSQG-UHFFFAOYSA-N	619000	US20230295110, Compound 32.	Prolyl hydroxylase EGLN3	Homo sapiens		<100							US Patent		10.7270/Q22V2M76		aid1919747	US20230295110	BLAISDELL, TP; ALLU, SR; FLEMING, PE	9/21/2023	10/30/2023	Akebia Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=619000	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5442&target=Prolyl+hydroxylase+EGLN3&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=619000&enzyme=Prolyl+hydroxylase+EGLN3&column=ki&startPg=0&Increment=50&submit=Search			162731709	485226315							1	MPLGHIMRLDLEKIALEYIVPCLHEVGFCYLDNFLGEVVGDCVLERVKQLHCTGALRDGQLAGPRAGVSKRHLRGDQITWIGGNEEGCEAISFLLSLIDRLVLYCGSRLGKYYVKERSKAMVACYPGNGTGYVRHVDNPNGDGRCITCIYYLNKNWDAKLHGGILRIFPEGKSFIADVEPIFDRLLFFWSDRRNPHEVQPSYATRYAMTVWYFDAEERAEAKKKFRNLTRKTESALTED		Prolyl hydroxylase EGLN3	EGLN3_HUMAN	Q9H6Z9	Q2TA79 Q3B8N4 Q6P1R2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1320856	Cc1c(O)c(ncc1-c1ccc2ccccc2c1)C(=O)NCC(O)=O	InChI=1S/C19H16N2O4/c1-11-15(14-7-6-12-4-2-3-5-13(12)8-14)9-20-17(18(11)24)19(25)21-10-16(22)23/h2-9,24H,10H2,1H3,(H,21,25)(H,22,23)	XTOHKKOPGVWGDQ-UHFFFAOYSA-N	619001	US20230295110, Compound 33.	Egl nine homolog 1	Homo sapiens		<100							US Patent		10.7270/Q22V2M76		aid1919747	US20230295110	BLAISDELL, TP; ALLU, SR; FLEMING, PE	9/21/2023	10/30/2023	Akebia Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=619001	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5440&target=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=619001&enzyme=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search			162731572	485226316							1	MANDSGGPGGPSPSERDRQYCELCGKMENLLRCSRCRSSFYCCKEHQRQDWKKHKLVCQGSEGALGHGVGPHQHSGPAPPAAVPPPRAGAREPRKAAARRDNASGDAAKGKVKAKPPADPAAAASPCRAAAGGQGSAVAAEAEPGKEEPPARSSLFQEKANLYPPSNTPGDALSPGGGLRPNGQTKPLPALKLALEYIVPCMNKHGICVVDDFLGKETGQQIGDEVRALHDTGKFTDGQLVSQKSDSSKDIRGDKITWIEGKEPGCETIGLLMSSMDDLIRHCNGKLGSYKINGRTKAMVACYPGNGTGYVRHVDNPNGDGRCVTCIYYLNKDWDAKVSGGILRIFPEGKAQFADIEPKFDRLLFFWSDRRNPHEVQPAYATRYAITVWYFDADERARAKVKYLTGEKGVRVELNKPSDSVGKDVF	6YW0,6YVZ,6YVX,6YVW,6YVT,5OX6,5OX5,5A3U,4BQY,4BQX,4BQW,2Y34,2Y33,8Y0V,7UJV,3HQU,2G1M,5LA9,5L9V,8Z33,8Z32,2HBU,2HBT,2G19,3OUJ,3OUH,5V18,8Q6E,8Q6D,8Q5S,7Q5X,7Q5V,6YW3,6YW2,6YW1,6ST3,6QGV,6ZBO,6ZBN,8J1K,8Z35,8Z31,6NMQ,3OUI	Egl nine homolog 1	EGLN1_HUMAN	Q9GZT9	Q8N3M8 Q9BZS8 Q9BZT0		hypoxia-inducible factor-proline dioxygenase	R4SCQ0_HUMAN	R4SCQ0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
1320857	Cc1c(O)c(ncc1-c1ccc2ccccc2c1)C(=O)NCC(O)=O	InChI=1S/C19H16N2O4/c1-11-15(14-7-6-12-4-2-3-5-13(12)8-14)9-20-17(18(11)24)19(25)21-10-16(22)23/h2-9,24H,10H2,1H3,(H,21,25)(H,22,23)	XTOHKKOPGVWGDQ-UHFFFAOYSA-N	619001	US20230295110, Compound 33.	Prolyl hydroxylase EGLN2	Homo sapiens		<100							US Patent		10.7270/Q22V2M76		aid1919747	US20230295110	BLAISDELL, TP; ALLU, SR; FLEMING, PE	9/21/2023	10/30/2023	Akebia Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=619001	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=619001&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search			162731572	485226316							1	MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT		Prolyl hydroxylase EGLN2	EGLN2_HUMAN	Q96KS0	A8K5S0 Q8WWY4 Q9BV14																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1320858	Cc1c(O)c(ncc1-c1ccc2ccccc2c1)C(=O)NCC(O)=O	InChI=1S/C19H16N2O4/c1-11-15(14-7-6-12-4-2-3-5-13(12)8-14)9-20-17(18(11)24)19(25)21-10-16(22)23/h2-9,24H,10H2,1H3,(H,21,25)(H,22,23)	XTOHKKOPGVWGDQ-UHFFFAOYSA-N	619001	US20230295110, Compound 33.	Prolyl hydroxylase EGLN3	Homo sapiens		<100							US Patent		10.7270/Q22V2M76		aid1919747	US20230295110	BLAISDELL, TP; ALLU, SR; FLEMING, PE	9/21/2023	10/30/2023	Akebia Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=619001	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5442&target=Prolyl+hydroxylase+EGLN3&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=619001&enzyme=Prolyl+hydroxylase+EGLN3&column=ki&startPg=0&Increment=50&submit=Search			162731572	485226316							1	MPLGHIMRLDLEKIALEYIVPCLHEVGFCYLDNFLGEVVGDCVLERVKQLHCTGALRDGQLAGPRAGVSKRHLRGDQITWIGGNEEGCEAISFLLSLIDRLVLYCGSRLGKYYVKERSKAMVACYPGNGTGYVRHVDNPNGDGRCITCIYYLNKNWDAKLHGGILRIFPEGKSFIADVEPIFDRLLFFWSDRRNPHEVQPSYATRYAMTVWYFDAEERAEAKKKFRNLTRKTESALTED		Prolyl hydroxylase EGLN3	EGLN3_HUMAN	Q9H6Z9	Q2TA79 Q3B8N4 Q6P1R2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1320859	Cc1c(O)c(ncc1-c1ccc2ncccc2c1)C(=O)NCC(O)=O	InChI=1S/C18H15N3O4/c1-10-13(11-4-5-14-12(7-11)3-2-6-19-14)8-20-16(17(10)24)18(25)21-9-15(22)23/h2-8,24H,9H2,1H3,(H,21,25)(H,22,23)	JMTKSXXATWTARU-UHFFFAOYSA-N	619002	US20230295110, Compound 34.	Egl nine homolog 1	Homo sapiens		<100							US Patent		10.7270/Q22V2M76		aid1919747	US20230295110	BLAISDELL, TP; ALLU, SR; FLEMING, PE	9/21/2023	10/30/2023	Akebia Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=619002	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5440&target=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=619002&enzyme=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search			162731503	485226317							1	MANDSGGPGGPSPSERDRQYCELCGKMENLLRCSRCRSSFYCCKEHQRQDWKKHKLVCQGSEGALGHGVGPHQHSGPAPPAAVPPPRAGAREPRKAAARRDNASGDAAKGKVKAKPPADPAAAASPCRAAAGGQGSAVAAEAEPGKEEPPARSSLFQEKANLYPPSNTPGDALSPGGGLRPNGQTKPLPALKLALEYIVPCMNKHGICVVDDFLGKETGQQIGDEVRALHDTGKFTDGQLVSQKSDSSKDIRGDKITWIEGKEPGCETIGLLMSSMDDLIRHCNGKLGSYKINGRTKAMVACYPGNGTGYVRHVDNPNGDGRCVTCIYYLNKDWDAKVSGGILRIFPEGKAQFADIEPKFDRLLFFWSDRRNPHEVQPAYATRYAITVWYFDADERARAKVKYLTGEKGVRVELNKPSDSVGKDVF	6YW0,6YVZ,6YVX,6YVW,6YVT,5OX6,5OX5,5A3U,4BQY,4BQX,4BQW,2Y34,2Y33,8Y0V,7UJV,3HQU,2G1M,5LA9,5L9V,8Z33,8Z32,2HBU,2HBT,2G19,3OUJ,3OUH,5V18,8Q6E,8Q6D,8Q5S,7Q5X,7Q5V,6YW3,6YW2,6YW1,6ST3,6QGV,6ZBO,6ZBN,8J1K,8Z35,8Z31,6NMQ,3OUI	Egl nine homolog 1	EGLN1_HUMAN	Q9GZT9	Q8N3M8 Q9BZS8 Q9BZT0		hypoxia-inducible factor-proline dioxygenase	R4SCQ0_HUMAN	R4SCQ0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
1320860	Cc1c(O)c(ncc1-c1ccc2ncccc2c1)C(=O)NCC(O)=O	InChI=1S/C18H15N3O4/c1-10-13(11-4-5-14-12(7-11)3-2-6-19-14)8-20-16(17(10)24)18(25)21-9-15(22)23/h2-8,24H,9H2,1H3,(H,21,25)(H,22,23)	JMTKSXXATWTARU-UHFFFAOYSA-N	619002	US20230295110, Compound 34.	Prolyl hydroxylase EGLN2	Homo sapiens		<100							US Patent		10.7270/Q22V2M76		aid1919747	US20230295110	BLAISDELL, TP; ALLU, SR; FLEMING, PE	9/21/2023	10/30/2023	Akebia Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=619002	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=619002&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search			162731503	485226317							1	MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT		Prolyl hydroxylase EGLN2	EGLN2_HUMAN	Q96KS0	A8K5S0 Q8WWY4 Q9BV14																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1320861	Cc1c(O)c(ncc1Oc1ccccc1)C(=O)NCC(O)=O	InChI=1S/C15H14N2O5/c1-9-11(22-10-5-3-2-4-6-10)7-16-13(14(9)20)15(21)17-8-12(18)19/h2-7,20H,8H2,1H3,(H,17,21)(H,18,19)	IZKSLSVNLIMACC-UHFFFAOYSA-N	619003	US20230295110, Compound 57.::US20230295110, Compound 35.	Egl nine homolog 1	Homo sapiens		 550							US Patent		10.7270/Q22V2M76		aid1919747	US20230295110	BLAISDELL, TP; ALLU, SR; FLEMING, PE	9/21/2023	10/30/2023	Akebia Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=619003	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5440&target=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=619003&enzyme=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search			162731467	485226318							1	MANDSGGPGGPSPSERDRQYCELCGKMENLLRCSRCRSSFYCCKEHQRQDWKKHKLVCQGSEGALGHGVGPHQHSGPAPPAAVPPPRAGAREPRKAAARRDNASGDAAKGKVKAKPPADPAAAASPCRAAAGGQGSAVAAEAEPGKEEPPARSSLFQEKANLYPPSNTPGDALSPGGGLRPNGQTKPLPALKLALEYIVPCMNKHGICVVDDFLGKETGQQIGDEVRALHDTGKFTDGQLVSQKSDSSKDIRGDKITWIEGKEPGCETIGLLMSSMDDLIRHCNGKLGSYKINGRTKAMVACYPGNGTGYVRHVDNPNGDGRCVTCIYYLNKDWDAKVSGGILRIFPEGKAQFADIEPKFDRLLFFWSDRRNPHEVQPAYATRYAITVWYFDADERARAKVKYLTGEKGVRVELNKPSDSVGKDVF	6YW0,6YVZ,6YVX,6YVW,6YVT,5OX6,5OX5,5A3U,4BQY,4BQX,4BQW,2Y34,2Y33,8Y0V,7UJV,3HQU,2G1M,5LA9,5L9V,8Z33,8Z32,2HBU,2HBT,2G19,3OUJ,3OUH,5V18,8Q6E,8Q6D,8Q5S,7Q5X,7Q5V,6YW3,6YW2,6YW1,6ST3,6QGV,6ZBO,6ZBN,8J1K,8Z35,8Z31,6NMQ,3OUI	Egl nine homolog 1	EGLN1_HUMAN	Q9GZT9	Q8N3M8 Q9BZS8 Q9BZT0		hypoxia-inducible factor-proline dioxygenase	R4SCQ0_HUMAN	R4SCQ0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
1320862	Cc1c(O)c(ncc1Oc1ccccc1)C(=O)NCC(O)=O	InChI=1S/C15H14N2O5/c1-9-11(22-10-5-3-2-4-6-10)7-16-13(14(9)20)15(21)17-8-12(18)19/h2-7,20H,8H2,1H3,(H,17,21)(H,18,19)	IZKSLSVNLIMACC-UHFFFAOYSA-N	619003	US20230295110, Compound 57.::US20230295110, Compound 35.	Prolyl hydroxylase EGLN2	Homo sapiens		 550							US Patent		10.7270/Q22V2M76		aid1919747	US20230295110	BLAISDELL, TP; ALLU, SR; FLEMING, PE	9/21/2023	10/30/2023	Akebia Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=619003	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=619003&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search			162731467	485226318							1	MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT		Prolyl hydroxylase EGLN2	EGLN2_HUMAN	Q96KS0	A8K5S0 Q8WWY4 Q9BV14																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1320863	Cc1c(O)c(ncc1-c1cc(Cl)cc(Cl)c1)C(=O)NCC(O)=O	InChI=1S/C15H12Cl2N2O4/c1-7-11(8-2-9(16)4-10(17)3-8)5-18-13(14(7)22)15(23)19-6-12(20)21/h2-5,22H,6H2,1H3,(H,19,23)(H,20,21)	OVMMAIBSFADPER-UHFFFAOYSA-N	619004	US20230295110, Compound 36.	Egl nine homolog 1	Homo sapiens		<100							US Patent		10.7270/Q22V2M76		aid1919747	US20230295110	BLAISDELL, TP; ALLU, SR; FLEMING, PE	9/21/2023	10/30/2023	Akebia Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=619004	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5440&target=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=619004&enzyme=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search			162731750	485226319							1	MANDSGGPGGPSPSERDRQYCELCGKMENLLRCSRCRSSFYCCKEHQRQDWKKHKLVCQGSEGALGHGVGPHQHSGPAPPAAVPPPRAGAREPRKAAARRDNASGDAAKGKVKAKPPADPAAAASPCRAAAGGQGSAVAAEAEPGKEEPPARSSLFQEKANLYPPSNTPGDALSPGGGLRPNGQTKPLPALKLALEYIVPCMNKHGICVVDDFLGKETGQQIGDEVRALHDTGKFTDGQLVSQKSDSSKDIRGDKITWIEGKEPGCETIGLLMSSMDDLIRHCNGKLGSYKINGRTKAMVACYPGNGTGYVRHVDNPNGDGRCVTCIYYLNKDWDAKVSGGILRIFPEGKAQFADIEPKFDRLLFFWSDRRNPHEVQPAYATRYAITVWYFDADERARAKVKYLTGEKGVRVELNKPSDSVGKDVF	6YW0,6YVZ,6YVX,6YVW,6YVT,5OX6,5OX5,5A3U,4BQY,4BQX,4BQW,2Y34,2Y33,8Y0V,7UJV,3HQU,2G1M,5LA9,5L9V,8Z33,8Z32,2HBU,2HBT,2G19,3OUJ,3OUH,5V18,8Q6E,8Q6D,8Q5S,7Q5X,7Q5V,6YW3,6YW2,6YW1,6ST3,6QGV,6ZBO,6ZBN,8J1K,8Z35,8Z31,6NMQ,3OUI	Egl nine homolog 1	EGLN1_HUMAN	Q9GZT9	Q8N3M8 Q9BZS8 Q9BZT0		hypoxia-inducible factor-proline dioxygenase	R4SCQ0_HUMAN	R4SCQ0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
1320864	Cc1c(O)c(ncc1-c1cc(Cl)cc(Cl)c1)C(=O)NCC(O)=O	InChI=1S/C15H12Cl2N2O4/c1-7-11(8-2-9(16)4-10(17)3-8)5-18-13(14(7)22)15(23)19-6-12(20)21/h2-5,22H,6H2,1H3,(H,19,23)(H,20,21)	OVMMAIBSFADPER-UHFFFAOYSA-N	619004	US20230295110, Compound 36.	Prolyl hydroxylase EGLN2	Homo sapiens		<100							US Patent		10.7270/Q22V2M76		aid1919747	US20230295110	BLAISDELL, TP; ALLU, SR; FLEMING, PE	9/21/2023	10/30/2023	Akebia Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=619004	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=619004&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search			162731750	485226319							1	MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT		Prolyl hydroxylase EGLN2	EGLN2_HUMAN	Q96KS0	A8K5S0 Q8WWY4 Q9BV14																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1320865	Cc1c(O)c(ncc1-c1cc(Cl)cc(Cl)c1)C(=O)NCC(O)=O	InChI=1S/C15H12Cl2N2O4/c1-7-11(8-2-9(16)4-10(17)3-8)5-18-13(14(7)22)15(23)19-6-12(20)21/h2-5,22H,6H2,1H3,(H,19,23)(H,20,21)	OVMMAIBSFADPER-UHFFFAOYSA-N	619004	US20230295110, Compound 36.	Prolyl hydroxylase EGLN3	Homo sapiens		<100							US Patent		10.7270/Q22V2M76		aid1919747	US20230295110	BLAISDELL, TP; ALLU, SR; FLEMING, PE	9/21/2023	10/30/2023	Akebia Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=619004	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5442&target=Prolyl+hydroxylase+EGLN3&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=619004&enzyme=Prolyl+hydroxylase+EGLN3&column=ki&startPg=0&Increment=50&submit=Search			162731750	485226319							1	MPLGHIMRLDLEKIALEYIVPCLHEVGFCYLDNFLGEVVGDCVLERVKQLHCTGALRDGQLAGPRAGVSKRHLRGDQITWIGGNEEGCEAISFLLSLIDRLVLYCGSRLGKYYVKERSKAMVACYPGNGTGYVRHVDNPNGDGRCITCIYYLNKNWDAKLHGGILRIFPEGKSFIADVEPIFDRLLFFWSDRRNPHEVQPSYATRYAMTVWYFDAEERAEAKKKFRNLTRKTESALTED		Prolyl hydroxylase EGLN3	EGLN3_HUMAN	Q9H6Z9	Q2TA79 Q3B8N4 Q6P1R2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1320866	Cc1nc(sc1-c1cnc(C(=O)NCC(O)=O)c(O)c1C)-c1ccccc1	InChI=1S/C19H17N3O4S/c1-10-13(8-20-15(16(10)25)18(26)21-9-14(23)24)17-11(2)22-19(27-17)12-6-4-3-5-7-12/h3-8,25H,9H2,1-2H3,(H,21,26)(H,23,24)	SFGZDSAMNUBPEB-UHFFFAOYSA-N	619005	US20230295110, Compound 37.	Egl nine homolog 1	Homo sapiens		<100							US Patent		10.7270/Q22V2M76		aid1919747	US20230295110	BLAISDELL, TP; ALLU, SR; FLEMING, PE	9/21/2023	10/30/2023	Akebia Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=619005	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5440&target=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=619005&enzyme=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search			162731563	485226320							1	MANDSGGPGGPSPSERDRQYCELCGKMENLLRCSRCRSSFYCCKEHQRQDWKKHKLVCQGSEGALGHGVGPHQHSGPAPPAAVPPPRAGAREPRKAAARRDNASGDAAKGKVKAKPPADPAAAASPCRAAAGGQGSAVAAEAEPGKEEPPARSSLFQEKANLYPPSNTPGDALSPGGGLRPNGQTKPLPALKLALEYIVPCMNKHGICVVDDFLGKETGQQIGDEVRALHDTGKFTDGQLVSQKSDSSKDIRGDKITWIEGKEPGCETIGLLMSSMDDLIRHCNGKLGSYKINGRTKAMVACYPGNGTGYVRHVDNPNGDGRCVTCIYYLNKDWDAKVSGGILRIFPEGKAQFADIEPKFDRLLFFWSDRRNPHEVQPAYATRYAITVWYFDADERARAKVKYLTGEKGVRVELNKPSDSVGKDVF	6YW0,6YVZ,6YVX,6YVW,6YVT,5OX6,5OX5,5A3U,4BQY,4BQX,4BQW,2Y34,2Y33,8Y0V,7UJV,3HQU,2G1M,5LA9,5L9V,8Z33,8Z32,2HBU,2HBT,2G19,3OUJ,3OUH,5V18,8Q6E,8Q6D,8Q5S,7Q5X,7Q5V,6YW3,6YW2,6YW1,6ST3,6QGV,6ZBO,6ZBN,8J1K,8Z35,8Z31,6NMQ,3OUI	Egl nine homolog 1	EGLN1_HUMAN	Q9GZT9	Q8N3M8 Q9BZS8 Q9BZT0		hypoxia-inducible factor-proline dioxygenase	R4SCQ0_HUMAN	R4SCQ0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
1320867	Cc1nc(sc1-c1cnc(C(=O)NCC(O)=O)c(O)c1C)-c1ccccc1	InChI=1S/C19H17N3O4S/c1-10-13(8-20-15(16(10)25)18(26)21-9-14(23)24)17-11(2)22-19(27-17)12-6-4-3-5-7-12/h3-8,25H,9H2,1-2H3,(H,21,26)(H,23,24)	SFGZDSAMNUBPEB-UHFFFAOYSA-N	619005	US20230295110, Compound 37.	Prolyl hydroxylase EGLN2	Homo sapiens		<100							US Patent		10.7270/Q22V2M76		aid1919747	US20230295110	BLAISDELL, TP; ALLU, SR; FLEMING, PE	9/21/2023	10/30/2023	Akebia Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=619005	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=619005&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search			162731563	485226320							1	MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT		Prolyl hydroxylase EGLN2	EGLN2_HUMAN	Q96KS0	A8K5S0 Q8WWY4 Q9BV14																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1320868	Cc1nc(sc1-c1cnc(C(=O)NCC(O)=O)c(O)c1C)-c1ccccc1	InChI=1S/C19H17N3O4S/c1-10-13(8-20-15(16(10)25)18(26)21-9-14(23)24)17-11(2)22-19(27-17)12-6-4-3-5-7-12/h3-8,25H,9H2,1-2H3,(H,21,26)(H,23,24)	SFGZDSAMNUBPEB-UHFFFAOYSA-N	619005	US20230295110, Compound 37.	Prolyl hydroxylase EGLN3	Homo sapiens		<100							US Patent		10.7270/Q22V2M76		aid1919747	US20230295110	BLAISDELL, TP; ALLU, SR; FLEMING, PE	9/21/2023	10/30/2023	Akebia Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=619005	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5442&target=Prolyl+hydroxylase+EGLN3&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=619005&enzyme=Prolyl+hydroxylase+EGLN3&column=ki&startPg=0&Increment=50&submit=Search			162731563	485226320							1	MPLGHIMRLDLEKIALEYIVPCLHEVGFCYLDNFLGEVVGDCVLERVKQLHCTGALRDGQLAGPRAGVSKRHLRGDQITWIGGNEEGCEAISFLLSLIDRLVLYCGSRLGKYYVKERSKAMVACYPGNGTGYVRHVDNPNGDGRCITCIYYLNKNWDAKLHGGILRIFPEGKSFIADVEPIFDRLLFFWSDRRNPHEVQPSYATRYAMTVWYFDAEERAEAKKKFRNLTRKTESALTED		Prolyl hydroxylase EGLN3	EGLN3_HUMAN	Q9H6Z9	Q2TA79 Q3B8N4 Q6P1R2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1320869	Cc1nn(cc1-c1cnc(C(=O)NCC(O)=O)c(O)c1C)-c1ccc(F)cc1	InChI=1S/C19H17FN4O4/c1-10-14(7-21-17(18(10)27)19(28)22-8-16(25)26)15-9-24(23-11(15)2)13-5-3-12(20)4-6-13/h3-7,9,27H,8H2,1-2H3,(H,22,28)(H,25,26)	NWCZRWXCEDMEAA-UHFFFAOYSA-N	619006	US20230295110, Compound 38.	Egl nine homolog 1	Homo sapiens		<100							US Patent		10.7270/Q22V2M76		aid1919747	US20230295110	BLAISDELL, TP; ALLU, SR; FLEMING, PE	9/21/2023	10/30/2023	Akebia Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=619006	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5440&target=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=619006&enzyme=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search			162731770	485226321							1	MANDSGGPGGPSPSERDRQYCELCGKMENLLRCSRCRSSFYCCKEHQRQDWKKHKLVCQGSEGALGHGVGPHQHSGPAPPAAVPPPRAGAREPRKAAARRDNASGDAAKGKVKAKPPADPAAAASPCRAAAGGQGSAVAAEAEPGKEEPPARSSLFQEKANLYPPSNTPGDALSPGGGLRPNGQTKPLPALKLALEYIVPCMNKHGICVVDDFLGKETGQQIGDEVRALHDTGKFTDGQLVSQKSDSSKDIRGDKITWIEGKEPGCETIGLLMSSMDDLIRHCNGKLGSYKINGRTKAMVACYPGNGTGYVRHVDNPNGDGRCVTCIYYLNKDWDAKVSGGILRIFPEGKAQFADIEPKFDRLLFFWSDRRNPHEVQPAYATRYAITVWYFDADERARAKVKYLTGEKGVRVELNKPSDSVGKDVF	6YW0,6YVZ,6YVX,6YVW,6YVT,5OX6,5OX5,5A3U,4BQY,4BQX,4BQW,2Y34,2Y33,8Y0V,7UJV,3HQU,2G1M,5LA9,5L9V,8Z33,8Z32,2HBU,2HBT,2G19,3OUJ,3OUH,5V18,8Q6E,8Q6D,8Q5S,7Q5X,7Q5V,6YW3,6YW2,6YW1,6ST3,6QGV,6ZBO,6ZBN,8J1K,8Z35,8Z31,6NMQ,3OUI	Egl nine homolog 1	EGLN1_HUMAN	Q9GZT9	Q8N3M8 Q9BZS8 Q9BZT0		hypoxia-inducible factor-proline dioxygenase	R4SCQ0_HUMAN	R4SCQ0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
1320870	Cc1nn(cc1-c1cnc(C(=O)NCC(O)=O)c(O)c1C)-c1ccc(F)cc1	InChI=1S/C19H17FN4O4/c1-10-14(7-21-17(18(10)27)19(28)22-8-16(25)26)15-9-24(23-11(15)2)13-5-3-12(20)4-6-13/h3-7,9,27H,8H2,1-2H3,(H,22,28)(H,25,26)	NWCZRWXCEDMEAA-UHFFFAOYSA-N	619006	US20230295110, Compound 38.	Prolyl hydroxylase EGLN2	Homo sapiens		<100							US Patent		10.7270/Q22V2M76		aid1919747	US20230295110	BLAISDELL, TP; ALLU, SR; FLEMING, PE	9/21/2023	10/30/2023	Akebia Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=619006	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=619006&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search			162731770	485226321							1	MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT		Prolyl hydroxylase EGLN2	EGLN2_HUMAN	Q96KS0	A8K5S0 Q8WWY4 Q9BV14																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1320871	Cc1nn(cc1-c1cnc(C(=O)NCC(O)=O)c(O)c1C)-c1ccc(F)cc1	InChI=1S/C19H17FN4O4/c1-10-14(7-21-17(18(10)27)19(28)22-8-16(25)26)15-9-24(23-11(15)2)13-5-3-12(20)4-6-13/h3-7,9,27H,8H2,1-2H3,(H,22,28)(H,25,26)	NWCZRWXCEDMEAA-UHFFFAOYSA-N	619006	US20230295110, Compound 38.	Prolyl hydroxylase EGLN3	Homo sapiens		<100							US Patent		10.7270/Q22V2M76		aid1919747	US20230295110	BLAISDELL, TP; ALLU, SR; FLEMING, PE	9/21/2023	10/30/2023	Akebia Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=619006	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5442&target=Prolyl+hydroxylase+EGLN3&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=619006&enzyme=Prolyl+hydroxylase+EGLN3&column=ki&startPg=0&Increment=50&submit=Search			162731770	485226321							1	MPLGHIMRLDLEKIALEYIVPCLHEVGFCYLDNFLGEVVGDCVLERVKQLHCTGALRDGQLAGPRAGVSKRHLRGDQITWIGGNEEGCEAISFLLSLIDRLVLYCGSRLGKYYVKERSKAMVACYPGNGTGYVRHVDNPNGDGRCITCIYYLNKNWDAKLHGGILRIFPEGKSFIADVEPIFDRLLFFWSDRRNPHEVQPSYATRYAMTVWYFDAEERAEAKKKFRNLTRKTESALTED		Prolyl hydroxylase EGLN3	EGLN3_HUMAN	Q9H6Z9	Q2TA79 Q3B8N4 Q6P1R2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1320872	Cc1nn(cc1-c1cnc(C(=O)NCC(O)=O)c(O)c1C)-c1cccc(F)c1	InChI=1S/C19H17FN4O4/c1-10-14(7-21-17(18(10)27)19(28)22-8-16(25)26)15-9-24(23-11(15)2)13-5-3-4-12(20)6-13/h3-7,9,27H,8H2,1-2H3,(H,22,28)(H,25,26)	TVQXZSGCUMZDGM-UHFFFAOYSA-N	619007	US20230295110, Compound 39.	Egl nine homolog 1	Homo sapiens		<100							US Patent		10.7270/Q22V2M76		aid1919747	US20230295110	BLAISDELL, TP; ALLU, SR; FLEMING, PE	9/21/2023	10/30/2023	Akebia Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=619007	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5440&target=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=619007&enzyme=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search			162731593	485226322							1	MANDSGGPGGPSPSERDRQYCELCGKMENLLRCSRCRSSFYCCKEHQRQDWKKHKLVCQGSEGALGHGVGPHQHSGPAPPAAVPPPRAGAREPRKAAARRDNASGDAAKGKVKAKPPADPAAAASPCRAAAGGQGSAVAAEAEPGKEEPPARSSLFQEKANLYPPSNTPGDALSPGGGLRPNGQTKPLPALKLALEYIVPCMNKHGICVVDDFLGKETGQQIGDEVRALHDTGKFTDGQLVSQKSDSSKDIRGDKITWIEGKEPGCETIGLLMSSMDDLIRHCNGKLGSYKINGRTKAMVACYPGNGTGYVRHVDNPNGDGRCVTCIYYLNKDWDAKVSGGILRIFPEGKAQFADIEPKFDRLLFFWSDRRNPHEVQPAYATRYAITVWYFDADERARAKVKYLTGEKGVRVELNKPSDSVGKDVF	6YW0,6YVZ,6YVX,6YVW,6YVT,5OX6,5OX5,5A3U,4BQY,4BQX,4BQW,2Y34,2Y33,8Y0V,7UJV,3HQU,2G1M,5LA9,5L9V,8Z33,8Z32,2HBU,2HBT,2G19,3OUJ,3OUH,5V18,8Q6E,8Q6D,8Q5S,7Q5X,7Q5V,6YW3,6YW2,6YW1,6ST3,6QGV,6ZBO,6ZBN,8J1K,8Z35,8Z31,6NMQ,3OUI	Egl nine homolog 1	EGLN1_HUMAN	Q9GZT9	Q8N3M8 Q9BZS8 Q9BZT0		hypoxia-inducible factor-proline dioxygenase	R4SCQ0_HUMAN	R4SCQ0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
1320873	Cc1nn(cc1-c1cnc(C(=O)NCC(O)=O)c(O)c1C)-c1cccc(F)c1	InChI=1S/C19H17FN4O4/c1-10-14(7-21-17(18(10)27)19(28)22-8-16(25)26)15-9-24(23-11(15)2)13-5-3-4-12(20)6-13/h3-7,9,27H,8H2,1-2H3,(H,22,28)(H,25,26)	TVQXZSGCUMZDGM-UHFFFAOYSA-N	619007	US20230295110, Compound 39.	Prolyl hydroxylase EGLN2	Homo sapiens		<100							US Patent		10.7270/Q22V2M76		aid1919747	US20230295110	BLAISDELL, TP; ALLU, SR; FLEMING, PE	9/21/2023	10/30/2023	Akebia Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=619007	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=619007&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search			162731593	485226322							1	MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT		Prolyl hydroxylase EGLN2	EGLN2_HUMAN	Q96KS0	A8K5S0 Q8WWY4 Q9BV14																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1320874	Cc1nn(cc1-c1cnc(C(=O)NCC(O)=O)c(O)c1C)-c1cccc(F)c1	InChI=1S/C19H17FN4O4/c1-10-14(7-21-17(18(10)27)19(28)22-8-16(25)26)15-9-24(23-11(15)2)13-5-3-4-12(20)6-13/h3-7,9,27H,8H2,1-2H3,(H,22,28)(H,25,26)	TVQXZSGCUMZDGM-UHFFFAOYSA-N	619007	US20230295110, Compound 39.	Prolyl hydroxylase EGLN3	Homo sapiens		<100							US Patent		10.7270/Q22V2M76		aid1919747	US20230295110	BLAISDELL, TP; ALLU, SR; FLEMING, PE	9/21/2023	10/30/2023	Akebia Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=619007	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5442&target=Prolyl+hydroxylase+EGLN3&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=619007&enzyme=Prolyl+hydroxylase+EGLN3&column=ki&startPg=0&Increment=50&submit=Search			162731593	485226322							1	MPLGHIMRLDLEKIALEYIVPCLHEVGFCYLDNFLGEVVGDCVLERVKQLHCTGALRDGQLAGPRAGVSKRHLRGDQITWIGGNEEGCEAISFLLSLIDRLVLYCGSRLGKYYVKERSKAMVACYPGNGTGYVRHVDNPNGDGRCITCIYYLNKNWDAKLHGGILRIFPEGKSFIADVEPIFDRLLFFWSDRRNPHEVQPSYATRYAMTVWYFDAEERAEAKKKFRNLTRKTESALTED		Prolyl hydroxylase EGLN3	EGLN3_HUMAN	Q9H6Z9	Q2TA79 Q3B8N4 Q6P1R2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1320875	Cc1c(O)c(ncc1C(=O)c1ccccc1)C(=O)NCC(O)=O	InChI=1S/C16H14N2O5/c1-9-11(15(22)10-5-3-2-4-6-10)7-17-13(14(9)21)16(23)18-8-12(19)20/h2-7,21H,8H2,1H3,(H,18,23)(H,19,20)	JGNKZSHYWZETBS-UHFFFAOYSA-N	619008	US20230295110, Compound 40.	Egl nine homolog 1	Homo sapiens		 550							US Patent		10.7270/Q22V2M76		aid1919747	US20230295110	BLAISDELL, TP; ALLU, SR; FLEMING, PE	9/21/2023	10/30/2023	Akebia Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=619008	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5440&target=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=619008&enzyme=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search			162731564	485226323							1	MANDSGGPGGPSPSERDRQYCELCGKMENLLRCSRCRSSFYCCKEHQRQDWKKHKLVCQGSEGALGHGVGPHQHSGPAPPAAVPPPRAGAREPRKAAARRDNASGDAAKGKVKAKPPADPAAAASPCRAAAGGQGSAVAAEAEPGKEEPPARSSLFQEKANLYPPSNTPGDALSPGGGLRPNGQTKPLPALKLALEYIVPCMNKHGICVVDDFLGKETGQQIGDEVRALHDTGKFTDGQLVSQKSDSSKDIRGDKITWIEGKEPGCETIGLLMSSMDDLIRHCNGKLGSYKINGRTKAMVACYPGNGTGYVRHVDNPNGDGRCVTCIYYLNKDWDAKVSGGILRIFPEGKAQFADIEPKFDRLLFFWSDRRNPHEVQPAYATRYAITVWYFDADERARAKVKYLTGEKGVRVELNKPSDSVGKDVF	6YW0,6YVZ,6YVX,6YVW,6YVT,5OX6,5OX5,5A3U,4BQY,4BQX,4BQW,2Y34,2Y33,8Y0V,7UJV,3HQU,2G1M,5LA9,5L9V,8Z33,8Z32,2HBU,2HBT,2G19,3OUJ,3OUH,5V18,8Q6E,8Q6D,8Q5S,7Q5X,7Q5V,6YW3,6YW2,6YW1,6ST3,6QGV,6ZBO,6ZBN,8J1K,8Z35,8Z31,6NMQ,3OUI	Egl nine homolog 1	EGLN1_HUMAN	Q9GZT9	Q8N3M8 Q9BZS8 Q9BZT0		hypoxia-inducible factor-proline dioxygenase	R4SCQ0_HUMAN	R4SCQ0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
1320876	Cc1c(O)c(ncc1C(=O)c1ccccc1)C(=O)NCC(O)=O	InChI=1S/C16H14N2O5/c1-9-11(15(22)10-5-3-2-4-6-10)7-17-13(14(9)21)16(23)18-8-12(19)20/h2-7,21H,8H2,1H3,(H,18,23)(H,19,20)	JGNKZSHYWZETBS-UHFFFAOYSA-N	619008	US20230295110, Compound 40.	Prolyl hydroxylase EGLN2	Homo sapiens		 550							US Patent		10.7270/Q22V2M76		aid1919747	US20230295110	BLAISDELL, TP; ALLU, SR; FLEMING, PE	9/21/2023	10/30/2023	Akebia Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=619008	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=619008&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search			162731564	485226323							1	MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT		Prolyl hydroxylase EGLN2	EGLN2_HUMAN	Q96KS0	A8K5S0 Q8WWY4 Q9BV14																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1320877	Cc1c(O)c(ncc1-c1cn(nn1)-c1ccc(F)cc1)C(=O)NCC(O)=O	InChI=1S/C17H14FN5O4/c1-9-12(6-19-15(16(9)26)17(27)20-7-14(24)25)13-8-23(22-21-13)11-4-2-10(18)3-5-11/h2-6,8,26H,7H2,1H3,(H,20,27)(H,24,25)	SMGAXPXETHLXNE-UHFFFAOYSA-N	619009	US20230295110, Compound 41.	Egl nine homolog 1	Homo sapiens		<100							US Patent		10.7270/Q22V2M76		aid1919747	US20230295110	BLAISDELL, TP; ALLU, SR; FLEMING, PE	9/21/2023	10/30/2023	Akebia Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=619009	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5440&target=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=619009&enzyme=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search			162731534	485226324							1	MANDSGGPGGPSPSERDRQYCELCGKMENLLRCSRCRSSFYCCKEHQRQDWKKHKLVCQGSEGALGHGVGPHQHSGPAPPAAVPPPRAGAREPRKAAARRDNASGDAAKGKVKAKPPADPAAAASPCRAAAGGQGSAVAAEAEPGKEEPPARSSLFQEKANLYPPSNTPGDALSPGGGLRPNGQTKPLPALKLALEYIVPCMNKHGICVVDDFLGKETGQQIGDEVRALHDTGKFTDGQLVSQKSDSSKDIRGDKITWIEGKEPGCETIGLLMSSMDDLIRHCNGKLGSYKINGRTKAMVACYPGNGTGYVRHVDNPNGDGRCVTCIYYLNKDWDAKVSGGILRIFPEGKAQFADIEPKFDRLLFFWSDRRNPHEVQPAYATRYAITVWYFDADERARAKVKYLTGEKGVRVELNKPSDSVGKDVF	6YW0,6YVZ,6YVX,6YVW,6YVT,5OX6,5OX5,5A3U,4BQY,4BQX,4BQW,2Y34,2Y33,8Y0V,7UJV,3HQU,2G1M,5LA9,5L9V,8Z33,8Z32,2HBU,2HBT,2G19,3OUJ,3OUH,5V18,8Q6E,8Q6D,8Q5S,7Q5X,7Q5V,6YW3,6YW2,6YW1,6ST3,6QGV,6ZBO,6ZBN,8J1K,8Z35,8Z31,6NMQ,3OUI	Egl nine homolog 1	EGLN1_HUMAN	Q9GZT9	Q8N3M8 Q9BZS8 Q9BZT0		hypoxia-inducible factor-proline dioxygenase	R4SCQ0_HUMAN	R4SCQ0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
1320878	Cc1c(O)c(ncc1-c1cn(nn1)-c1ccc(F)cc1)C(=O)NCC(O)=O	InChI=1S/C17H14FN5O4/c1-9-12(6-19-15(16(9)26)17(27)20-7-14(24)25)13-8-23(22-21-13)11-4-2-10(18)3-5-11/h2-6,8,26H,7H2,1H3,(H,20,27)(H,24,25)	SMGAXPXETHLXNE-UHFFFAOYSA-N	619009	US20230295110, Compound 41.	Prolyl hydroxylase EGLN2	Homo sapiens		<100							US Patent		10.7270/Q22V2M76		aid1919747	US20230295110	BLAISDELL, TP; ALLU, SR; FLEMING, PE	9/21/2023	10/30/2023	Akebia Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=619009	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=619009&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search			162731534	485226324							1	MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT		Prolyl hydroxylase EGLN2	EGLN2_HUMAN	Q96KS0	A8K5S0 Q8WWY4 Q9BV14																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1320879	Cc1c(O)c(ncc1-c1cn(nn1)-c1ccc(F)cc1)C(=O)NCC(O)=O	InChI=1S/C17H14FN5O4/c1-9-12(6-19-15(16(9)26)17(27)20-7-14(24)25)13-8-23(22-21-13)11-4-2-10(18)3-5-11/h2-6,8,26H,7H2,1H3,(H,20,27)(H,24,25)	SMGAXPXETHLXNE-UHFFFAOYSA-N	619009	US20230295110, Compound 41.	Prolyl hydroxylase EGLN3	Homo sapiens		<100							US Patent		10.7270/Q22V2M76		aid1919747	US20230295110	BLAISDELL, TP; ALLU, SR; FLEMING, PE	9/21/2023	10/30/2023	Akebia Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=619009	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5442&target=Prolyl+hydroxylase+EGLN3&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=619009&enzyme=Prolyl+hydroxylase+EGLN3&column=ki&startPg=0&Increment=50&submit=Search			162731534	485226324							1	MPLGHIMRLDLEKIALEYIVPCLHEVGFCYLDNFLGEVVGDCVLERVKQLHCTGALRDGQLAGPRAGVSKRHLRGDQITWIGGNEEGCEAISFLLSLIDRLVLYCGSRLGKYYVKERSKAMVACYPGNGTGYVRHVDNPNGDGRCITCIYYLNKNWDAKLHGGILRIFPEGKSFIADVEPIFDRLLFFWSDRRNPHEVQPSYATRYAMTVWYFDAEERAEAKKKFRNLTRKTESALTED		Prolyl hydroxylase EGLN3	EGLN3_HUMAN	Q9H6Z9	Q2TA79 Q3B8N4 Q6P1R2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1320880	Cc1c(O)c(ncc1-c1cn(CCc2ccc(Cl)cc2)nn1)C(=O)NCC(O)=O	InChI=1S/C19H18ClN5O4/c1-11-14(8-21-17(18(11)28)19(29)22-9-16(26)27)15-10-25(24-23-15)7-6-12-2-4-13(20)5-3-12/h2-5,8,10,28H,6-7,9H2,1H3,(H,22,29)(H,26,27)	ABEHCNCJBYECBD-UHFFFAOYSA-N	619010	US20230295110, Compound 42.	Egl nine homolog 1	Homo sapiens		<100							US Patent		10.7270/Q22V2M76		aid1919747	US20230295110	BLAISDELL, TP; ALLU, SR; FLEMING, PE	9/21/2023	10/30/2023	Akebia Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=619010	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5440&target=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=619010&enzyme=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search			162731751	485226325							1	MANDSGGPGGPSPSERDRQYCELCGKMENLLRCSRCRSSFYCCKEHQRQDWKKHKLVCQGSEGALGHGVGPHQHSGPAPPAAVPPPRAGAREPRKAAARRDNASGDAAKGKVKAKPPADPAAAASPCRAAAGGQGSAVAAEAEPGKEEPPARSSLFQEKANLYPPSNTPGDALSPGGGLRPNGQTKPLPALKLALEYIVPCMNKHGICVVDDFLGKETGQQIGDEVRALHDTGKFTDGQLVSQKSDSSKDIRGDKITWIEGKEPGCETIGLLMSSMDDLIRHCNGKLGSYKINGRTKAMVACYPGNGTGYVRHVDNPNGDGRCVTCIYYLNKDWDAKVSGGILRIFPEGKAQFADIEPKFDRLLFFWSDRRNPHEVQPAYATRYAITVWYFDADERARAKVKYLTGEKGVRVELNKPSDSVGKDVF	6YW0,6YVZ,6YVX,6YVW,6YVT,5OX6,5OX5,5A3U,4BQY,4BQX,4BQW,2Y34,2Y33,8Y0V,7UJV,3HQU,2G1M,5LA9,5L9V,8Z33,8Z32,2HBU,2HBT,2G19,3OUJ,3OUH,5V18,8Q6E,8Q6D,8Q5S,7Q5X,7Q5V,6YW3,6YW2,6YW1,6ST3,6QGV,6ZBO,6ZBN,8J1K,8Z35,8Z31,6NMQ,3OUI	Egl nine homolog 1	EGLN1_HUMAN	Q9GZT9	Q8N3M8 Q9BZS8 Q9BZT0		hypoxia-inducible factor-proline dioxygenase	R4SCQ0_HUMAN	R4SCQ0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
1320881	Cc1c(O)c(ncc1-c1cn(CCc2ccc(Cl)cc2)nn1)C(=O)NCC(O)=O	InChI=1S/C19H18ClN5O4/c1-11-14(8-21-17(18(11)28)19(29)22-9-16(26)27)15-10-25(24-23-15)7-6-12-2-4-13(20)5-3-12/h2-5,8,10,28H,6-7,9H2,1H3,(H,22,29)(H,26,27)	ABEHCNCJBYECBD-UHFFFAOYSA-N	619010	US20230295110, Compound 42.	Prolyl hydroxylase EGLN2	Homo sapiens		<100							US Patent		10.7270/Q22V2M76		aid1919747	US20230295110	BLAISDELL, TP; ALLU, SR; FLEMING, PE	9/21/2023	10/30/2023	Akebia Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=619010	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=619010&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search			162731751	485226325							1	MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT		Prolyl hydroxylase EGLN2	EGLN2_HUMAN	Q96KS0	A8K5S0 Q8WWY4 Q9BV14																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1320882	Cc1c(O)c(ncc1-c1cn(CCc2ccc(Cl)cc2)nn1)C(=O)NCC(O)=O	InChI=1S/C19H18ClN5O4/c1-11-14(8-21-17(18(11)28)19(29)22-9-16(26)27)15-10-25(24-23-15)7-6-12-2-4-13(20)5-3-12/h2-5,8,10,28H,6-7,9H2,1H3,(H,22,29)(H,26,27)	ABEHCNCJBYECBD-UHFFFAOYSA-N	619010	US20230295110, Compound 42.	Prolyl hydroxylase EGLN3	Homo sapiens		<100							US Patent		10.7270/Q22V2M76		aid1919747	US20230295110	BLAISDELL, TP; ALLU, SR; FLEMING, PE	9/21/2023	10/30/2023	Akebia Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=619010	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5442&target=Prolyl+hydroxylase+EGLN3&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=619010&enzyme=Prolyl+hydroxylase+EGLN3&column=ki&startPg=0&Increment=50&submit=Search			162731751	485226325							1	MPLGHIMRLDLEKIALEYIVPCLHEVGFCYLDNFLGEVVGDCVLERVKQLHCTGALRDGQLAGPRAGVSKRHLRGDQITWIGGNEEGCEAISFLLSLIDRLVLYCGSRLGKYYVKERSKAMVACYPGNGTGYVRHVDNPNGDGRCITCIYYLNKNWDAKLHGGILRIFPEGKSFIADVEPIFDRLLFFWSDRRNPHEVQPSYATRYAMTVWYFDAEERAEAKKKFRNLTRKTESALTED		Prolyl hydroxylase EGLN3	EGLN3_HUMAN	Q9H6Z9	Q2TA79 Q3B8N4 Q6P1R2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1320883	Cc1c(O)c(ncc1-c1cn(CCCc2ccc(Cl)cc2)nn1)C(=O)NCC(O)=O	InChI=1S/C20H20ClN5O4/c1-12-15(9-22-18(19(12)29)20(30)23-10-17(27)28)16-11-26(25-24-16)8-2-3-13-4-6-14(21)7-5-13/h4-7,9,11,29H,2-3,8,10H2,1H3,(H,23,30)(H,27,28)	UBSDUDWDHZMFDW-UHFFFAOYSA-N	619011	US20230295110, Compound 43.	Egl nine homolog 1	Homo sapiens		<100							US Patent		10.7270/Q22V2M76		aid1919747	US20230295110	BLAISDELL, TP; ALLU, SR; FLEMING, PE	9/21/2023	10/30/2023	Akebia Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=619011	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5440&target=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=619011&enzyme=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search			162731747	485226326							1	MANDSGGPGGPSPSERDRQYCELCGKMENLLRCSRCRSSFYCCKEHQRQDWKKHKLVCQGSEGALGHGVGPHQHSGPAPPAAVPPPRAGAREPRKAAARRDNASGDAAKGKVKAKPPADPAAAASPCRAAAGGQGSAVAAEAEPGKEEPPARSSLFQEKANLYPPSNTPGDALSPGGGLRPNGQTKPLPALKLALEYIVPCMNKHGICVVDDFLGKETGQQIGDEVRALHDTGKFTDGQLVSQKSDSSKDIRGDKITWIEGKEPGCETIGLLMSSMDDLIRHCNGKLGSYKINGRTKAMVACYPGNGTGYVRHVDNPNGDGRCVTCIYYLNKDWDAKVSGGILRIFPEGKAQFADIEPKFDRLLFFWSDRRNPHEVQPAYATRYAITVWYFDADERARAKVKYLTGEKGVRVELNKPSDSVGKDVF	6YW0,6YVZ,6YVX,6YVW,6YVT,5OX6,5OX5,5A3U,4BQY,4BQX,4BQW,2Y34,2Y33,8Y0V,7UJV,3HQU,2G1M,5LA9,5L9V,8Z33,8Z32,2HBU,2HBT,2G19,3OUJ,3OUH,5V18,8Q6E,8Q6D,8Q5S,7Q5X,7Q5V,6YW3,6YW2,6YW1,6ST3,6QGV,6ZBO,6ZBN,8J1K,8Z35,8Z31,6NMQ,3OUI	Egl nine homolog 1	EGLN1_HUMAN	Q9GZT9	Q8N3M8 Q9BZS8 Q9BZT0		hypoxia-inducible factor-proline dioxygenase	R4SCQ0_HUMAN	R4SCQ0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
1320884	Cc1c(O)c(ncc1-c1cn(CCCc2ccc(Cl)cc2)nn1)C(=O)NCC(O)=O	InChI=1S/C20H20ClN5O4/c1-12-15(9-22-18(19(12)29)20(30)23-10-17(27)28)16-11-26(25-24-16)8-2-3-13-4-6-14(21)7-5-13/h4-7,9,11,29H,2-3,8,10H2,1H3,(H,23,30)(H,27,28)	UBSDUDWDHZMFDW-UHFFFAOYSA-N	619011	US20230295110, Compound 43.	Prolyl hydroxylase EGLN2	Homo sapiens		<100							US Patent		10.7270/Q22V2M76		aid1919747	US20230295110	BLAISDELL, TP; ALLU, SR; FLEMING, PE	9/21/2023	10/30/2023	Akebia Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=619011	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=619011&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search			162731747	485226326							1	MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT		Prolyl hydroxylase EGLN2	EGLN2_HUMAN	Q96KS0	A8K5S0 Q8WWY4 Q9BV14																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1320885	Cc1c(O)c(ncc1-c1cn(CCCc2ccc(Cl)cc2)nn1)C(=O)NCC(O)=O	InChI=1S/C20H20ClN5O4/c1-12-15(9-22-18(19(12)29)20(30)23-10-17(27)28)16-11-26(25-24-16)8-2-3-13-4-6-14(21)7-5-13/h4-7,9,11,29H,2-3,8,10H2,1H3,(H,23,30)(H,27,28)	UBSDUDWDHZMFDW-UHFFFAOYSA-N	619011	US20230295110, Compound 43.	Prolyl hydroxylase EGLN3	Homo sapiens		<100							US Patent		10.7270/Q22V2M76		aid1919747	US20230295110	BLAISDELL, TP; ALLU, SR; FLEMING, PE	9/21/2023	10/30/2023	Akebia Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=619011	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5442&target=Prolyl+hydroxylase+EGLN3&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=619011&enzyme=Prolyl+hydroxylase+EGLN3&column=ki&startPg=0&Increment=50&submit=Search			162731747	485226326							1	MPLGHIMRLDLEKIALEYIVPCLHEVGFCYLDNFLGEVVGDCVLERVKQLHCTGALRDGQLAGPRAGVSKRHLRGDQITWIGGNEEGCEAISFLLSLIDRLVLYCGSRLGKYYVKERSKAMVACYPGNGTGYVRHVDNPNGDGRCITCIYYLNKNWDAKLHGGILRIFPEGKSFIADVEPIFDRLLFFWSDRRNPHEVQPSYATRYAMTVWYFDAEERAEAKKKFRNLTRKTESALTED		Prolyl hydroxylase EGLN3	EGLN3_HUMAN	Q9H6Z9	Q2TA79 Q3B8N4 Q6P1R2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1320886	Cc1c(O)c(ncc1-c1cn(nn1)-c1ccccc1)C(=O)NCC(O)=O	InChI=1S/C17H15N5O4/c1-10-12(7-18-15(16(10)25)17(26)19-8-14(23)24)13-9-22(21-20-13)11-5-3-2-4-6-11/h2-7,9,25H,8H2,1H3,(H,19,26)(H,23,24)	QMLYBMDZNXVJGE-UHFFFAOYSA-N	619012	US20230295110, Compound 44.	Egl nine homolog 1	Homo sapiens		<100							US Patent		10.7270/Q22V2M76		aid1919747	US20230295110	BLAISDELL, TP; ALLU, SR; FLEMING, PE	9/21/2023	10/30/2023	Akebia Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=619012	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5440&target=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=619012&enzyme=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search			162731578	485226327							1	MANDSGGPGGPSPSERDRQYCELCGKMENLLRCSRCRSSFYCCKEHQRQDWKKHKLVCQGSEGALGHGVGPHQHSGPAPPAAVPPPRAGAREPRKAAARRDNASGDAAKGKVKAKPPADPAAAASPCRAAAGGQGSAVAAEAEPGKEEPPARSSLFQEKANLYPPSNTPGDALSPGGGLRPNGQTKPLPALKLALEYIVPCMNKHGICVVDDFLGKETGQQIGDEVRALHDTGKFTDGQLVSQKSDSSKDIRGDKITWIEGKEPGCETIGLLMSSMDDLIRHCNGKLGSYKINGRTKAMVACYPGNGTGYVRHVDNPNGDGRCVTCIYYLNKDWDAKVSGGILRIFPEGKAQFADIEPKFDRLLFFWSDRRNPHEVQPAYATRYAITVWYFDADERARAKVKYLTGEKGVRVELNKPSDSVGKDVF	6YW0,6YVZ,6YVX,6YVW,6YVT,5OX6,5OX5,5A3U,4BQY,4BQX,4BQW,2Y34,2Y33,8Y0V,7UJV,3HQU,2G1M,5LA9,5L9V,8Z33,8Z32,2HBU,2HBT,2G19,3OUJ,3OUH,5V18,8Q6E,8Q6D,8Q5S,7Q5X,7Q5V,6YW3,6YW2,6YW1,6ST3,6QGV,6ZBO,6ZBN,8J1K,8Z35,8Z31,6NMQ,3OUI	Egl nine homolog 1	EGLN1_HUMAN	Q9GZT9	Q8N3M8 Q9BZS8 Q9BZT0		hypoxia-inducible factor-proline dioxygenase	R4SCQ0_HUMAN	R4SCQ0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
1320887	Cc1c(O)c(ncc1-c1cn(nn1)-c1ccccc1)C(=O)NCC(O)=O	InChI=1S/C17H15N5O4/c1-10-12(7-18-15(16(10)25)17(26)19-8-14(23)24)13-9-22(21-20-13)11-5-3-2-4-6-11/h2-7,9,25H,8H2,1H3,(H,19,26)(H,23,24)	QMLYBMDZNXVJGE-UHFFFAOYSA-N	619012	US20230295110, Compound 44.	Prolyl hydroxylase EGLN2	Homo sapiens		<100							US Patent		10.7270/Q22V2M76		aid1919747	US20230295110	BLAISDELL, TP; ALLU, SR; FLEMING, PE	9/21/2023	10/30/2023	Akebia Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=619012	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=619012&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search			162731578	485226327							1	MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT		Prolyl hydroxylase EGLN2	EGLN2_HUMAN	Q96KS0	A8K5S0 Q8WWY4 Q9BV14																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1320888	Cc1c(O)c(ncc1-c1cn(nn1)-c1ccccc1)C(=O)NCC(O)=O	InChI=1S/C17H15N5O4/c1-10-12(7-18-15(16(10)25)17(26)19-8-14(23)24)13-9-22(21-20-13)11-5-3-2-4-6-11/h2-7,9,25H,8H2,1H3,(H,19,26)(H,23,24)	QMLYBMDZNXVJGE-UHFFFAOYSA-N	619012	US20230295110, Compound 44.	Prolyl hydroxylase EGLN3	Homo sapiens		<100							US Patent		10.7270/Q22V2M76		aid1919747	US20230295110	BLAISDELL, TP; ALLU, SR; FLEMING, PE	9/21/2023	10/30/2023	Akebia Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=619012	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5442&target=Prolyl+hydroxylase+EGLN3&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=619012&enzyme=Prolyl+hydroxylase+EGLN3&column=ki&startPg=0&Increment=50&submit=Search			162731578	485226327							1	MPLGHIMRLDLEKIALEYIVPCLHEVGFCYLDNFLGEVVGDCVLERVKQLHCTGALRDGQLAGPRAGVSKRHLRGDQITWIGGNEEGCEAISFLLSLIDRLVLYCGSRLGKYYVKERSKAMVACYPGNGTGYVRHVDNPNGDGRCITCIYYLNKNWDAKLHGGILRIFPEGKSFIADVEPIFDRLLFFWSDRRNPHEVQPSYATRYAMTVWYFDAEERAEAKKKFRNLTRKTESALTED		Prolyl hydroxylase EGLN3	EGLN3_HUMAN	Q9H6Z9	Q2TA79 Q3B8N4 Q6P1R2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1320889	Cc1c(O)c(ncc1-c1nnn(n1)-c1cc(Cl)cc(Cl)c1)C(=O)NCC(O)=O	InChI=1S/C16H12Cl2N6O4/c1-7-11(5-19-13(14(7)27)16(28)20-6-12(25)26)15-21-23-24(22-15)10-3-8(17)2-9(18)4-10/h2-5,27H,6H2,1H3,(H,20,28)(H,25,26)	HQOQKQGQCXBDSD-UHFFFAOYSA-N	619013	US20230295110, Compound 45.	Egl nine homolog 1	Homo sapiens		<100							US Patent		10.7270/Q22V2M76		aid1919747	US20230295110	BLAISDELL, TP; ALLU, SR; FLEMING, PE	9/21/2023	10/30/2023	Akebia Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=619013	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5440&target=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=619013&enzyme=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search			162731583	485226328							1	MANDSGGPGGPSPSERDRQYCELCGKMENLLRCSRCRSSFYCCKEHQRQDWKKHKLVCQGSEGALGHGVGPHQHSGPAPPAAVPPPRAGAREPRKAAARRDNASGDAAKGKVKAKPPADPAAAASPCRAAAGGQGSAVAAEAEPGKEEPPARSSLFQEKANLYPPSNTPGDALSPGGGLRPNGQTKPLPALKLALEYIVPCMNKHGICVVDDFLGKETGQQIGDEVRALHDTGKFTDGQLVSQKSDSSKDIRGDKITWIEGKEPGCETIGLLMSSMDDLIRHCNGKLGSYKINGRTKAMVACYPGNGTGYVRHVDNPNGDGRCVTCIYYLNKDWDAKVSGGILRIFPEGKAQFADIEPKFDRLLFFWSDRRNPHEVQPAYATRYAITVWYFDADERARAKVKYLTGEKGVRVELNKPSDSVGKDVF	6YW0,6YVZ,6YVX,6YVW,6YVT,5OX6,5OX5,5A3U,4BQY,4BQX,4BQW,2Y34,2Y33,8Y0V,7UJV,3HQU,2G1M,5LA9,5L9V,8Z33,8Z32,2HBU,2HBT,2G19,3OUJ,3OUH,5V18,8Q6E,8Q6D,8Q5S,7Q5X,7Q5V,6YW3,6YW2,6YW1,6ST3,6QGV,6ZBO,6ZBN,8J1K,8Z35,8Z31,6NMQ,3OUI	Egl nine homolog 1	EGLN1_HUMAN	Q9GZT9	Q8N3M8 Q9BZS8 Q9BZT0		hypoxia-inducible factor-proline dioxygenase	R4SCQ0_HUMAN	R4SCQ0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
1320890	Cc1c(O)c(ncc1-c1nnn(n1)-c1cc(Cl)cc(Cl)c1)C(=O)NCC(O)=O	InChI=1S/C16H12Cl2N6O4/c1-7-11(5-19-13(14(7)27)16(28)20-6-12(25)26)15-21-23-24(22-15)10-3-8(17)2-9(18)4-10/h2-5,27H,6H2,1H3,(H,20,28)(H,25,26)	HQOQKQGQCXBDSD-UHFFFAOYSA-N	619013	US20230295110, Compound 45.	Prolyl hydroxylase EGLN2	Homo sapiens		<100							US Patent		10.7270/Q22V2M76		aid1919747	US20230295110	BLAISDELL, TP; ALLU, SR; FLEMING, PE	9/21/2023	10/30/2023	Akebia Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=619013	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=619013&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search			162731583	485226328							1	MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT		Prolyl hydroxylase EGLN2	EGLN2_HUMAN	Q96KS0	A8K5S0 Q8WWY4 Q9BV14																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1320891	CCc1c(O)c(ncc1-c1cccc(Cl)c1)C(=O)NCC(O)=O	InChI=1S/C16H15ClN2O4/c1-2-11-12(9-4-3-5-10(17)6-9)7-18-14(15(11)22)16(23)19-8-13(20)21/h3-7,22H,2,8H2,1H3,(H,19,23)(H,20,21)	NDWSPMAEYWFJML-UHFFFAOYSA-N	619014	US20230295110, Compound 46.	Egl nine homolog 1	Homo sapiens		<100							US Patent		10.7270/Q22V2M76		aid1919747	US20230295110	BLAISDELL, TP; ALLU, SR; FLEMING, PE	9/21/2023	10/30/2023	Akebia Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=619014	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5440&target=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=619014&enzyme=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search			162731717	485226329							1	MANDSGGPGGPSPSERDRQYCELCGKMENLLRCSRCRSSFYCCKEHQRQDWKKHKLVCQGSEGALGHGVGPHQHSGPAPPAAVPPPRAGAREPRKAAARRDNASGDAAKGKVKAKPPADPAAAASPCRAAAGGQGSAVAAEAEPGKEEPPARSSLFQEKANLYPPSNTPGDALSPGGGLRPNGQTKPLPALKLALEYIVPCMNKHGICVVDDFLGKETGQQIGDEVRALHDTGKFTDGQLVSQKSDSSKDIRGDKITWIEGKEPGCETIGLLMSSMDDLIRHCNGKLGSYKINGRTKAMVACYPGNGTGYVRHVDNPNGDGRCVTCIYYLNKDWDAKVSGGILRIFPEGKAQFADIEPKFDRLLFFWSDRRNPHEVQPAYATRYAITVWYFDADERARAKVKYLTGEKGVRVELNKPSDSVGKDVF	6YW0,6YVZ,6YVX,6YVW,6YVT,5OX6,5OX5,5A3U,4BQY,4BQX,4BQW,2Y34,2Y33,8Y0V,7UJV,3HQU,2G1M,5LA9,5L9V,8Z33,8Z32,2HBU,2HBT,2G19,3OUJ,3OUH,5V18,8Q6E,8Q6D,8Q5S,7Q5X,7Q5V,6YW3,6YW2,6YW1,6ST3,6QGV,6ZBO,6ZBN,8J1K,8Z35,8Z31,6NMQ,3OUI	Egl nine homolog 1	EGLN1_HUMAN	Q9GZT9	Q8N3M8 Q9BZS8 Q9BZT0		hypoxia-inducible factor-proline dioxygenase	R4SCQ0_HUMAN	R4SCQ0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
1320892	CCc1c(O)c(ncc1-c1cccc(Cl)c1)C(=O)NCC(O)=O	InChI=1S/C16H15ClN2O4/c1-2-11-12(9-4-3-5-10(17)6-9)7-18-14(15(11)22)16(23)19-8-13(20)21/h3-7,22H,2,8H2,1H3,(H,19,23)(H,20,21)	NDWSPMAEYWFJML-UHFFFAOYSA-N	619014	US20230295110, Compound 46.	Prolyl hydroxylase EGLN2	Homo sapiens		<100							US Patent		10.7270/Q22V2M76		aid1919747	US20230295110	BLAISDELL, TP; ALLU, SR; FLEMING, PE	9/21/2023	10/30/2023	Akebia Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=619014	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=619014&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search			162731717	485226329							1	MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT		Prolyl hydroxylase EGLN2	EGLN2_HUMAN	Q96KS0	A8K5S0 Q8WWY4 Q9BV14																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1320893	C[C@H](NC(=O)c1ncc(-c2cnn(c2)-c2ccccc2)c(C)c1O)C(O)=O |r|	InChI=1S/C19H18N4O4/c1-11-15(13-8-21-23(10-13)14-6-4-3-5-7-14)9-20-16(17(11)24)18(25)22-12(2)19(26)27/h3-10,12,24H,1-2H3,(H,22,25)(H,26,27)	REMUREJFNJSHSC-UHFFFAOYSA-N	618999	US20230295110, Compound 47.::US20230295110, Compound 31.	Egl nine homolog 1	Homo sapiens		<100							US Patent		10.7270/Q22V2M76		aid1919747	US20230295110	BLAISDELL, TP; ALLU, SR; FLEMING, PE	9/21/2023	10/30/2023	Akebia Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=618999	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5440&target=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=618999&enzyme=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search			162731672	485226314							1	MANDSGGPGGPSPSERDRQYCELCGKMENLLRCSRCRSSFYCCKEHQRQDWKKHKLVCQGSEGALGHGVGPHQHSGPAPPAAVPPPRAGAREPRKAAARRDNASGDAAKGKVKAKPPADPAAAASPCRAAAGGQGSAVAAEAEPGKEEPPARSSLFQEKANLYPPSNTPGDALSPGGGLRPNGQTKPLPALKLALEYIVPCMNKHGICVVDDFLGKETGQQIGDEVRALHDTGKFTDGQLVSQKSDSSKDIRGDKITWIEGKEPGCETIGLLMSSMDDLIRHCNGKLGSYKINGRTKAMVACYPGNGTGYVRHVDNPNGDGRCVTCIYYLNKDWDAKVSGGILRIFPEGKAQFADIEPKFDRLLFFWSDRRNPHEVQPAYATRYAITVWYFDADERARAKVKYLTGEKGVRVELNKPSDSVGKDVF	6YW0,6YVZ,6YVX,6YVW,6YVT,5OX6,5OX5,5A3U,4BQY,4BQX,4BQW,2Y34,2Y33,8Y0V,7UJV,3HQU,2G1M,5LA9,5L9V,8Z33,8Z32,2HBU,2HBT,2G19,3OUJ,3OUH,5V18,8Q6E,8Q6D,8Q5S,7Q5X,7Q5V,6YW3,6YW2,6YW1,6ST3,6QGV,6ZBO,6ZBN,8J1K,8Z35,8Z31,6NMQ,3OUI	Egl nine homolog 1	EGLN1_HUMAN	Q9GZT9	Q8N3M8 Q9BZS8 Q9BZT0		hypoxia-inducible factor-proline dioxygenase	R4SCQ0_HUMAN	R4SCQ0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
1320894	C[C@H](NC(=O)c1ncc(-c2cnn(c2)-c2ccccc2)c(C)c1O)C(O)=O |r|	InChI=1S/C19H18N4O4/c1-11-15(13-8-21-23(10-13)14-6-4-3-5-7-14)9-20-16(17(11)24)18(25)22-12(2)19(26)27/h3-10,12,24H,1-2H3,(H,22,25)(H,26,27)	REMUREJFNJSHSC-UHFFFAOYSA-N	618999	US20230295110, Compound 47.::US20230295110, Compound 31.	Prolyl hydroxylase EGLN2	Homo sapiens		<100							US Patent		10.7270/Q22V2M76		aid1919747	US20230295110	BLAISDELL, TP; ALLU, SR; FLEMING, PE	9/21/2023	10/30/2023	Akebia Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=618999	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=618999&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search			162731672	485226314							1	MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT		Prolyl hydroxylase EGLN2	EGLN2_HUMAN	Q96KS0	A8K5S0 Q8WWY4 Q9BV14																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1320895	C[C@H](NC(=O)c1ncc(-c2cnn(c2)-c2ccccc2)c(C)c1O)C(O)=O |r|	InChI=1S/C19H18N4O4/c1-11-15(13-8-21-23(10-13)14-6-4-3-5-7-14)9-20-16(17(11)24)18(25)22-12(2)19(26)27/h3-10,12,24H,1-2H3,(H,22,25)(H,26,27)	REMUREJFNJSHSC-UHFFFAOYSA-N	618999	US20230295110, Compound 47.::US20230295110, Compound 31.	Prolyl hydroxylase EGLN3	Homo sapiens		<100							US Patent		10.7270/Q22V2M76		aid1919747	US20230295110	BLAISDELL, TP; ALLU, SR; FLEMING, PE	9/21/2023	10/30/2023	Akebia Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=618999	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5442&target=Prolyl+hydroxylase+EGLN3&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=618999&enzyme=Prolyl+hydroxylase+EGLN3&column=ki&startPg=0&Increment=50&submit=Search			162731672	485226314							1	MPLGHIMRLDLEKIALEYIVPCLHEVGFCYLDNFLGEVVGDCVLERVKQLHCTGALRDGQLAGPRAGVSKRHLRGDQITWIGGNEEGCEAISFLLSLIDRLVLYCGSRLGKYYVKERSKAMVACYPGNGTGYVRHVDNPNGDGRCITCIYYLNKNWDAKLHGGILRIFPEGKSFIADVEPIFDRLLFFWSDRRNPHEVQPSYATRYAMTVWYFDAEERAEAKKKFRNLTRKTESALTED		Prolyl hydroxylase EGLN3	EGLN3_HUMAN	Q9H6Z9	Q2TA79 Q3B8N4 Q6P1R2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1320896	C[C@@H](NC(=O)c1ncc(-c2cnn(c2)-c2ccccc2)c(C)c1O)C(O)=O |r|	InChI=1S/C19H18N4O4/c1-11-15(13-8-21-23(10-13)14-6-4-3-5-7-14)9-20-16(17(11)24)18(25)22-12(2)19(26)27/h3-10,12,24H,1-2H3,(H,22,25)(H,26,27)	REMUREJFNJSHSC-UHFFFAOYSA-N	618998	US20230295110, Compound 48.::US20230295110, Compound 30.	Egl nine homolog 1	Homo sapiens		 5500							US Patent		10.7270/Q22V2M76		aid1919747	US20230295110	BLAISDELL, TP; ALLU, SR; FLEMING, PE	9/21/2023	10/30/2023	Akebia Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=618998	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5440&target=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=618998&enzyme=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search			162731615	485226313							1	MANDSGGPGGPSPSERDRQYCELCGKMENLLRCSRCRSSFYCCKEHQRQDWKKHKLVCQGSEGALGHGVGPHQHSGPAPPAAVPPPRAGAREPRKAAARRDNASGDAAKGKVKAKPPADPAAAASPCRAAAGGQGSAVAAEAEPGKEEPPARSSLFQEKANLYPPSNTPGDALSPGGGLRPNGQTKPLPALKLALEYIVPCMNKHGICVVDDFLGKETGQQIGDEVRALHDTGKFTDGQLVSQKSDSSKDIRGDKITWIEGKEPGCETIGLLMSSMDDLIRHCNGKLGSYKINGRTKAMVACYPGNGTGYVRHVDNPNGDGRCVTCIYYLNKDWDAKVSGGILRIFPEGKAQFADIEPKFDRLLFFWSDRRNPHEVQPAYATRYAITVWYFDADERARAKVKYLTGEKGVRVELNKPSDSVGKDVF	6YW0,6YVZ,6YVX,6YVW,6YVT,5OX6,5OX5,5A3U,4BQY,4BQX,4BQW,2Y34,2Y33,8Y0V,7UJV,3HQU,2G1M,5LA9,5L9V,8Z33,8Z32,2HBU,2HBT,2G19,3OUJ,3OUH,5V18,8Q6E,8Q6D,8Q5S,7Q5X,7Q5V,6YW3,6YW2,6YW1,6ST3,6QGV,6ZBO,6ZBN,8J1K,8Z35,8Z31,6NMQ,3OUI	Egl nine homolog 1	EGLN1_HUMAN	Q9GZT9	Q8N3M8 Q9BZS8 Q9BZT0		hypoxia-inducible factor-proline dioxygenase	R4SCQ0_HUMAN	R4SCQ0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
1320897	C[C@@H](NC(=O)c1ncc(-c2cnn(c2)-c2ccccc2)c(C)c1O)C(O)=O |r|	InChI=1S/C19H18N4O4/c1-11-15(13-8-21-23(10-13)14-6-4-3-5-7-14)9-20-16(17(11)24)18(25)22-12(2)19(26)27/h3-10,12,24H,1-2H3,(H,22,25)(H,26,27)	REMUREJFNJSHSC-UHFFFAOYSA-N	618998	US20230295110, Compound 48.::US20230295110, Compound 30.	Prolyl hydroxylase EGLN2	Homo sapiens		 5500							US Patent		10.7270/Q22V2M76		aid1919747	US20230295110	BLAISDELL, TP; ALLU, SR; FLEMING, PE	9/21/2023	10/30/2023	Akebia Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=618998	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=618998&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search			162731615	485226313							1	MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT		Prolyl hydroxylase EGLN2	EGLN2_HUMAN	Q96KS0	A8K5S0 Q8WWY4 Q9BV14																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1320898	Cc1c(O)c(ncc1-c1cnn(c1F)-c1ccccc1)C(=O)NCC(O)=O	InChI=1S/C18H15FN4O4/c1-10-12(7-20-15(16(10)26)18(27)21-9-14(24)25)13-8-22-23(17(13)19)11-5-3-2-4-6-11/h2-8,26H,9H2,1H3,(H,21,27)(H,24,25)	AYOBAXHFRHMJSA-UHFFFAOYSA-N	619017	US20230295110, Compound 49.	Egl nine homolog 1	Homo sapiens		<100							US Patent		10.7270/Q22V2M76		aid1919747	US20230295110	BLAISDELL, TP; ALLU, SR; FLEMING, PE	9/21/2023	10/30/2023	Akebia Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=619017	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5440&target=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=619017&enzyme=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search			162731648	485226330							1	MANDSGGPGGPSPSERDRQYCELCGKMENLLRCSRCRSSFYCCKEHQRQDWKKHKLVCQGSEGALGHGVGPHQHSGPAPPAAVPPPRAGAREPRKAAARRDNASGDAAKGKVKAKPPADPAAAASPCRAAAGGQGSAVAAEAEPGKEEPPARSSLFQEKANLYPPSNTPGDALSPGGGLRPNGQTKPLPALKLALEYIVPCMNKHGICVVDDFLGKETGQQIGDEVRALHDTGKFTDGQLVSQKSDSSKDIRGDKITWIEGKEPGCETIGLLMSSMDDLIRHCNGKLGSYKINGRTKAMVACYPGNGTGYVRHVDNPNGDGRCVTCIYYLNKDWDAKVSGGILRIFPEGKAQFADIEPKFDRLLFFWSDRRNPHEVQPAYATRYAITVWYFDADERARAKVKYLTGEKGVRVELNKPSDSVGKDVF	6YW0,6YVZ,6YVX,6YVW,6YVT,5OX6,5OX5,5A3U,4BQY,4BQX,4BQW,2Y34,2Y33,8Y0V,7UJV,3HQU,2G1M,5LA9,5L9V,8Z33,8Z32,2HBU,2HBT,2G19,3OUJ,3OUH,5V18,8Q6E,8Q6D,8Q5S,7Q5X,7Q5V,6YW3,6YW2,6YW1,6ST3,6QGV,6ZBO,6ZBN,8J1K,8Z35,8Z31,6NMQ,3OUI	Egl nine homolog 1	EGLN1_HUMAN	Q9GZT9	Q8N3M8 Q9BZS8 Q9BZT0		hypoxia-inducible factor-proline dioxygenase	R4SCQ0_HUMAN	R4SCQ0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
1320899	Cc1c(O)c(ncc1-c1cnn(c1F)-c1ccccc1)C(=O)NCC(O)=O	InChI=1S/C18H15FN4O4/c1-10-12(7-20-15(16(10)26)18(27)21-9-14(24)25)13-8-22-23(17(13)19)11-5-3-2-4-6-11/h2-8,26H,9H2,1H3,(H,21,27)(H,24,25)	AYOBAXHFRHMJSA-UHFFFAOYSA-N	619017	US20230295110, Compound 49.	Prolyl hydroxylase EGLN2	Homo sapiens		<100							US Patent		10.7270/Q22V2M76		aid1919747	US20230295110	BLAISDELL, TP; ALLU, SR; FLEMING, PE	9/21/2023	10/30/2023	Akebia Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=619017	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=619017&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search			162731648	485226330							1	MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT		Prolyl hydroxylase EGLN2	EGLN2_HUMAN	Q96KS0	A8K5S0 Q8WWY4 Q9BV14																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1320900	Cc1c(cnn1-c1ccccc1)-c1cnc(C(=O)NCC(O)=O)c(O)c1C	InChI=1S/C19H18N4O4/c1-11-14(8-20-17(18(11)26)19(27)21-10-16(24)25)15-9-22-23(12(15)2)13-6-4-3-5-7-13/h3-9,26H,10H2,1-2H3,(H,21,27)(H,24,25)	KLPGBBDKNZOHLK-UHFFFAOYSA-N	619018	US20230295110, Compound 50.	Egl nine homolog 1	Homo sapiens		 550							US Patent		10.7270/Q22V2M76		aid1919747	US20230295110	BLAISDELL, TP; ALLU, SR; FLEMING, PE	9/21/2023	10/30/2023	Akebia Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=619018	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5440&target=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=619018&enzyme=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search			162731723	485226331							1	MANDSGGPGGPSPSERDRQYCELCGKMENLLRCSRCRSSFYCCKEHQRQDWKKHKLVCQGSEGALGHGVGPHQHSGPAPPAAVPPPRAGAREPRKAAARRDNASGDAAKGKVKAKPPADPAAAASPCRAAAGGQGSAVAAEAEPGKEEPPARSSLFQEKANLYPPSNTPGDALSPGGGLRPNGQTKPLPALKLALEYIVPCMNKHGICVVDDFLGKETGQQIGDEVRALHDTGKFTDGQLVSQKSDSSKDIRGDKITWIEGKEPGCETIGLLMSSMDDLIRHCNGKLGSYKINGRTKAMVACYPGNGTGYVRHVDNPNGDGRCVTCIYYLNKDWDAKVSGGILRIFPEGKAQFADIEPKFDRLLFFWSDRRNPHEVQPAYATRYAITVWYFDADERARAKVKYLTGEKGVRVELNKPSDSVGKDVF	6YW0,6YVZ,6YVX,6YVW,6YVT,5OX6,5OX5,5A3U,4BQY,4BQX,4BQW,2Y34,2Y33,8Y0V,7UJV,3HQU,2G1M,5LA9,5L9V,8Z33,8Z32,2HBU,2HBT,2G19,3OUJ,3OUH,5V18,8Q6E,8Q6D,8Q5S,7Q5X,7Q5V,6YW3,6YW2,6YW1,6ST3,6QGV,6ZBO,6ZBN,8J1K,8Z35,8Z31,6NMQ,3OUI	Egl nine homolog 1	EGLN1_HUMAN	Q9GZT9	Q8N3M8 Q9BZS8 Q9BZT0		hypoxia-inducible factor-proline dioxygenase	R4SCQ0_HUMAN	R4SCQ0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
1320901	Cc1c(cnn1-c1ccccc1)-c1cnc(C(=O)NCC(O)=O)c(O)c1C	InChI=1S/C19H18N4O4/c1-11-14(8-20-17(18(11)26)19(27)21-10-16(24)25)15-9-22-23(12(15)2)13-6-4-3-5-7-13/h3-9,26H,10H2,1-2H3,(H,21,27)(H,24,25)	KLPGBBDKNZOHLK-UHFFFAOYSA-N	619018	US20230295110, Compound 50.	Prolyl hydroxylase EGLN2	Homo sapiens		 550							US Patent		10.7270/Q22V2M76		aid1919747	US20230295110	BLAISDELL, TP; ALLU, SR; FLEMING, PE	9/21/2023	10/30/2023	Akebia Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=619018	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=619018&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search			162731723	485226331							1	MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT		Prolyl hydroxylase EGLN2	EGLN2_HUMAN	Q96KS0	A8K5S0 Q8WWY4 Q9BV14																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1320902	Cc1c(O)c(ncc1-c1ccn(c1)-c1ccccc1)C(=O)NCC(O)=O	InChI=1S/C19H17N3O4/c1-12-15(9-20-17(18(12)25)19(26)21-10-16(23)24)13-7-8-22(11-13)14-5-3-2-4-6-14/h2-9,11,25H,10H2,1H3,(H,21,26)(H,23,24)	GCNIKTDYFOVTAC-UHFFFAOYSA-N	619019	US20230295110, Compound 51.	Egl nine homolog 1	Homo sapiens		<100							US Patent		10.7270/Q22V2M76		aid1919747	US20230295110	BLAISDELL, TP; ALLU, SR; FLEMING, PE	9/21/2023	10/30/2023	Akebia Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=619019	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5440&target=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=619019&enzyme=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search			162731625	485226332							1	MANDSGGPGGPSPSERDRQYCELCGKMENLLRCSRCRSSFYCCKEHQRQDWKKHKLVCQGSEGALGHGVGPHQHSGPAPPAAVPPPRAGAREPRKAAARRDNASGDAAKGKVKAKPPADPAAAASPCRAAAGGQGSAVAAEAEPGKEEPPARSSLFQEKANLYPPSNTPGDALSPGGGLRPNGQTKPLPALKLALEYIVPCMNKHGICVVDDFLGKETGQQIGDEVRALHDTGKFTDGQLVSQKSDSSKDIRGDKITWIEGKEPGCETIGLLMSSMDDLIRHCNGKLGSYKINGRTKAMVACYPGNGTGYVRHVDNPNGDGRCVTCIYYLNKDWDAKVSGGILRIFPEGKAQFADIEPKFDRLLFFWSDRRNPHEVQPAYATRYAITVWYFDADERARAKVKYLTGEKGVRVELNKPSDSVGKDVF	6YW0,6YVZ,6YVX,6YVW,6YVT,5OX6,5OX5,5A3U,4BQY,4BQX,4BQW,2Y34,2Y33,8Y0V,7UJV,3HQU,2G1M,5LA9,5L9V,8Z33,8Z32,2HBU,2HBT,2G19,3OUJ,3OUH,5V18,8Q6E,8Q6D,8Q5S,7Q5X,7Q5V,6YW3,6YW2,6YW1,6ST3,6QGV,6ZBO,6ZBN,8J1K,8Z35,8Z31,6NMQ,3OUI	Egl nine homolog 1	EGLN1_HUMAN	Q9GZT9	Q8N3M8 Q9BZS8 Q9BZT0		hypoxia-inducible factor-proline dioxygenase	R4SCQ0_HUMAN	R4SCQ0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
1320903	Cc1c(O)c(ncc1-c1ccn(c1)-c1ccccc1)C(=O)NCC(O)=O	InChI=1S/C19H17N3O4/c1-12-15(9-20-17(18(12)25)19(26)21-10-16(23)24)13-7-8-22(11-13)14-5-3-2-4-6-14/h2-9,11,25H,10H2,1H3,(H,21,26)(H,23,24)	GCNIKTDYFOVTAC-UHFFFAOYSA-N	619019	US20230295110, Compound 51.	Prolyl hydroxylase EGLN2	Homo sapiens		 550							US Patent		10.7270/Q22V2M76		aid1919747	US20230295110	BLAISDELL, TP; ALLU, SR; FLEMING, PE	9/21/2023	10/30/2023	Akebia Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=619019	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=619019&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search			162731625	485226332							1	MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT		Prolyl hydroxylase EGLN2	EGLN2_HUMAN	Q96KS0	A8K5S0 Q8WWY4 Q9BV14																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1320904	Cc1c(O)c(ncc1-c1nnn(n1)C1CC1)C(=O)NCC(O)=O	InChI=1S/C13H14N6O4/c1-6-8(12-16-18-19(17-12)7-2-3-7)4-14-10(11(6)22)13(23)15-5-9(20)21/h4,7,22H,2-3,5H2,1H3,(H,15,23)(H,20,21)	JDRISWAPRIZLCQ-UHFFFAOYSA-N	619020	US20230295110, Compound 52.	Egl nine homolog 1	Homo sapiens		<100							US Patent		10.7270/Q22V2M76		aid1919747	US20230295110	BLAISDELL, TP; ALLU, SR; FLEMING, PE	9/21/2023	10/30/2023	Akebia Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=619020	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5440&target=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=619020&enzyme=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search			162731767	485226333							1	MANDSGGPGGPSPSERDRQYCELCGKMENLLRCSRCRSSFYCCKEHQRQDWKKHKLVCQGSEGALGHGVGPHQHSGPAPPAAVPPPRAGAREPRKAAARRDNASGDAAKGKVKAKPPADPAAAASPCRAAAGGQGSAVAAEAEPGKEEPPARSSLFQEKANLYPPSNTPGDALSPGGGLRPNGQTKPLPALKLALEYIVPCMNKHGICVVDDFLGKETGQQIGDEVRALHDTGKFTDGQLVSQKSDSSKDIRGDKITWIEGKEPGCETIGLLMSSMDDLIRHCNGKLGSYKINGRTKAMVACYPGNGTGYVRHVDNPNGDGRCVTCIYYLNKDWDAKVSGGILRIFPEGKAQFADIEPKFDRLLFFWSDRRNPHEVQPAYATRYAITVWYFDADERARAKVKYLTGEKGVRVELNKPSDSVGKDVF	6YW0,6YVZ,6YVX,6YVW,6YVT,5OX6,5OX5,5A3U,4BQY,4BQX,4BQW,2Y34,2Y33,8Y0V,7UJV,3HQU,2G1M,5LA9,5L9V,8Z33,8Z32,2HBU,2HBT,2G19,3OUJ,3OUH,5V18,8Q6E,8Q6D,8Q5S,7Q5X,7Q5V,6YW3,6YW2,6YW1,6ST3,6QGV,6ZBO,6ZBN,8J1K,8Z35,8Z31,6NMQ,3OUI	Egl nine homolog 1	EGLN1_HUMAN	Q9GZT9	Q8N3M8 Q9BZS8 Q9BZT0		hypoxia-inducible factor-proline dioxygenase	R4SCQ0_HUMAN	R4SCQ0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
1320905	Cc1c(O)c(ncc1-c1nnn(n1)C1CC1)C(=O)NCC(O)=O	InChI=1S/C13H14N6O4/c1-6-8(12-16-18-19(17-12)7-2-3-7)4-14-10(11(6)22)13(23)15-5-9(20)21/h4,7,22H,2-3,5H2,1H3,(H,15,23)(H,20,21)	JDRISWAPRIZLCQ-UHFFFAOYSA-N	619020	US20230295110, Compound 52.	Prolyl hydroxylase EGLN2	Homo sapiens		<100							US Patent		10.7270/Q22V2M76		aid1919747	US20230295110	BLAISDELL, TP; ALLU, SR; FLEMING, PE	9/21/2023	10/30/2023	Akebia Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=619020	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=619020&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search			162731767	485226333							1	MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT		Prolyl hydroxylase EGLN2	EGLN2_HUMAN	Q96KS0	A8K5S0 Q8WWY4 Q9BV14																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1320906	Cc1c(O)c(ncc1C#CCOc1ccccc1)C(=O)NCC(O)=O	InChI=1S/C18H16N2O5/c1-12-13(6-5-9-25-14-7-3-2-4-8-14)10-19-16(17(12)23)18(24)20-11-15(21)22/h2-4,7-8,10,23H,9,11H2,1H3,(H,20,24)(H,21,22)	GWXFZRMPPZFURZ-UHFFFAOYSA-N	619022	US20230295110, Compound 53.	Egl nine homolog 1	Homo sapiens		<100							US Patent		10.7270/Q22V2M76		aid1919747	US20230295110	BLAISDELL, TP; ALLU, SR; FLEMING, PE	9/21/2023	10/30/2023	Akebia Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=619022	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5440&target=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=619022&enzyme=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search			162731778	485226335							1	MANDSGGPGGPSPSERDRQYCELCGKMENLLRCSRCRSSFYCCKEHQRQDWKKHKLVCQGSEGALGHGVGPHQHSGPAPPAAVPPPRAGAREPRKAAARRDNASGDAAKGKVKAKPPADPAAAASPCRAAAGGQGSAVAAEAEPGKEEPPARSSLFQEKANLYPPSNTPGDALSPGGGLRPNGQTKPLPALKLALEYIVPCMNKHGICVVDDFLGKETGQQIGDEVRALHDTGKFTDGQLVSQKSDSSKDIRGDKITWIEGKEPGCETIGLLMSSMDDLIRHCNGKLGSYKINGRTKAMVACYPGNGTGYVRHVDNPNGDGRCVTCIYYLNKDWDAKVSGGILRIFPEGKAQFADIEPKFDRLLFFWSDRRNPHEVQPAYATRYAITVWYFDADERARAKVKYLTGEKGVRVELNKPSDSVGKDVF	6YW0,6YVZ,6YVX,6YVW,6YVT,5OX6,5OX5,5A3U,4BQY,4BQX,4BQW,2Y34,2Y33,8Y0V,7UJV,3HQU,2G1M,5LA9,5L9V,8Z33,8Z32,2HBU,2HBT,2G19,3OUJ,3OUH,5V18,8Q6E,8Q6D,8Q5S,7Q5X,7Q5V,6YW3,6YW2,6YW1,6ST3,6QGV,6ZBO,6ZBN,8J1K,8Z35,8Z31,6NMQ,3OUI	Egl nine homolog 1	EGLN1_HUMAN	Q9GZT9	Q8N3M8 Q9BZS8 Q9BZT0		hypoxia-inducible factor-proline dioxygenase	R4SCQ0_HUMAN	R4SCQ0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
1320907	Cc1c(O)c(ncc1C#CCOc1ccccc1)C(=O)NCC(O)=O	InChI=1S/C18H16N2O5/c1-12-13(6-5-9-25-14-7-3-2-4-8-14)10-19-16(17(12)23)18(24)20-11-15(21)22/h2-4,7-8,10,23H,9,11H2,1H3,(H,20,24)(H,21,22)	GWXFZRMPPZFURZ-UHFFFAOYSA-N	619022	US20230295110, Compound 53.	Prolyl hydroxylase EGLN2	Homo sapiens		<100							US Patent		10.7270/Q22V2M76		aid1919747	US20230295110	BLAISDELL, TP; ALLU, SR; FLEMING, PE	9/21/2023	10/30/2023	Akebia Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=619022	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=619022&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search			162731778	485226335							1	MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT		Prolyl hydroxylase EGLN2	EGLN2_HUMAN	Q96KS0	A8K5S0 Q8WWY4 Q9BV14																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1320908	Cc1c(O)c(ncc1S(=O)(=O)c1ccccc1)C(=O)NCC(O)=O	InChI=1S/C15H14N2O6S/c1-9-11(24(22,23)10-5-3-2-4-6-10)7-16-13(14(9)20)15(21)17-8-12(18)19/h2-7,20H,8H2,1H3,(H,17,21)(H,18,19)	AAMYQRMCUMNIRU-UHFFFAOYSA-N	619023	US20230295110, Compound 54.	Egl nine homolog 1	Homo sapiens		 550							US Patent		10.7270/Q22V2M76		aid1919747	US20230295110	BLAISDELL, TP; ALLU, SR; FLEMING, PE	9/21/2023	10/30/2023	Akebia Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=619023	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5440&target=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=619023&enzyme=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search			162731495	485226336							1	MANDSGGPGGPSPSERDRQYCELCGKMENLLRCSRCRSSFYCCKEHQRQDWKKHKLVCQGSEGALGHGVGPHQHSGPAPPAAVPPPRAGAREPRKAAARRDNASGDAAKGKVKAKPPADPAAAASPCRAAAGGQGSAVAAEAEPGKEEPPARSSLFQEKANLYPPSNTPGDALSPGGGLRPNGQTKPLPALKLALEYIVPCMNKHGICVVDDFLGKETGQQIGDEVRALHDTGKFTDGQLVSQKSDSSKDIRGDKITWIEGKEPGCETIGLLMSSMDDLIRHCNGKLGSYKINGRTKAMVACYPGNGTGYVRHVDNPNGDGRCVTCIYYLNKDWDAKVSGGILRIFPEGKAQFADIEPKFDRLLFFWSDRRNPHEVQPAYATRYAITVWYFDADERARAKVKYLTGEKGVRVELNKPSDSVGKDVF	6YW0,6YVZ,6YVX,6YVW,6YVT,5OX6,5OX5,5A3U,4BQY,4BQX,4BQW,2Y34,2Y33,8Y0V,7UJV,3HQU,2G1M,5LA9,5L9V,8Z33,8Z32,2HBU,2HBT,2G19,3OUJ,3OUH,5V18,8Q6E,8Q6D,8Q5S,7Q5X,7Q5V,6YW3,6YW2,6YW1,6ST3,6QGV,6ZBO,6ZBN,8J1K,8Z35,8Z31,6NMQ,3OUI	Egl nine homolog 1	EGLN1_HUMAN	Q9GZT9	Q8N3M8 Q9BZS8 Q9BZT0		hypoxia-inducible factor-proline dioxygenase	R4SCQ0_HUMAN	R4SCQ0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
1320909	Cc1c(O)c(ncc1S(=O)(=O)c1ccccc1)C(=O)NCC(O)=O	InChI=1S/C15H14N2O6S/c1-9-11(24(22,23)10-5-3-2-4-6-10)7-16-13(14(9)20)15(21)17-8-12(18)19/h2-7,20H,8H2,1H3,(H,17,21)(H,18,19)	AAMYQRMCUMNIRU-UHFFFAOYSA-N	619023	US20230295110, Compound 54.	Prolyl hydroxylase EGLN2	Homo sapiens		 550							US Patent		10.7270/Q22V2M76		aid1919747	US20230295110	BLAISDELL, TP; ALLU, SR; FLEMING, PE	9/21/2023	10/30/2023	Akebia Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=619023	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=619023&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search			162731495	485226336							1	MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT		Prolyl hydroxylase EGLN2	EGLN2_HUMAN	Q96KS0	A8K5S0 Q8WWY4 Q9BV14																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1320910	Cc1c(O)c(ncc1N1CCN(CC1)c1ccccc1)C(=O)NCC(O)=O	InChI=1S/C19H22N4O4/c1-13-15(11-20-17(18(13)26)19(27)21-12-16(24)25)23-9-7-22(8-10-23)14-5-3-2-4-6-14/h2-6,11,26H,7-10,12H2,1H3,(H,21,27)(H,24,25)	DSSBIIXMUDMKTP-UHFFFAOYSA-N	619024	US20230295110, Compound 55.	Egl nine homolog 1	Homo sapiens		<100							US Patent		10.7270/Q22V2M76		aid1919747	US20230295110	BLAISDELL, TP; ALLU, SR; FLEMING, PE	9/21/2023	10/30/2023	Akebia Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=619024	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5440&target=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=619024&enzyme=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search			162731460	485226337							1	MANDSGGPGGPSPSERDRQYCELCGKMENLLRCSRCRSSFYCCKEHQRQDWKKHKLVCQGSEGALGHGVGPHQHSGPAPPAAVPPPRAGAREPRKAAARRDNASGDAAKGKVKAKPPADPAAAASPCRAAAGGQGSAVAAEAEPGKEEPPARSSLFQEKANLYPPSNTPGDALSPGGGLRPNGQTKPLPALKLALEYIVPCMNKHGICVVDDFLGKETGQQIGDEVRALHDTGKFTDGQLVSQKSDSSKDIRGDKITWIEGKEPGCETIGLLMSSMDDLIRHCNGKLGSYKINGRTKAMVACYPGNGTGYVRHVDNPNGDGRCVTCIYYLNKDWDAKVSGGILRIFPEGKAQFADIEPKFDRLLFFWSDRRNPHEVQPAYATRYAITVWYFDADERARAKVKYLTGEKGVRVELNKPSDSVGKDVF	6YW0,6YVZ,6YVX,6YVW,6YVT,5OX6,5OX5,5A3U,4BQY,4BQX,4BQW,2Y34,2Y33,8Y0V,7UJV,3HQU,2G1M,5LA9,5L9V,8Z33,8Z32,2HBU,2HBT,2G19,3OUJ,3OUH,5V18,8Q6E,8Q6D,8Q5S,7Q5X,7Q5V,6YW3,6YW2,6YW1,6ST3,6QGV,6ZBO,6ZBN,8J1K,8Z35,8Z31,6NMQ,3OUI	Egl nine homolog 1	EGLN1_HUMAN	Q9GZT9	Q8N3M8 Q9BZS8 Q9BZT0		hypoxia-inducible factor-proline dioxygenase	R4SCQ0_HUMAN	R4SCQ0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
1320911	Cc1c(O)c(ncc1N1CCN(CC1)c1ccccc1)C(=O)NCC(O)=O	InChI=1S/C19H22N4O4/c1-13-15(11-20-17(18(13)26)19(27)21-12-16(24)25)23-9-7-22(8-10-23)14-5-3-2-4-6-14/h2-6,11,26H,7-10,12H2,1H3,(H,21,27)(H,24,25)	DSSBIIXMUDMKTP-UHFFFAOYSA-N	619024	US20230295110, Compound 55.	Prolyl hydroxylase EGLN2	Homo sapiens		 550							US Patent		10.7270/Q22V2M76		aid1919747	US20230295110	BLAISDELL, TP; ALLU, SR; FLEMING, PE	9/21/2023	10/30/2023	Akebia Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=619024	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=619024&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search			162731460	485226337							1	MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT		Prolyl hydroxylase EGLN2	EGLN2_HUMAN	Q96KS0	A8K5S0 Q8WWY4 Q9BV14																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1320912	Cc1c(O)c(ncc1N1CCC(CC1)c1ccccc1)C(=O)NCC(O)=O	InChI=1S/C20H23N3O4/c1-13-16(11-21-18(19(13)26)20(27)22-12-17(24)25)23-9-7-15(8-10-23)14-5-3-2-4-6-14/h2-6,11,15,26H,7-10,12H2,1H3,(H,22,27)(H,24,25)	CNIDLZVDVCQOTN-UHFFFAOYSA-N	619025	US20230295110, Compound 56.	Egl nine homolog 1	Homo sapiens		<100							US Patent		10.7270/Q22V2M76		aid1919747	US20230295110	BLAISDELL, TP; ALLU, SR; FLEMING, PE	9/21/2023	10/30/2023	Akebia Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=619025	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5440&target=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=619025&enzyme=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search			162731633	485226338							1	MANDSGGPGGPSPSERDRQYCELCGKMENLLRCSRCRSSFYCCKEHQRQDWKKHKLVCQGSEGALGHGVGPHQHSGPAPPAAVPPPRAGAREPRKAAARRDNASGDAAKGKVKAKPPADPAAAASPCRAAAGGQGSAVAAEAEPGKEEPPARSSLFQEKANLYPPSNTPGDALSPGGGLRPNGQTKPLPALKLALEYIVPCMNKHGICVVDDFLGKETGQQIGDEVRALHDTGKFTDGQLVSQKSDSSKDIRGDKITWIEGKEPGCETIGLLMSSMDDLIRHCNGKLGSYKINGRTKAMVACYPGNGTGYVRHVDNPNGDGRCVTCIYYLNKDWDAKVSGGILRIFPEGKAQFADIEPKFDRLLFFWSDRRNPHEVQPAYATRYAITVWYFDADERARAKVKYLTGEKGVRVELNKPSDSVGKDVF	6YW0,6YVZ,6YVX,6YVW,6YVT,5OX6,5OX5,5A3U,4BQY,4BQX,4BQW,2Y34,2Y33,8Y0V,7UJV,3HQU,2G1M,5LA9,5L9V,8Z33,8Z32,2HBU,2HBT,2G19,3OUJ,3OUH,5V18,8Q6E,8Q6D,8Q5S,7Q5X,7Q5V,6YW3,6YW2,6YW1,6ST3,6QGV,6ZBO,6ZBN,8J1K,8Z35,8Z31,6NMQ,3OUI	Egl nine homolog 1	EGLN1_HUMAN	Q9GZT9	Q8N3M8 Q9BZS8 Q9BZT0		hypoxia-inducible factor-proline dioxygenase	R4SCQ0_HUMAN	R4SCQ0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
1320913	Cc1c(O)c(ncc1N1CCC(CC1)c1ccccc1)C(=O)NCC(O)=O	InChI=1S/C20H23N3O4/c1-13-16(11-21-18(19(13)26)20(27)22-12-17(24)25)23-9-7-15(8-10-23)14-5-3-2-4-6-14/h2-6,11,15,26H,7-10,12H2,1H3,(H,22,27)(H,24,25)	CNIDLZVDVCQOTN-UHFFFAOYSA-N	619025	US20230295110, Compound 56.	Prolyl hydroxylase EGLN2	Homo sapiens		<100							US Patent		10.7270/Q22V2M76		aid1919747	US20230295110	BLAISDELL, TP; ALLU, SR; FLEMING, PE	9/21/2023	10/30/2023	Akebia Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=619025	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=619025&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search			162731633	485226338							1	MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT		Prolyl hydroxylase EGLN2	EGLN2_HUMAN	Q96KS0	A8K5S0 Q8WWY4 Q9BV14																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1320914	Cc1c(O)c(ncc1Oc1ccccc1)C(=O)NCC(O)=O	InChI=1S/C15H14N2O5/c1-9-11(22-10-5-3-2-4-6-10)7-16-13(14(9)20)15(21)17-8-12(18)19/h2-7,20H,8H2,1H3,(H,17,21)(H,18,19)	IZKSLSVNLIMACC-UHFFFAOYSA-N	619003	US20230295110, Compound 57.::US20230295110, Compound 35.	Egl nine homolog 1	Homo sapiens		 5500							US Patent		10.7270/Q22V2M76		aid1919747	US20230295110	BLAISDELL, TP; ALLU, SR; FLEMING, PE	9/21/2023	10/30/2023	Akebia Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=619003	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5440&target=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=619003&enzyme=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search			162731467	485226318							1	MANDSGGPGGPSPSERDRQYCELCGKMENLLRCSRCRSSFYCCKEHQRQDWKKHKLVCQGSEGALGHGVGPHQHSGPAPPAAVPPPRAGAREPRKAAARRDNASGDAAKGKVKAKPPADPAAAASPCRAAAGGQGSAVAAEAEPGKEEPPARSSLFQEKANLYPPSNTPGDALSPGGGLRPNGQTKPLPALKLALEYIVPCMNKHGICVVDDFLGKETGQQIGDEVRALHDTGKFTDGQLVSQKSDSSKDIRGDKITWIEGKEPGCETIGLLMSSMDDLIRHCNGKLGSYKINGRTKAMVACYPGNGTGYVRHVDNPNGDGRCVTCIYYLNKDWDAKVSGGILRIFPEGKAQFADIEPKFDRLLFFWSDRRNPHEVQPAYATRYAITVWYFDADERARAKVKYLTGEKGVRVELNKPSDSVGKDVF	6YW0,6YVZ,6YVX,6YVW,6YVT,5OX6,5OX5,5A3U,4BQY,4BQX,4BQW,2Y34,2Y33,8Y0V,7UJV,3HQU,2G1M,5LA9,5L9V,8Z33,8Z32,2HBU,2HBT,2G19,3OUJ,3OUH,5V18,8Q6E,8Q6D,8Q5S,7Q5X,7Q5V,6YW3,6YW2,6YW1,6ST3,6QGV,6ZBO,6ZBN,8J1K,8Z35,8Z31,6NMQ,3OUI	Egl nine homolog 1	EGLN1_HUMAN	Q9GZT9	Q8N3M8 Q9BZS8 Q9BZT0		hypoxia-inducible factor-proline dioxygenase	R4SCQ0_HUMAN	R4SCQ0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
1320915	Cc1c(O)c(ncc1Oc1ccccc1)C(=O)NCC(O)=O	InChI=1S/C15H14N2O5/c1-9-11(22-10-5-3-2-4-6-10)7-16-13(14(9)20)15(21)17-8-12(18)19/h2-7,20H,8H2,1H3,(H,17,21)(H,18,19)	IZKSLSVNLIMACC-UHFFFAOYSA-N	619003	US20230295110, Compound 57.::US20230295110, Compound 35.	Prolyl hydroxylase EGLN2	Homo sapiens		 550							US Patent		10.7270/Q22V2M76		aid1919747	US20230295110	BLAISDELL, TP; ALLU, SR; FLEMING, PE	9/21/2023	10/30/2023	Akebia Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=619003	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=619003&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search			162731467	485226318							1	MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT		Prolyl hydroxylase EGLN2	EGLN2_HUMAN	Q96KS0	A8K5S0 Q8WWY4 Q9BV14																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1320916	Cc1c(Cc2ccccc2)cnc(C(=O)NCC(O)=O)c1O	InChI=1S/C16H16N2O4/c1-10-12(7-11-5-3-2-4-6-11)8-17-14(15(10)21)16(22)18-9-13(19)20/h2-6,8,21H,7,9H2,1H3,(H,18,22)(H,19,20)	NZUZMJFIRNIYKZ-UHFFFAOYSA-N	619027	US20230295110, Compound 58.	Egl nine homolog 1	Homo sapiens		 5500							US Patent		10.7270/Q22V2M76		aid1919747	US20230295110	BLAISDELL, TP; ALLU, SR; FLEMING, PE	9/21/2023	10/30/2023	Akebia Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=619027	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5440&target=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=619027&enzyme=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search			162731708	485226339							1	MANDSGGPGGPSPSERDRQYCELCGKMENLLRCSRCRSSFYCCKEHQRQDWKKHKLVCQGSEGALGHGVGPHQHSGPAPPAAVPPPRAGAREPRKAAARRDNASGDAAKGKVKAKPPADPAAAASPCRAAAGGQGSAVAAEAEPGKEEPPARSSLFQEKANLYPPSNTPGDALSPGGGLRPNGQTKPLPALKLALEYIVPCMNKHGICVVDDFLGKETGQQIGDEVRALHDTGKFTDGQLVSQKSDSSKDIRGDKITWIEGKEPGCETIGLLMSSMDDLIRHCNGKLGSYKINGRTKAMVACYPGNGTGYVRHVDNPNGDGRCVTCIYYLNKDWDAKVSGGILRIFPEGKAQFADIEPKFDRLLFFWSDRRNPHEVQPAYATRYAITVWYFDADERARAKVKYLTGEKGVRVELNKPSDSVGKDVF	6YW0,6YVZ,6YVX,6YVW,6YVT,5OX6,5OX5,5A3U,4BQY,4BQX,4BQW,2Y34,2Y33,8Y0V,7UJV,3HQU,2G1M,5LA9,5L9V,8Z33,8Z32,2HBU,2HBT,2G19,3OUJ,3OUH,5V18,8Q6E,8Q6D,8Q5S,7Q5X,7Q5V,6YW3,6YW2,6YW1,6ST3,6QGV,6ZBO,6ZBN,8J1K,8Z35,8Z31,6NMQ,3OUI	Egl nine homolog 1	EGLN1_HUMAN	Q9GZT9	Q8N3M8 Q9BZS8 Q9BZT0		hypoxia-inducible factor-proline dioxygenase	R4SCQ0_HUMAN	R4SCQ0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
1320917	Cc1c(Cc2ccccc2)cnc(C(=O)NCC(O)=O)c1O	InChI=1S/C16H16N2O4/c1-10-12(7-11-5-3-2-4-6-11)8-17-14(15(10)21)16(22)18-9-13(19)20/h2-6,8,21H,7,9H2,1H3,(H,18,22)(H,19,20)	NZUZMJFIRNIYKZ-UHFFFAOYSA-N	619027	US20230295110, Compound 58.	Prolyl hydroxylase EGLN2	Homo sapiens		 550							US Patent		10.7270/Q22V2M76		aid1919747	US20230295110	BLAISDELL, TP; ALLU, SR; FLEMING, PE	9/21/2023	10/30/2023	Akebia Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=619027	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=619027&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search			162731708	485226339							1	MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT		Prolyl hydroxylase EGLN2	EGLN2_HUMAN	Q96KS0	A8K5S0 Q8WWY4 Q9BV14																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1320918	Cc1c(O)c(ncc1Sc1ccccc1)C(=O)NCC(O)=O	InChI=1S/C15H14N2O4S/c1-9-11(22-10-5-3-2-4-6-10)7-16-13(14(9)20)15(21)17-8-12(18)19/h2-7,20H,8H2,1H3,(H,17,21)(H,18,19)	RZCWCSDEDRWNKI-UHFFFAOYSA-N	619028	US20230295110, Compound 59.	Egl nine homolog 1	Homo sapiens		 5500							US Patent		10.7270/Q22V2M76		aid1919747	US20230295110	BLAISDELL, TP; ALLU, SR; FLEMING, PE	9/21/2023	10/30/2023	Akebia Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=619028	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5440&target=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=619028&enzyme=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search			162731501	485226340							1	MANDSGGPGGPSPSERDRQYCELCGKMENLLRCSRCRSSFYCCKEHQRQDWKKHKLVCQGSEGALGHGVGPHQHSGPAPPAAVPPPRAGAREPRKAAARRDNASGDAAKGKVKAKPPADPAAAASPCRAAAGGQGSAVAAEAEPGKEEPPARSSLFQEKANLYPPSNTPGDALSPGGGLRPNGQTKPLPALKLALEYIVPCMNKHGICVVDDFLGKETGQQIGDEVRALHDTGKFTDGQLVSQKSDSSKDIRGDKITWIEGKEPGCETIGLLMSSMDDLIRHCNGKLGSYKINGRTKAMVACYPGNGTGYVRHVDNPNGDGRCVTCIYYLNKDWDAKVSGGILRIFPEGKAQFADIEPKFDRLLFFWSDRRNPHEVQPAYATRYAITVWYFDADERARAKVKYLTGEKGVRVELNKPSDSVGKDVF	6YW0,6YVZ,6YVX,6YVW,6YVT,5OX6,5OX5,5A3U,4BQY,4BQX,4BQW,2Y34,2Y33,8Y0V,7UJV,3HQU,2G1M,5LA9,5L9V,8Z33,8Z32,2HBU,2HBT,2G19,3OUJ,3OUH,5V18,8Q6E,8Q6D,8Q5S,7Q5X,7Q5V,6YW3,6YW2,6YW1,6ST3,6QGV,6ZBO,6ZBN,8J1K,8Z35,8Z31,6NMQ,3OUI	Egl nine homolog 1	EGLN1_HUMAN	Q9GZT9	Q8N3M8 Q9BZS8 Q9BZT0		hypoxia-inducible factor-proline dioxygenase	R4SCQ0_HUMAN	R4SCQ0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
1320919	Cc1c(O)c(ncc1Sc1ccccc1)C(=O)NCC(O)=O	InChI=1S/C15H14N2O4S/c1-9-11(22-10-5-3-2-4-6-10)7-16-13(14(9)20)15(21)17-8-12(18)19/h2-7,20H,8H2,1H3,(H,17,21)(H,18,19)	RZCWCSDEDRWNKI-UHFFFAOYSA-N	619028	US20230295110, Compound 59.	Prolyl hydroxylase EGLN2	Homo sapiens		 550							US Patent		10.7270/Q22V2M76		aid1919747	US20230295110	BLAISDELL, TP; ALLU, SR; FLEMING, PE	9/21/2023	10/30/2023	Akebia Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=619028	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=619028&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search			162731501	485226340							1	MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT		Prolyl hydroxylase EGLN2	EGLN2_HUMAN	Q96KS0	A8K5S0 Q8WWY4 Q9BV14																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1320920	Cc1c(O)c(ncc1-c1cnn(c1)-c1ccc(Cl)cc1Cl)C(=O)NCC(O)=O	InChI=1S/C18H14Cl2N4O4/c1-9-12(6-21-16(17(9)27)18(28)22-7-15(25)26)10-5-23-24(8-10)14-3-2-11(19)4-13(14)20/h2-6,8,27H,7H2,1H3,(H,22,28)(H,25,26)	PUIRQSUNNLMZJL-UHFFFAOYSA-N	619029	US20230295110, Compound 60.	Egl nine homolog 1	Homo sapiens		<100							US Patent		10.7270/Q22V2M76		aid1919747	US20230295110	BLAISDELL, TP; ALLU, SR; FLEMING, PE	9/21/2023	10/30/2023	Akebia Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=619029	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5440&target=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=619029&enzyme=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search			162731602	485226341							1	MANDSGGPGGPSPSERDRQYCELCGKMENLLRCSRCRSSFYCCKEHQRQDWKKHKLVCQGSEGALGHGVGPHQHSGPAPPAAVPPPRAGAREPRKAAARRDNASGDAAKGKVKAKPPADPAAAASPCRAAAGGQGSAVAAEAEPGKEEPPARSSLFQEKANLYPPSNTPGDALSPGGGLRPNGQTKPLPALKLALEYIVPCMNKHGICVVDDFLGKETGQQIGDEVRALHDTGKFTDGQLVSQKSDSSKDIRGDKITWIEGKEPGCETIGLLMSSMDDLIRHCNGKLGSYKINGRTKAMVACYPGNGTGYVRHVDNPNGDGRCVTCIYYLNKDWDAKVSGGILRIFPEGKAQFADIEPKFDRLLFFWSDRRNPHEVQPAYATRYAITVWYFDADERARAKVKYLTGEKGVRVELNKPSDSVGKDVF	6YW0,6YVZ,6YVX,6YVW,6YVT,5OX6,5OX5,5A3U,4BQY,4BQX,4BQW,2Y34,2Y33,8Y0V,7UJV,3HQU,2G1M,5LA9,5L9V,8Z33,8Z32,2HBU,2HBT,2G19,3OUJ,3OUH,5V18,8Q6E,8Q6D,8Q5S,7Q5X,7Q5V,6YW3,6YW2,6YW1,6ST3,6QGV,6ZBO,6ZBN,8J1K,8Z35,8Z31,6NMQ,3OUI	Egl nine homolog 1	EGLN1_HUMAN	Q9GZT9	Q8N3M8 Q9BZS8 Q9BZT0		hypoxia-inducible factor-proline dioxygenase	R4SCQ0_HUMAN	R4SCQ0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
1320921	Cc1c(O)c(ncc1-c1cnn(c1)-c1ccc(Cl)cc1Cl)C(=O)NCC(O)=O	InChI=1S/C18H14Cl2N4O4/c1-9-12(6-21-16(17(9)27)18(28)22-7-15(25)26)10-5-23-24(8-10)14-3-2-11(19)4-13(14)20/h2-6,8,27H,7H2,1H3,(H,22,28)(H,25,26)	PUIRQSUNNLMZJL-UHFFFAOYSA-N	619029	US20230295110, Compound 60.	Prolyl hydroxylase EGLN2	Homo sapiens		<100							US Patent		10.7270/Q22V2M76		aid1919747	US20230295110	BLAISDELL, TP; ALLU, SR; FLEMING, PE	9/21/2023	10/30/2023	Akebia Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=619029	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=619029&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search			162731602	485226341							1	MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT		Prolyl hydroxylase EGLN2	EGLN2_HUMAN	Q96KS0	A8K5S0 Q8WWY4 Q9BV14																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1320922	Cc1c(CCc2ccccc2)cnc(C(=O)NCC(O)=O)c1O	InChI=1S/C17H18N2O4/c1-11-13(8-7-12-5-3-2-4-6-12)9-18-15(16(11)22)17(23)19-10-14(20)21/h2-6,9,22H,7-8,10H2,1H3,(H,19,23)(H,20,21)	JSSCISKACGHOBX-UHFFFAOYSA-N	619030	US20230295110, Compound 61.	Egl nine homolog 1	Homo sapiens		 550							US Patent		10.7270/Q22V2M76		aid1919747	US20230295110	BLAISDELL, TP; ALLU, SR; FLEMING, PE	9/21/2023	10/30/2023	Akebia Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=619030	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5440&target=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=619030&enzyme=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search			162731472	485226342							1	MANDSGGPGGPSPSERDRQYCELCGKMENLLRCSRCRSSFYCCKEHQRQDWKKHKLVCQGSEGALGHGVGPHQHSGPAPPAAVPPPRAGAREPRKAAARRDNASGDAAKGKVKAKPPADPAAAASPCRAAAGGQGSAVAAEAEPGKEEPPARSSLFQEKANLYPPSNTPGDALSPGGGLRPNGQTKPLPALKLALEYIVPCMNKHGICVVDDFLGKETGQQIGDEVRALHDTGKFTDGQLVSQKSDSSKDIRGDKITWIEGKEPGCETIGLLMSSMDDLIRHCNGKLGSYKINGRTKAMVACYPGNGTGYVRHVDNPNGDGRCVTCIYYLNKDWDAKVSGGILRIFPEGKAQFADIEPKFDRLLFFWSDRRNPHEVQPAYATRYAITVWYFDADERARAKVKYLTGEKGVRVELNKPSDSVGKDVF	6YW0,6YVZ,6YVX,6YVW,6YVT,5OX6,5OX5,5A3U,4BQY,4BQX,4BQW,2Y34,2Y33,8Y0V,7UJV,3HQU,2G1M,5LA9,5L9V,8Z33,8Z32,2HBU,2HBT,2G19,3OUJ,3OUH,5V18,8Q6E,8Q6D,8Q5S,7Q5X,7Q5V,6YW3,6YW2,6YW1,6ST3,6QGV,6ZBO,6ZBN,8J1K,8Z35,8Z31,6NMQ,3OUI	Egl nine homolog 1	EGLN1_HUMAN	Q9GZT9	Q8N3M8 Q9BZS8 Q9BZT0		hypoxia-inducible factor-proline dioxygenase	R4SCQ0_HUMAN	R4SCQ0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
1320923	Cc1c(CCc2ccccc2)cnc(C(=O)NCC(O)=O)c1O	InChI=1S/C17H18N2O4/c1-11-13(8-7-12-5-3-2-4-6-12)9-18-15(16(11)22)17(23)19-10-14(20)21/h2-6,9,22H,7-8,10H2,1H3,(H,19,23)(H,20,21)	JSSCISKACGHOBX-UHFFFAOYSA-N	619030	US20230295110, Compound 61.	Prolyl hydroxylase EGLN2	Homo sapiens		 550							US Patent		10.7270/Q22V2M76		aid1919747	US20230295110	BLAISDELL, TP; ALLU, SR; FLEMING, PE	9/21/2023	10/30/2023	Akebia Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=619030	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=619030&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search			162731472	485226342							1	MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT		Prolyl hydroxylase EGLN2	EGLN2_HUMAN	Q96KS0	A8K5S0 Q8WWY4 Q9BV14																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1320924	Cc1c(O)c(ncc1C#Cc1ccccc1)C(=O)NCC(O)=O	InChI=1S/C17H14N2O4/c1-11-13(8-7-12-5-3-2-4-6-12)9-18-15(16(11)22)17(23)19-10-14(20)21/h2-6,9,22H,10H2,1H3,(H,19,23)(H,20,21)	BMEAIFRIYWKTCD-UHFFFAOYSA-N	619031	US20230295110, Compound 62.	Egl nine homolog 1	Homo sapiens		<100							US Patent		10.7270/Q22V2M76		aid1919747	US20230295110	BLAISDELL, TP; ALLU, SR; FLEMING, PE	9/21/2023	10/30/2023	Akebia Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=619031	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5440&target=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=619031&enzyme=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search			162731506	485226343							1	MANDSGGPGGPSPSERDRQYCELCGKMENLLRCSRCRSSFYCCKEHQRQDWKKHKLVCQGSEGALGHGVGPHQHSGPAPPAAVPPPRAGAREPRKAAARRDNASGDAAKGKVKAKPPADPAAAASPCRAAAGGQGSAVAAEAEPGKEEPPARSSLFQEKANLYPPSNTPGDALSPGGGLRPNGQTKPLPALKLALEYIVPCMNKHGICVVDDFLGKETGQQIGDEVRALHDTGKFTDGQLVSQKSDSSKDIRGDKITWIEGKEPGCETIGLLMSSMDDLIRHCNGKLGSYKINGRTKAMVACYPGNGTGYVRHVDNPNGDGRCVTCIYYLNKDWDAKVSGGILRIFPEGKAQFADIEPKFDRLLFFWSDRRNPHEVQPAYATRYAITVWYFDADERARAKVKYLTGEKGVRVELNKPSDSVGKDVF	6YW0,6YVZ,6YVX,6YVW,6YVT,5OX6,5OX5,5A3U,4BQY,4BQX,4BQW,2Y34,2Y33,8Y0V,7UJV,3HQU,2G1M,5LA9,5L9V,8Z33,8Z32,2HBU,2HBT,2G19,3OUJ,3OUH,5V18,8Q6E,8Q6D,8Q5S,7Q5X,7Q5V,6YW3,6YW2,6YW1,6ST3,6QGV,6ZBO,6ZBN,8J1K,8Z35,8Z31,6NMQ,3OUI	Egl nine homolog 1	EGLN1_HUMAN	Q9GZT9	Q8N3M8 Q9BZS8 Q9BZT0		hypoxia-inducible factor-proline dioxygenase	R4SCQ0_HUMAN	R4SCQ0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
1320925	Cc1c(O)c(ncc1C#Cc1ccccc1)C(=O)NCC(O)=O	InChI=1S/C17H14N2O4/c1-11-13(8-7-12-5-3-2-4-6-12)9-18-15(16(11)22)17(23)19-10-14(20)21/h2-6,9,22H,10H2,1H3,(H,19,23)(H,20,21)	BMEAIFRIYWKTCD-UHFFFAOYSA-N	619031	US20230295110, Compound 62.	Prolyl hydroxylase EGLN2	Homo sapiens		<100							US Patent		10.7270/Q22V2M76		aid1919747	US20230295110	BLAISDELL, TP; ALLU, SR; FLEMING, PE	9/21/2023	10/30/2023	Akebia Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=619031	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=619031&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search			162731506	485226343							1	MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT		Prolyl hydroxylase EGLN2	EGLN2_HUMAN	Q96KS0	A8K5S0 Q8WWY4 Q9BV14																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1320926	Cc1c(O)c(ncc1-c1nnn(n1)-c1ccc(Cl)cc1)C(=O)NCC(O)=O	InChI=1S/C16H13ClN6O4/c1-8-11(6-18-13(14(8)26)16(27)19-7-12(24)25)15-20-22-23(21-15)10-4-2-9(17)3-5-10/h2-6,26H,7H2,1H3,(H,19,27)(H,24,25)	SEWPBSJNNRSZOV-UHFFFAOYSA-N	619032	US20230295110, Compound 63.	Egl nine homolog 1	Homo sapiens		<100							US Patent		10.7270/Q22V2M76		aid1919747	US20230295110	BLAISDELL, TP; ALLU, SR; FLEMING, PE	9/21/2023	10/30/2023	Akebia Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=619032	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5440&target=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=619032&enzyme=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search			162731702	485226344							1	MANDSGGPGGPSPSERDRQYCELCGKMENLLRCSRCRSSFYCCKEHQRQDWKKHKLVCQGSEGALGHGVGPHQHSGPAPPAAVPPPRAGAREPRKAAARRDNASGDAAKGKVKAKPPADPAAAASPCRAAAGGQGSAVAAEAEPGKEEPPARSSLFQEKANLYPPSNTPGDALSPGGGLRPNGQTKPLPALKLALEYIVPCMNKHGICVVDDFLGKETGQQIGDEVRALHDTGKFTDGQLVSQKSDSSKDIRGDKITWIEGKEPGCETIGLLMSSMDDLIRHCNGKLGSYKINGRTKAMVACYPGNGTGYVRHVDNPNGDGRCVTCIYYLNKDWDAKVSGGILRIFPEGKAQFADIEPKFDRLLFFWSDRRNPHEVQPAYATRYAITVWYFDADERARAKVKYLTGEKGVRVELNKPSDSVGKDVF	6YW0,6YVZ,6YVX,6YVW,6YVT,5OX6,5OX5,5A3U,4BQY,4BQX,4BQW,2Y34,2Y33,8Y0V,7UJV,3HQU,2G1M,5LA9,5L9V,8Z33,8Z32,2HBU,2HBT,2G19,3OUJ,3OUH,5V18,8Q6E,8Q6D,8Q5S,7Q5X,7Q5V,6YW3,6YW2,6YW1,6ST3,6QGV,6ZBO,6ZBN,8J1K,8Z35,8Z31,6NMQ,3OUI	Egl nine homolog 1	EGLN1_HUMAN	Q9GZT9	Q8N3M8 Q9BZS8 Q9BZT0		hypoxia-inducible factor-proline dioxygenase	R4SCQ0_HUMAN	R4SCQ0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
1320927	Cc1c(O)c(ncc1-c1nnn(n1)-c1ccc(Cl)cc1)C(=O)NCC(O)=O	InChI=1S/C16H13ClN6O4/c1-8-11(6-18-13(14(8)26)16(27)19-7-12(24)25)15-20-22-23(21-15)10-4-2-9(17)3-5-10/h2-6,26H,7H2,1H3,(H,19,27)(H,24,25)	SEWPBSJNNRSZOV-UHFFFAOYSA-N	619032	US20230295110, Compound 63.	Prolyl hydroxylase EGLN2	Homo sapiens		<100							US Patent		10.7270/Q22V2M76		aid1919747	US20230295110	BLAISDELL, TP; ALLU, SR; FLEMING, PE	9/21/2023	10/30/2023	Akebia Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=619032	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=619032&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search			162731702	485226344							1	MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT		Prolyl hydroxylase EGLN2	EGLN2_HUMAN	Q96KS0	A8K5S0 Q8WWY4 Q9BV14																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1320928	Cc1c(O)c(ncc1-c1nn[nH]n1)C(=O)NCC(O)=O	InChI=1S/C10H10N6O4/c1-4-5(9-13-15-16-14-9)2-11-7(8(4)19)10(20)12-3-6(17)18/h2,19H,3H2,1H3,(H,12,20)(H,17,18)(H,13,14,15,16)	SZAOYFJIEALNQB-UHFFFAOYSA-N	619033	US20230295110, Compound 64.	Egl nine homolog 1	Homo sapiens		 550							US Patent		10.7270/Q22V2M76		aid1919747	US20230295110	BLAISDELL, TP; ALLU, SR; FLEMING, PE	9/21/2023	10/30/2023	Akebia Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=619033	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5440&target=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=619033&enzyme=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search			162731774	485226345							1	MANDSGGPGGPSPSERDRQYCELCGKMENLLRCSRCRSSFYCCKEHQRQDWKKHKLVCQGSEGALGHGVGPHQHSGPAPPAAVPPPRAGAREPRKAAARRDNASGDAAKGKVKAKPPADPAAAASPCRAAAGGQGSAVAAEAEPGKEEPPARSSLFQEKANLYPPSNTPGDALSPGGGLRPNGQTKPLPALKLALEYIVPCMNKHGICVVDDFLGKETGQQIGDEVRALHDTGKFTDGQLVSQKSDSSKDIRGDKITWIEGKEPGCETIGLLMSSMDDLIRHCNGKLGSYKINGRTKAMVACYPGNGTGYVRHVDNPNGDGRCVTCIYYLNKDWDAKVSGGILRIFPEGKAQFADIEPKFDRLLFFWSDRRNPHEVQPAYATRYAITVWYFDADERARAKVKYLTGEKGVRVELNKPSDSVGKDVF	6YW0,6YVZ,6YVX,6YVW,6YVT,5OX6,5OX5,5A3U,4BQY,4BQX,4BQW,2Y34,2Y33,8Y0V,7UJV,3HQU,2G1M,5LA9,5L9V,8Z33,8Z32,2HBU,2HBT,2G19,3OUJ,3OUH,5V18,8Q6E,8Q6D,8Q5S,7Q5X,7Q5V,6YW3,6YW2,6YW1,6ST3,6QGV,6ZBO,6ZBN,8J1K,8Z35,8Z31,6NMQ,3OUI	Egl nine homolog 1	EGLN1_HUMAN	Q9GZT9	Q8N3M8 Q9BZS8 Q9BZT0		hypoxia-inducible factor-proline dioxygenase	R4SCQ0_HUMAN	R4SCQ0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
1320929	Cc1c(O)c(ncc1-c1nn[nH]n1)C(=O)NCC(O)=O	InChI=1S/C10H10N6O4/c1-4-5(9-13-15-16-14-9)2-11-7(8(4)19)10(20)12-3-6(17)18/h2,19H,3H2,1H3,(H,12,20)(H,17,18)(H,13,14,15,16)	SZAOYFJIEALNQB-UHFFFAOYSA-N	619033	US20230295110, Compound 64.	Prolyl hydroxylase EGLN2	Homo sapiens		 550							US Patent		10.7270/Q22V2M76		aid1919747	US20230295110	BLAISDELL, TP; ALLU, SR; FLEMING, PE	9/21/2023	10/30/2023	Akebia Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=619033	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=619033&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search			162731774	485226345							1	MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT		Prolyl hydroxylase EGLN2	EGLN2_HUMAN	Q96KS0	A8K5S0 Q8WWY4 Q9BV14																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1320930	Cc1c(O)c(ncc1-c1nnn(n1)-c1ccccc1)C(=O)NCC(O)=O	InChI=1S/C16H14N6O4/c1-9-11(7-17-13(14(9)25)16(26)18-8-12(23)24)15-19-21-22(20-15)10-5-3-2-4-6-10/h2-7,25H,8H2,1H3,(H,18,26)(H,23,24)	LVSISVYDJDILDW-UHFFFAOYSA-N	619034	US20230295110, Compound 65.	Egl nine homolog 1	Homo sapiens		<100							US Patent		10.7270/Q22V2M76		aid1919747	US20230295110	BLAISDELL, TP; ALLU, SR; FLEMING, PE	9/21/2023	10/30/2023	Akebia Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=619034	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5440&target=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=619034&enzyme=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search			162731687	485226346							1	MANDSGGPGGPSPSERDRQYCELCGKMENLLRCSRCRSSFYCCKEHQRQDWKKHKLVCQGSEGALGHGVGPHQHSGPAPPAAVPPPRAGAREPRKAAARRDNASGDAAKGKVKAKPPADPAAAASPCRAAAGGQGSAVAAEAEPGKEEPPARSSLFQEKANLYPPSNTPGDALSPGGGLRPNGQTKPLPALKLALEYIVPCMNKHGICVVDDFLGKETGQQIGDEVRALHDTGKFTDGQLVSQKSDSSKDIRGDKITWIEGKEPGCETIGLLMSSMDDLIRHCNGKLGSYKINGRTKAMVACYPGNGTGYVRHVDNPNGDGRCVTCIYYLNKDWDAKVSGGILRIFPEGKAQFADIEPKFDRLLFFWSDRRNPHEVQPAYATRYAITVWYFDADERARAKVKYLTGEKGVRVELNKPSDSVGKDVF	6YW0,6YVZ,6YVX,6YVW,6YVT,5OX6,5OX5,5A3U,4BQY,4BQX,4BQW,2Y34,2Y33,8Y0V,7UJV,3HQU,2G1M,5LA9,5L9V,8Z33,8Z32,2HBU,2HBT,2G19,3OUJ,3OUH,5V18,8Q6E,8Q6D,8Q5S,7Q5X,7Q5V,6YW3,6YW2,6YW1,6ST3,6QGV,6ZBO,6ZBN,8J1K,8Z35,8Z31,6NMQ,3OUI	Egl nine homolog 1	EGLN1_HUMAN	Q9GZT9	Q8N3M8 Q9BZS8 Q9BZT0		hypoxia-inducible factor-proline dioxygenase	R4SCQ0_HUMAN	R4SCQ0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
1320931	Cc1c(O)c(ncc1-c1nnn(n1)-c1ccccc1)C(=O)NCC(O)=O	InChI=1S/C16H14N6O4/c1-9-11(7-17-13(14(9)25)16(26)18-8-12(23)24)15-19-21-22(20-15)10-5-3-2-4-6-10/h2-7,25H,8H2,1H3,(H,18,26)(H,23,24)	LVSISVYDJDILDW-UHFFFAOYSA-N	619034	US20230295110, Compound 65.	Prolyl hydroxylase EGLN2	Homo sapiens		<100							US Patent		10.7270/Q22V2M76		aid1919747	US20230295110	BLAISDELL, TP; ALLU, SR; FLEMING, PE	9/21/2023	10/30/2023	Akebia Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=619034	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=619034&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search			162731687	485226346							1	MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT		Prolyl hydroxylase EGLN2	EGLN2_HUMAN	Q96KS0	A8K5S0 Q8WWY4 Q9BV14																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1320932	Cc1c(O)c(ncc1-c1cnn(c1)-c1cc(Cl)cc(Cl)c1)C(=O)NCC(O)=O	InChI=1S/C18H14Cl2N4O4/c1-9-14(6-21-16(17(9)27)18(28)22-7-15(25)26)10-5-23-24(8-10)13-3-11(19)2-12(20)4-13/h2-6,8,27H,7H2,1H3,(H,22,28)(H,25,26)	MJHCCFQPXKOCHS-UHFFFAOYSA-N	619035	US20230295110, Compound 66.	Egl nine homolog 1	Homo sapiens		<100							US Patent		10.7270/Q22V2M76		aid1919747	US20230295110	BLAISDELL, TP; ALLU, SR; FLEMING, PE	9/21/2023	10/30/2023	Akebia Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=619035	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5440&target=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=619035&enzyme=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search			162731659	485226347							1	MANDSGGPGGPSPSERDRQYCELCGKMENLLRCSRCRSSFYCCKEHQRQDWKKHKLVCQGSEGALGHGVGPHQHSGPAPPAAVPPPRAGAREPRKAAARRDNASGDAAKGKVKAKPPADPAAAASPCRAAAGGQGSAVAAEAEPGKEEPPARSSLFQEKANLYPPSNTPGDALSPGGGLRPNGQTKPLPALKLALEYIVPCMNKHGICVVDDFLGKETGQQIGDEVRALHDTGKFTDGQLVSQKSDSSKDIRGDKITWIEGKEPGCETIGLLMSSMDDLIRHCNGKLGSYKINGRTKAMVACYPGNGTGYVRHVDNPNGDGRCVTCIYYLNKDWDAKVSGGILRIFPEGKAQFADIEPKFDRLLFFWSDRRNPHEVQPAYATRYAITVWYFDADERARAKVKYLTGEKGVRVELNKPSDSVGKDVF	6YW0,6YVZ,6YVX,6YVW,6YVT,5OX6,5OX5,5A3U,4BQY,4BQX,4BQW,2Y34,2Y33,8Y0V,7UJV,3HQU,2G1M,5LA9,5L9V,8Z33,8Z32,2HBU,2HBT,2G19,3OUJ,3OUH,5V18,8Q6E,8Q6D,8Q5S,7Q5X,7Q5V,6YW3,6YW2,6YW1,6ST3,6QGV,6ZBO,6ZBN,8J1K,8Z35,8Z31,6NMQ,3OUI	Egl nine homolog 1	EGLN1_HUMAN	Q9GZT9	Q8N3M8 Q9BZS8 Q9BZT0		hypoxia-inducible factor-proline dioxygenase	R4SCQ0_HUMAN	R4SCQ0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
1320933	Cc1c(O)c(ncc1-c1cnn(c1)-c1cc(Cl)cc(Cl)c1)C(=O)NCC(O)=O	InChI=1S/C18H14Cl2N4O4/c1-9-14(6-21-16(17(9)27)18(28)22-7-15(25)26)10-5-23-24(8-10)13-3-11(19)2-12(20)4-13/h2-6,8,27H,7H2,1H3,(H,22,28)(H,25,26)	MJHCCFQPXKOCHS-UHFFFAOYSA-N	619035	US20230295110, Compound 66.	Prolyl hydroxylase EGLN2	Homo sapiens		<100							US Patent		10.7270/Q22V2M76		aid1919747	US20230295110	BLAISDELL, TP; ALLU, SR; FLEMING, PE	9/21/2023	10/30/2023	Akebia Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=619035	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=619035&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search			162731659	485226347							1	MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT		Prolyl hydroxylase EGLN2	EGLN2_HUMAN	Q96KS0	A8K5S0 Q8WWY4 Q9BV14																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1320934	Cc1c(O)c(ncc1-c1cnn(c1)-c1ccc(cc1)C(F)(F)F)C(=O)NCC(O)=O	InChI=1S/C19H15F3N4O4/c1-10-14(7-23-16(17(10)29)18(30)24-8-15(27)28)11-6-25-26(9-11)13-4-2-12(3-5-13)19(20,21)22/h2-7,9,29H,8H2,1H3,(H,24,30)(H,27,28)	DMUZDJZYVYMGGW-UHFFFAOYSA-N	619036	US20230295110, Compound 67.	Egl nine homolog 1	Homo sapiens		<100							US Patent		10.7270/Q22V2M76		aid1919747	US20230295110	BLAISDELL, TP; ALLU, SR; FLEMING, PE	9/21/2023	10/30/2023	Akebia Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=619036	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5440&target=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=619036&enzyme=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search			162731686	485226348							1	MANDSGGPGGPSPSERDRQYCELCGKMENLLRCSRCRSSFYCCKEHQRQDWKKHKLVCQGSEGALGHGVGPHQHSGPAPPAAVPPPRAGAREPRKAAARRDNASGDAAKGKVKAKPPADPAAAASPCRAAAGGQGSAVAAEAEPGKEEPPARSSLFQEKANLYPPSNTPGDALSPGGGLRPNGQTKPLPALKLALEYIVPCMNKHGICVVDDFLGKETGQQIGDEVRALHDTGKFTDGQLVSQKSDSSKDIRGDKITWIEGKEPGCETIGLLMSSMDDLIRHCNGKLGSYKINGRTKAMVACYPGNGTGYVRHVDNPNGDGRCVTCIYYLNKDWDAKVSGGILRIFPEGKAQFADIEPKFDRLLFFWSDRRNPHEVQPAYATRYAITVWYFDADERARAKVKYLTGEKGVRVELNKPSDSVGKDVF	6YW0,6YVZ,6YVX,6YVW,6YVT,5OX6,5OX5,5A3U,4BQY,4BQX,4BQW,2Y34,2Y33,8Y0V,7UJV,3HQU,2G1M,5LA9,5L9V,8Z33,8Z32,2HBU,2HBT,2G19,3OUJ,3OUH,5V18,8Q6E,8Q6D,8Q5S,7Q5X,7Q5V,6YW3,6YW2,6YW1,6ST3,6QGV,6ZBO,6ZBN,8J1K,8Z35,8Z31,6NMQ,3OUI	Egl nine homolog 1	EGLN1_HUMAN	Q9GZT9	Q8N3M8 Q9BZS8 Q9BZT0		hypoxia-inducible factor-proline dioxygenase	R4SCQ0_HUMAN	R4SCQ0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
1320935	Cc1c(O)c(ncc1-c1cnn(c1)-c1ccc(cc1)C(F)(F)F)C(=O)NCC(O)=O	InChI=1S/C19H15F3N4O4/c1-10-14(7-23-16(17(10)29)18(30)24-8-15(27)28)11-6-25-26(9-11)13-4-2-12(3-5-13)19(20,21)22/h2-7,9,29H,8H2,1H3,(H,24,30)(H,27,28)	DMUZDJZYVYMGGW-UHFFFAOYSA-N	619036	US20230295110, Compound 67.	Prolyl hydroxylase EGLN2	Homo sapiens		<100							US Patent		10.7270/Q22V2M76		aid1919747	US20230295110	BLAISDELL, TP; ALLU, SR; FLEMING, PE	9/21/2023	10/30/2023	Akebia Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=619036	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=619036&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search			162731686	485226348							1	MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT		Prolyl hydroxylase EGLN2	EGLN2_HUMAN	Q96KS0	A8K5S0 Q8WWY4 Q9BV14																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1320936	Cc1c(O)c(ncc1-c1cnn(c1)-c1ccc(Cl)cc1)C(=O)NCC(O)=O	InChI=1S/C18H15ClN4O4/c1-10-14(7-20-16(17(10)26)18(27)21-8-15(24)25)11-6-22-23(9-11)13-4-2-12(19)3-5-13/h2-7,9,26H,8H2,1H3,(H,21,27)(H,24,25)	RBYPSCPUADDVQE-UHFFFAOYSA-N	619037	US20230295110, Compound 68.	Egl nine homolog 1	Homo sapiens		<100							US Patent		10.7270/Q22V2M76		aid1919747	US20230295110	BLAISDELL, TP; ALLU, SR; FLEMING, PE	9/21/2023	10/30/2023	Akebia Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=619037	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5440&target=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=619037&enzyme=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search			162731552	485226349							1	MANDSGGPGGPSPSERDRQYCELCGKMENLLRCSRCRSSFYCCKEHQRQDWKKHKLVCQGSEGALGHGVGPHQHSGPAPPAAVPPPRAGAREPRKAAARRDNASGDAAKGKVKAKPPADPAAAASPCRAAAGGQGSAVAAEAEPGKEEPPARSSLFQEKANLYPPSNTPGDALSPGGGLRPNGQTKPLPALKLALEYIVPCMNKHGICVVDDFLGKETGQQIGDEVRALHDTGKFTDGQLVSQKSDSSKDIRGDKITWIEGKEPGCETIGLLMSSMDDLIRHCNGKLGSYKINGRTKAMVACYPGNGTGYVRHVDNPNGDGRCVTCIYYLNKDWDAKVSGGILRIFPEGKAQFADIEPKFDRLLFFWSDRRNPHEVQPAYATRYAITVWYFDADERARAKVKYLTGEKGVRVELNKPSDSVGKDVF	6YW0,6YVZ,6YVX,6YVW,6YVT,5OX6,5OX5,5A3U,4BQY,4BQX,4BQW,2Y34,2Y33,8Y0V,7UJV,3HQU,2G1M,5LA9,5L9V,8Z33,8Z32,2HBU,2HBT,2G19,3OUJ,3OUH,5V18,8Q6E,8Q6D,8Q5S,7Q5X,7Q5V,6YW3,6YW2,6YW1,6ST3,6QGV,6ZBO,6ZBN,8J1K,8Z35,8Z31,6NMQ,3OUI	Egl nine homolog 1	EGLN1_HUMAN	Q9GZT9	Q8N3M8 Q9BZS8 Q9BZT0		hypoxia-inducible factor-proline dioxygenase	R4SCQ0_HUMAN	R4SCQ0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
1320937	Cc1c(O)c(ncc1-c1cnn(c1)-c1ccc(Cl)cc1)C(=O)NCC(O)=O	InChI=1S/C18H15ClN4O4/c1-10-14(7-20-16(17(10)26)18(27)21-8-15(24)25)11-6-22-23(9-11)13-4-2-12(19)3-5-13/h2-7,9,26H,8H2,1H3,(H,21,27)(H,24,25)	RBYPSCPUADDVQE-UHFFFAOYSA-N	619037	US20230295110, Compound 68.	Prolyl hydroxylase EGLN2	Homo sapiens		<100							US Patent		10.7270/Q22V2M76		aid1919747	US20230295110	BLAISDELL, TP; ALLU, SR; FLEMING, PE	9/21/2023	10/30/2023	Akebia Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=619037	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=619037&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search			162731552	485226349							1	MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT		Prolyl hydroxylase EGLN2	EGLN2_HUMAN	Q96KS0	A8K5S0 Q8WWY4 Q9BV14																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1320938	OC(=O)CNC(=O)c1ncc(-c2cccc(Cl)c2)c(C2CC2)c1O	InChI=1S/C17H15ClN2O4/c18-11-3-1-2-10(6-11)12-7-19-15(17(24)20-8-13(21)22)16(23)14(12)9-4-5-9/h1-3,6-7,9,23H,4-5,8H2,(H,20,24)(H,21,22)	OUEBQGNQVJFGFO-UHFFFAOYSA-N	619038	US20230295110, Compound 69.	Egl nine homolog 1	Homo sapiens		 550							US Patent		10.7270/Q22V2M76		aid1919747	US20230295110	BLAISDELL, TP; ALLU, SR; FLEMING, PE	9/21/2023	10/30/2023	Akebia Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=619038	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5440&target=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=619038&enzyme=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search			162731568	485226350							1	MANDSGGPGGPSPSERDRQYCELCGKMENLLRCSRCRSSFYCCKEHQRQDWKKHKLVCQGSEGALGHGVGPHQHSGPAPPAAVPPPRAGAREPRKAAARRDNASGDAAKGKVKAKPPADPAAAASPCRAAAGGQGSAVAAEAEPGKEEPPARSSLFQEKANLYPPSNTPGDALSPGGGLRPNGQTKPLPALKLALEYIVPCMNKHGICVVDDFLGKETGQQIGDEVRALHDTGKFTDGQLVSQKSDSSKDIRGDKITWIEGKEPGCETIGLLMSSMDDLIRHCNGKLGSYKINGRTKAMVACYPGNGTGYVRHVDNPNGDGRCVTCIYYLNKDWDAKVSGGILRIFPEGKAQFADIEPKFDRLLFFWSDRRNPHEVQPAYATRYAITVWYFDADERARAKVKYLTGEKGVRVELNKPSDSVGKDVF	6YW0,6YVZ,6YVX,6YVW,6YVT,5OX6,5OX5,5A3U,4BQY,4BQX,4BQW,2Y34,2Y33,8Y0V,7UJV,3HQU,2G1M,5LA9,5L9V,8Z33,8Z32,2HBU,2HBT,2G19,3OUJ,3OUH,5V18,8Q6E,8Q6D,8Q5S,7Q5X,7Q5V,6YW3,6YW2,6YW1,6ST3,6QGV,6ZBO,6ZBN,8J1K,8Z35,8Z31,6NMQ,3OUI	Egl nine homolog 1	EGLN1_HUMAN	Q9GZT9	Q8N3M8 Q9BZS8 Q9BZT0		hypoxia-inducible factor-proline dioxygenase	R4SCQ0_HUMAN	R4SCQ0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
1320939	OC(=O)CNC(=O)c1ncc(-c2cccc(Cl)c2)c(C2CC2)c1O	InChI=1S/C17H15ClN2O4/c18-11-3-1-2-10(6-11)12-7-19-15(17(24)20-8-13(21)22)16(23)14(12)9-4-5-9/h1-3,6-7,9,23H,4-5,8H2,(H,20,24)(H,21,22)	OUEBQGNQVJFGFO-UHFFFAOYSA-N	619038	US20230295110, Compound 69.	Prolyl hydroxylase EGLN2	Homo sapiens		 550							US Patent		10.7270/Q22V2M76		aid1919747	US20230295110	BLAISDELL, TP; ALLU, SR; FLEMING, PE	9/21/2023	10/30/2023	Akebia Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=619038	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=619038&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search			162731568	485226350							1	MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT		Prolyl hydroxylase EGLN2	EGLN2_HUMAN	Q96KS0	A8K5S0 Q8WWY4 Q9BV14																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1320940	OC(=O)CNC(=O)c1ncc(-c2cccc(Cl)c2)c(C(F)F)c1O	InChI=1S/C15H11ClF2N2O4/c16-8-3-1-2-7(4-8)9-5-19-12(13(23)11(9)14(17)18)15(24)20-6-10(21)22/h1-5,14,23H,6H2,(H,20,24)(H,21,22)	GDJSRSCDJMQVEW-UHFFFAOYSA-N	619039	US20230295110, Compound 70.	Egl nine homolog 1	Homo sapiens		 550							US Patent		10.7270/Q22V2M76		aid1919747	US20230295110	BLAISDELL, TP; ALLU, SR; FLEMING, PE	9/21/2023	10/30/2023	Akebia Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=619039	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5440&target=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=619039&enzyme=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search			162731735	485226351							1	MANDSGGPGGPSPSERDRQYCELCGKMENLLRCSRCRSSFYCCKEHQRQDWKKHKLVCQGSEGALGHGVGPHQHSGPAPPAAVPPPRAGAREPRKAAARRDNASGDAAKGKVKAKPPADPAAAASPCRAAAGGQGSAVAAEAEPGKEEPPARSSLFQEKANLYPPSNTPGDALSPGGGLRPNGQTKPLPALKLALEYIVPCMNKHGICVVDDFLGKETGQQIGDEVRALHDTGKFTDGQLVSQKSDSSKDIRGDKITWIEGKEPGCETIGLLMSSMDDLIRHCNGKLGSYKINGRTKAMVACYPGNGTGYVRHVDNPNGDGRCVTCIYYLNKDWDAKVSGGILRIFPEGKAQFADIEPKFDRLLFFWSDRRNPHEVQPAYATRYAITVWYFDADERARAKVKYLTGEKGVRVELNKPSDSVGKDVF	6YW0,6YVZ,6YVX,6YVW,6YVT,5OX6,5OX5,5A3U,4BQY,4BQX,4BQW,2Y34,2Y33,8Y0V,7UJV,3HQU,2G1M,5LA9,5L9V,8Z33,8Z32,2HBU,2HBT,2G19,3OUJ,3OUH,5V18,8Q6E,8Q6D,8Q5S,7Q5X,7Q5V,6YW3,6YW2,6YW1,6ST3,6QGV,6ZBO,6ZBN,8J1K,8Z35,8Z31,6NMQ,3OUI	Egl nine homolog 1	EGLN1_HUMAN	Q9GZT9	Q8N3M8 Q9BZS8 Q9BZT0		hypoxia-inducible factor-proline dioxygenase	R4SCQ0_HUMAN	R4SCQ0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
1320941	OC(=O)CNC(=O)c1ncc(-c2cccc(Cl)c2)c(C(F)F)c1O	InChI=1S/C15H11ClF2N2O4/c16-8-3-1-2-7(4-8)9-5-19-12(13(23)11(9)14(17)18)15(24)20-6-10(21)22/h1-5,14,23H,6H2,(H,20,24)(H,21,22)	GDJSRSCDJMQVEW-UHFFFAOYSA-N	619039	US20230295110, Compound 70.	Prolyl hydroxylase EGLN2	Homo sapiens		 550							US Patent		10.7270/Q22V2M76		aid1919747	US20230295110	BLAISDELL, TP; ALLU, SR; FLEMING, PE	9/21/2023	10/30/2023	Akebia Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=619039	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=619039&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search			162731735	485226351							1	MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT		Prolyl hydroxylase EGLN2	EGLN2_HUMAN	Q96KS0	A8K5S0 Q8WWY4 Q9BV14